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The delivery process of non-viral gene vectors through the cell face a number of barriers, many of 
which have not been fully characterised. A key limitation has been the inability to quantify the dynamic 
behaviour of delivered DNA as it traffics through the live cell. However, recent developments in the 
field of Fluorescence Correlation Spectroscopy (FCS) now provide a means to study the fluctuations of 
individual particles from image series. Such approaches have the ability of extract information on the 
dynamics and aggregation of fluorescently labelled particles. 
Throughout this thesis a series of image-based FCS approaches have been applied to gain a deeper 
understanding of DNA processing when delivered through lipofection. Across these studies DNA 
sequences of various lengths labelled with a small molecular probe were delivered into myoblast cells.  
Before this work, no previous studies have applied such techniques to the uptake of macromolecules, 
therefore, this thesis focuses on four major factors that are critical in gene delivery and cell biology; (i) 
how the DNA moves through the cell (RICS and iMSD), (ii) quantifying the aggregation of delivered 
DNA (N&B), (iii) determining the extent of degradation that occurs (ccRICS and ccN&B), and (iv) 
how the cellular physiology can affect the delivered DNA behaviour.  
The novel application of these techniques demonstrated that DNA processing exhibited a clear 
predefined pathway. Studies on the dynamics of the delivered DNA revealed that the rate of motion 
were similar across different DNA sizes, which also exhibited a spatial dependence on the transport 
mechanisms. The aggregation of delivered DNA was quantified for the first time, showing that 
extensive aggregation occurs throughout the cell and is influenced by the DNA size and sequence, and 
serum concentrations. The rate of degradation was explored, which has exhibited a slow rate of 
degradation in the lipoplex delivered DNA with a longer half-life compared to previous studies. 
Degradation was also shown to be dependent on a number of factors, including the amount of DNA 
present, aggregation, and the transport mechanism and location of the cell. Finally, the effects of 
membrane states was explored, demonstrating that the membrane plays a pivotal role in how the DNA 
is taken up, and behaves within the cell. 
The techniques applied to study the molecular mechanisms of delivered DNA, provide the opportunity 
to better understand the gene delivery process through the study of the dynamics of the cell. In 
addition, this work also presents a model to study the update and processing of other macromolecules. 
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1 Introduction 
 
 
Gene delivery or gene therapy involves the coupling of a nucleic acid sequences with a delivery 
vehicle, such as viruses or lipids, to facilitate uptake into the target cell. During the delivery of the 
exogenous nucleic acid sequences a number of obstacles are faced. As a result there has been a 
significant emphasis on developing an understanding of the processes involved. To date most studies 
have focused on limited time intervals or small regions of the cell, or fixed samples. Developing a real-
time, multi-level information approach to characterise the live cell responses to exogenous nucleic acid 
sequences is expected to underpin optimising Gene Therapy methodology. In addition, it is likely this 
approach could be applied to drug delivery and enhance our understanding of cellular processing.  
Fluorescence Correlation Spectroscopy (FCS) is one approach to analyse single molecules of 
extremely low concentration with high spatial and temporal resolution (for example, 600 particles are 
expected to be within the illumination volume at a given time in a 1 µM solution of a small molecule). 
Compared to other fluorescence-based approaches FCS measures the spontaneous intensity 
fluctuations caused by minute changes in particle behaviour, rather than relying on the emission 
intensity of fluorescence. Fundamentally, FCS has the potential to measure and fully quantify all 
physical processes occurring in a cell that give rise to fluctuations in the fluorescence signal including 
mobility and aggregation. 
Although a powerful technique, a significant limitation in the FCS approach is that only a single, 
small volume can be observed at one given time. Therefore, several approaches have been devised that 
involve scanning the FCS volume across a sample essentially obtaining a large number of FCS 
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measurements in the form of an image. Such approaches have demonstrated their potential to extract 
information on mobility, aggregation and molecular interactions 1-4. In addition, the approach requires a 
process where the particle of interest must be fluorescently labelled. 
FCS based approaches now offer a means of further characterising the delivery of therapeutic 
molecules, including but not limited to synthetic drugs, gene delivery vectors and other nanoparticles, 
or potentially detrimental amalgams such as toxins or viruses, all of which have the potential to be 
labelled with small fluorescence tags. Therefore, this study aims to fill this void by studying 
macromolecule delivery through the application of FCS-based techniques including: 
? Raster Image Correlation Spectroscopy (RICS),  
? Number and Molecular Brightness (N&B), 
? Image-based Means Square Displacement (iMSD), and 
? Spectral phasor 
For this study the non-viral gene delivery approach, lipofection, has been used as a model, as 
lipoplexes (the composition of DNA and lipids) have the potential to be a relevant model for other 
delivery systems. This thesis has been structured to first provide an insight into the principle concepts 
of FCS, followed by an in depth review of processes for lipoplex delivery through the cell. The relevant 
background for each bioimaging tool is introduced at the beginning of the respective chapter, which 
address critical factors that can influence gene delivery outcomes: Including mobility and dynamics, 
aggregation, degradation, and how the cell physiology can affect them. 
 1.1 Fluorescence Correlation Spectroscopy 
Fluorescence Correlation Spectroscopy (FCS), or point-FCS, is a sensitive technique that was 
initially developed to study the dynamic processes of fluorescently labelled molecules within 
equilibrium environments 5. The technique provides information of many molecules at a single 
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molecule level and, by averaging the behaviour of the molecules enable comprehensive statistical data 
and analysis 6. 
The principles and concepts of FCS were first developed in the 1970’s by Magde et al. (1972) 
who studied the binding of ethidium bromide to double stranded DNA 7. Although the principles of 
the technique were established they could not be applied due to limited technology. The necessary 
technology for FCS, developed in the 1990’s, included the confocal microscope and efficient photon 
detectors 5,6,8. 
The FCS field was originally derived from the dynamic light scattering technique 6, which 
depends on the scattering of light from particles within the volume of a sample 9. Instead, FCS takes 
advantage of fluorescence fluctuations emitted from fluorophores passing through a small illumination 
volume 6. A small open-volume is created by focusing a laser beam into a sample (termed, Point Spread 
Function (PSF), beam waist, or ω) 5. Within the confocal volume, fluorophores will be excited resulting 
in a burst of fluorescence photons (or signals) (Figure 1.1). Time courses of fluctuations contain 
information on the dynamic processes and chemical kinetics of the molecules within the defined 
illumination volume (Figure 1.2). Molecules will enter and/or exit the excitation volume, leading to 
changes in the fluorescence signals that are detected 5. The FCS technique is sufficiently sensitive to 
detect single molecules within the excitation volume 6.  
Figure 1.1 – A Single  Molecule  in FCS Il luminat ion Volume 
As a molecule (green) moves in a solution via Brownian motion it passes though the 
volume of excitation (red) and fluoresces to emit photons, which are detected as statistical 
signals. (Sourced from Digman and Gratton, 2011 6) 
 
 
 
 
 
The FCS analysis is commonly achieved by applying correlation functions, however a number 
of other methods and approaches have also been proposed 6,10,11. This project focused on using the 
correlation function approach, in which two aspects are calculated in a fluctuation record 6. The first 
CHAPTER ONE: INTRODUCTION 
 
INTRODUCTION  4 
aspect is the determination of the temporal spectrum of fluctuations through the application of the 
Autocorrelation Function (ACF) approach 6. The second aspect applies the Photon Counting 
Histogram (PCH) (or fluctuation intensity distribution analysis) in order to analyse the amplitude 
spectrum of the fluctuation range 6 (Figure 1.2). 
 
 
 
 
 
 
 
 
 
Figure 1.2 – Fluorescence  Corre lat ion Spectroscopy Data and Analys is  
 
Fluctuations in photons are counted over time (A), the analysis of these fluctuations of the sampling period enables the rate 
of motion to be calculated through the autocorrelation function 𝐺𝐺(𝜏𝜏) (B) and provides the photon counting histogram 
(PCH) analysis (C). (Sourced from Digman and Gratton, 2011 6) 
 
The diffusion constant for translational movement is calculated from the ACF (𝐺𝐺(𝜏𝜏)), which 
relates to the fluorescence intensity (F) at a given time (𝑡𝑡) to the given 𝜏𝜏 seconds later: 
𝐺𝐺 𝜏𝜏 =   
𝛿𝛿𝛿𝛿 𝑡𝑡 ∙ 𝛿𝛿𝛿𝛿   𝑡𝑡 + 𝜏𝜏
𝐼𝐼 𝑡𝑡 ?
 
Equation 1 -  Normalised Autocorre lat ion Funct ion 
where 𝛿𝛿𝛿𝛿 denotes the fluctuation of the fluorescence intensity around the mean value 𝐼𝐼 𝑡𝑡  5,6. 
The PCH approach focuses on the probability distribution to detect photons per sample time. 
The distribution of the detected photons enables the characterisation of the average number of 
molecules (N) and the molecular brightness (𝜀𝜀) of a fluorescence fluctuation experiment 12.  
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 1.1.1 Scanning Corre lat ion Spec troscopy 
A significant limitation of FCS is the inability to acquire spatial information on the fluctuations 
occurring outside of the relatively small measured volume. Many processes involved in chemistry, 
physics and biology require spatial details. However, by moving the excitation volume in a defined 
pattern (i.e. a circular orbit, raster scan or straight line), at a rate that is relative to the movement of the 
molecules during the defined period, will provide a record of the intensity fluctuations and will contain 
spatial information about where these fluctuations have occurred within a sample. Since scanning 
introduces a spatial and temporal structure to the observation, both the spatial and temporal 
information can be extracted and related to the physical processes that have occurred in biological 
systems, such as mammalian cells 6.  
Scanning FCS entails the acquisition along a specific pattern, by the laser, over a sample in a 
laser scanning microscope 6. The principle of scanning FCS is to calculate the Spatial Auto-Correlation 
Function (SACF) of a data series or an image. Within the cell, the technique provides information on 
the mobility, degree of aggregation and number of fluorescently labelled molecules 6. 
The concept of extending FCS to study images has resulted in the development of a number of 
bioimaging tools, which include (but are not limited to) the Raster Image Correlation Spectroscopy 
(RICS), image-based Means Square Displacement (iMSD) and Number and molecular Brightness 
(N&B) approaches, all of which are applied throughout this project; enabling the determination of 
mobility rates, mechanisms of motion and degree of aggregation, respectively. 
 1.2  Intracellular Trafficking of Nucleic Acid Sequences 
Gene delivery involves the trafficking of the introduced nucleic acid sequences, coupled with a 
vector, through the cellular milieu within the cytoplasm, the nucleus or another organelle, depending on 
its fate, which may include nucleic acid degradation, recycling, toxic build up, and expulsion.  During 
gene trafficking, the nucleic acids are expected to encounter a number of obstacles, which are the cause 
of many limitations in current gene therapy approaches, many of which have yet to be fully 
characterized in real time.   
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Figure 1.3 – Traf f i cking Overview of  Non-viral  Gene Del ivery  
 
Firstly, the vector encounters the extra-cellular matrix where it may be immobilized by certain compounds within the 
matrix (such as albumin).  During entry into the cell, the vector interacts with membrane receptors or membrane 
compounds leading to the internalization of the vector complex, a similar process occurs for some viruses.  However, the 
vector can be internalised through mechanical means, such as electroporation. The vector is transported within a vesicle to 
fuse with early endosomes, where it is either released back out of the cell or further processed into late endosomes.  The 
vector must escape from the endosome, be transported along the microtubule network and then enters the nucleus either 
during mitosis or through a nuclear pore complex after interacting with cytoplasmic components. (Sourced from Vaughan 
et al. 2006 13) 
 
 
Initially, the nucleic acid will encounter the extracellular matrix (ECM) (unless it is directly inserted into 
the cell through microinjection).  It then must enter the cell through the plasma membrane, most likely 
via endocytosis, and if internalized through endocytosis, the nucleic acid sequences appear to become 
entrapped within membrane bound vesicles, known as endosomes, and risk being degraded by 
lysosomes.   
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It is not certain if the nucleic acid sequences are transported towards the peri-nuclear region 
within endosomes or free within the cytoplasm, regardless, it has been established that transportation is 
achieved through the exploitation of the microtubule network and motor proteins 14.  If targeted for 
the nucleus, the nucleic acid sequences must transverse the nuclear envelope, which has been identified 
as the most significant physical barrier to non-viral gene delivery 15.  Once within the nucleus, which is 
maintained as a complex and organized structure, the nucleic acid sequences may induce the desired 
effect on the cell’s expression profile. Due to the approaches employed by this project, the main focus 
is on trafficking of synthetic non-viral vectors. A pictorial overview of the gene trafficking process is 
shown above (Figure 1.3). 
 1.3 Gene Therapy Vectors 
The primary role of a gene therapy vector is to provide the delivered nucleic acid sequence 
passage in the cell, in particular a route through the plasma membrane into the cytoplasm. Initially, 
gene transfer started with basic mechanisms of nucleic acid sequence delivery but rapidly evolved 
applying specialized viruses, polymers and lipids. Due to the interest in gene therapy, an abundance of 
vectors have been developed, optimized and applied 16. These vectors can be placed in two main 
categories: viral vectors, and non-viral vectors (further subdivided into physical mechanisms and 
synthetic vectors).  
 1.3.1 Viral  Vectors  
Viral vectors are a class of viruses exploited to deliver foreign nucleic acid sequences into 
targeted cells.  To-date, viral vectors have been the most commonly applied vectors in clinical trials.  
Viruses have had millennia to develop efficient nucleic acid sequence transfer into mammalian cells. 
Viruses can now be commercially engineered to contain foreign nucleic acid sequences within their 
genomes’.  Then through the viruses’ natural mechanisms, the foreign nucleic acid sequences can be 
delivered to the targeted cell with relative efficiency 17.   
Viral vectors can be: integrating vectors (which insert their genome into the host’s genome), 
and non-integrating vectors (whose genomes persist within the cell’s nucleus usually (but not always) as 
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an extrachromosomal episome) 17,18.  Common viral vectors include (but are not limited to) 
retroviruses, lentiviruses, adenoviruses, adeno-associated viruses and herpes simplex viruses. 
 1.3.2 Non-Viral  Vectors  
Non-viral gene therapy vectors are those not utilizing live viruses and can be: (i) physical forces 
or methods, and (ii) chemical-based vectors.  Non-viral gene therapy offers a number of advantages 
over viral vectors including being less immunogenic 19 and having no size limit of the nucleic acid that 
must be delivered 16.  Non-viral vectors are also generally time and cost efficient to produce, with the 
potential for repeated administration when non-immunogenic 19.  Non-viral vectors have not been 
generally regarded as efficient as their viral counterparts.  Non-viral vectors offer the potential to 
deliver to many different cell types and culture systems, making them a feasible approach for ex vivo 
applications. However, there has been little success achieving efficient and safe gene transfer in vivo 16. 
 Physical & Mechanical Mechanisms 
A large number and array of physical or mechanical methods of transferring nucleic acid 
sequences have emerged in gene therapy over the past few decades and include (but are not limited to) 
direct injection of the naked nucleic acid, transfer by Gene Gun, Electroporation, Optoporation, 
Sonoporation and Hydrodynamic gene transfer.  The main aim of many physical methods of gene 
delivery is to by-pass cellular membranes and generally utilize ‘naked’ nucleic acid sequences, such as 
direct injection, which involves the injection of the nucleic acid into the tissue or cells of interest 20,21.    
 Chemical-based or Synthetic vectors 
Chemical-based or synthetic vectors are by far the most popular non-viral gene therapy strategy 
and applications to date.  The approach of synthetic non-viral gene therapy involves the packaging of 
naked nucleic acid sequences (most commonly plasmid DNA) with either cationic lipids (lipoplex), or 
polymers (either synthetic or organic) (polyplex), or a combination of both (lipopolyplex) 16.  The 
cationic chemical vector forms condensed complexes with the negatively charged nucleic acids through 
electrostatic interactions, which then facilitate the nucleic acid in trafficking into and through the cell 
16,19. 
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 Cationic Lipids (Lipoplex) 
Cationic lipid-based gene transfer was first pioneered by Felgner and colleagues in 1987 22.  
Forming lipoplexes with nucleic acids, liposome-mediated gene delivery (also termed lipofection) is the 
most extensively researched and commonly used non-viral gene therapy approach in use.  Since 1987, 
hundreds of different lipids have been developed, however, they all share the common structure of a 
positively charged hydrophilic head and hydrophobic tail that are connected by a linker structure.  The 
positively charged head group, usually composed of primary, secondary, tertiary amines or quaternary 
ammonium salts, is necessary for binding to the negatively charged phosphate backbone in nucleic 
acids.  The hydrophobic tails are usually composed of two types of hydrophobic moieties, aliphatic 
chains, cholesterol or other types of steroid rings.  The linker between the heads and tails are 
commonly ester, carbamate, or amide bonds, which reflect the rate of biodegradability of the lipid and 
therefore, the toxicity of the vector 22. 
Transfection efficiencies of lipofection varies dramatically depending on the structure of the 
cationic lipid, including the overall geometric shape, the number of charged groups per molecule, the 
nature of the lipid anchor, and the linker bondage; the charge ratio used to form lipoplexes, and the 
properties of any colipid (helper lipid) used 23.  Upon mixing the nucleic acid with the cationic lipids, 
lipoplexes spontaneously form.  The process involves two steps, first an initial and rapid association of 
the cationic liposomes and anionic DNA through electrostatic interactions, then followed by a slower 
lipid rearrangement process 24.  Forming the compacted structure called a lipoplex, the nucleic acid 
molecules are surrounded by the positively charged lipids.  Lipoplexes come in various forms, 
influenced by the packing parameter (P), which is defined as the ratio of the hydrophilic head volume 
and the length of the hydrophobic tail 25.  When the value of P is at or very close to 1, the nucleic acid 
molecules lends to be sandwiched between cationic lipid bilayers (𝐿𝐿?? ) (Figure 1.4A).  When above a P 
value of 1, the lipids will form inverted micelle or inverted hexagonal structures, in which the nucleic 
acid will be internal and separated from the external environment (Figure 1.4B).  For a P value less than 
0.3 a micelle structure is expected to form and when between 0.3 to 1, a hexagonal structure should 
form, in which the nucleic acid will be bound to the external surface of the lipoplex (Figure 1.4C) 26,27. 
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Figure 1.4 – Phase Structure o f  Lipoplexes 
based on the ir  Packing Parameter   
Lipoplexes contain three regions: hydrophilic head (in 
red), hydrophobic tail (in grey) and linker.  The 
structure of the lipid is based on the packing parameter 
P, which is defined as the ratio of the hydrophilic head 
volume and the length of the hydrophobic tail. When 
the P value at or very close to 1, the nucleic acid 
molecules (in blue) lend to be sandwiched between 
cationic lipid bilayers (𝐿𝐿?? ).  As the values becomes 
greater than 1 the lipids will form a inverted hexagonal 
structure (𝐻𝐻??
? ), in which the nucleic acid will be 
internal.  For a P value between 0.3-1, a hexagonal 
structure should form, in which the nucleic acid will be 
bound to the external surface of the lipoplex. (Sourced 
from Tresset, 2009 28) 
 
 
 
 
 
 
 
 
 
 Cationic Polymers (Polyplex) 
Cationic polymers are another class of chemical-based non-viral gene therapy vector which 
have been used extensively for gene transfer 19. Cationic polymer-based gene delivery utilizes cationic 
polymers, either synthetic or naturally occurring, that form nanosized complexes with nucleic acids 
(termed polyplexes) 19.  Typically polyplexes are more stable than lipoplexes 19.   
Poly-L-lysine (PLL) was one of the first cationic polymers to be used for in vivo gene transfer 29.  
However, like cationic lipid transfer, over the years a large number of carriers have been applied for 
both in vitro and in vivo gene delivery.  This class of vectors includes PLL 29,  polyethylenimine (PEI) 30-32, 
polyamidoamine 33, cationic dextran 34, chitosan 35, cationic proteins 36, and cationic peptides 37,38.  
Although most cationic polymers share the function of condensing DNA particles and facilitating their 
transfer into and through the cell, their transfection efficiency and cell toxicity differ dramatically 19. 
Transfection efficiency and toxicity of cationic polymers depends on the molecular weight, 
configuration, the charge ratio of the polymer to the DNA, and the biodegradability of the polymer 19. 
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 Nanoparticles 
An emerging class of non-viral vectors utilize inorganic nanoparticles.  Usually prepared with 
metals, including iron, gold and silver; inorganic salts or ceramics, such as phosphate or carbonate salts 
of calcium, magnesium or silicon, complexes are typically between 10 – 100 nm in diameter 39.  The 
surface of the nanoparticles are coated with the nucleic acid, which facilitates the uptake of the nucleic 
acid sequence transported into the cell through specific membrane receptors or nucleolin, thus 
delivering the nucleic acid sequence to the nucleus and by-passing endosomal/lysosomal degradation 40.  
Additionally due to the small size of these complexes, most physiological and cellular barriers are 
avoided, gene expression is generally higher (compared to other non-viral approaches), they tend to 
show little or no toxicity and typically do not activate an immune system response 41,42. 
 1.4 Extracellular Matrix 
Within the ECM, the nucleic acid sequence/vector complex is expected to face a number of 
obstacles.  Depending on the vector applied it may induce an immune response once within the body, 
which has demonstrated to have the potential to kill 43. If injected intravenously, the nucleic acid 
complex is expected to travel from the site of injection and through the vascular system to the heart 
and lungs. Then enter back through the circulatory system to reach the targeted tissue or organ 44-46. 
Once within the ECM, nucleic acid sequences complexed with cationic particles have a 
propensity to interact with endogenous proteins and other constituents, such as glycosaminoglcans 47, 
serum albumin 48, lipoproteins and immunoglobulins 49, when the vector complex is produced with an 
excess positive charge.  Additionally, positively charged nucleic acid/vector complexes often manifest 
in reduced colloidal stability, as the increased ionic strength encountered once introduced into the 
cellular environment may also have an effect on the complexes’ physical properties 50.  Physical studies 
demonstrated that the interaction of positively charged nucleic acid complexes and serum may results 
in a number of undesirable effects, including aggregation, ζ-potential neutralization, destabilization of 
the lipoplex structure leading to early nucleic acid release, and degradation 50,51. When complexes near 
charge neutrality, aggregation between the vector complexes is frequently observed 50.  When in vitro, 
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nucleic acid and cationic vector complexes may also bind non-specifically to cells, including 
erythrocytes, lymphocytes and endothelial cells, and to ECM proteins and components 49.  
The presence of nucleases within the extracellular milieu also pose a significant obstacle to in 
vivo gene transfer 50.  Degradation of nucleic acids may be rapid when administrated both intravenously 
52 and intramuscularly 53.  
 1.5 Cellular Uptake 
The internalisation of the nucleic acid vector by the targeted cell represents the first step in the 
gene delivery process.  It was first believed that cationic lipoplexes were internalized through a fusion 
process 22, however more recently it has been determined that only a few posses this ability 54,55 (Table 
1).  It has now been accepted that internalisation occurs through endocytosis, where the binding to or 
association of the cationic vector with surface receptors activates intracellular signalling pathways 
promoting endocytosis 56.  Confocal and electron microscopy studies have confirmed endocytosis. For 
example, cationic lipoplexes were visualized within endosomal compartments within one hour of 
administration using electron microscopy 57, and the localization of gold-labeled DNA complexes 
represented cytoplasmic vesicles, most likely endosomes 58.  Further the process of internalisation has 
been reported as one of the most witnessed processes of gene trafficking 15 (Table 1). 
Mammalian cells demonstrate several forms of importation of extracellular components, 
including clathrin- and caveolae-mediated endocytosis and macropinocytosis.   Each of these processes 
has been implicated in the internalisation of various vectors, both viral and non-viral, across a wide 
range of cell lines (Table 1).  
 1.5.1 Clathr in-mediated Endocytos i s  
Clathrin-mediated endocytosis is involved in the majority of receptor-ligand complexes entering 
the cell 59.  The process is generally triggered by receptor binding, leading to the accumulation of 
clathrin structures on the cytoplasmic surface of the plasma membrane as it begins to form clathrin-
coated pits 56.  The coat is composed of heavy and light clathrin chains, which assemble into triskelions  
CHAPTER ONE: INTRODUCTION 
 
INTRODUCTION  13 
Table 1 -  Summary o f  Internal isat ion Processes  Employed by Del ivery Vectors  
  
Internalisation Mechanism Vector Class Vector Type Cell Line Reference 
Fusion Liposome Fusogenic liposome HeLa 54 
 Lipopolyplex Targeted lipopolyplex HUVEC 60 
Clathrin-Dependent Polyplex Chitosan A549, Caco-2 61,62 
  Histidylated PLL HepG2 63 
  Polystyrene (<200nm) B16 64 
  PEI A549, HeLa 65 
 Lipoplex Targeted Lipofectamine Fetal tracheal epithelial cells 66 
  pH-sensitive liposomes COS7 67 
  DOTAP A549, HeLa 65 
  SAINT-2/DOPE COS7 68 
 Lipopolyplex Targeted PEGylated liposome HUVEC 
60 
 Viral-based AAV HeLa 69 
  HIV-I HeLa 70 
  HIV-TAT T–Cell (Jurkat) 71 
  Coxsackievirus HeLa 72 
  Hepatitis C 293T, Huh7 73 
  Hepatitis B HepG2, COS7 74 
Caveolae-Dependent Polyplex Targeted PLGA A549 75 
  Polystyrene (200-500nm) B16 64 
  PEI A549, HeLa 65 
 Lipoplex pH-sensitive liposomes COS7 67 
 Viral-based HIV-1 TAT HeLa, COS1, Jurkat 76 
Macropinocytosis Vector-free Naked DNA Human keratinocytes 77 
 Polyplex Histidylated PLL HepG2 63 
  Chitosan A549 61 
  PLGA RCEC 78 
 Lipoplex Targeted DC-cholesterol: DOPE 293-T7 
79 
 Viral-based TAT fusion peptide HeLa 80 
 
and associate with adaptor proteins.  As the pit continues to invaginate, vesicles are pinched off 
through a process involving dynamin, a GTPase 81,82, facilitated by a number of different effector 
proteins 83.  The vesicles are then uncoated by an ATP-dependent protein 84 and transported rapidly to 
early endosomes (to be discussed next) (Figure 1.5).  
Figure 1.5 – Clathrin-mediated Endocytos is  
The core components of clathrin-mediated endocytosis 
include clathrin triskelions (composed of three clathrin 
heavy chains and three tightly associated light chains, 
Adaptor Complex 2 and Dynamin. Mediated by the 
adaptor complex 2, clathrin triskelions form a lattice to 
help form the membrane into a coated pit.  Then the 
cargo interacts with receptors within the pit and 
accumulates. Dynamin is recruited to the neck of the 
pit, where is assembles into a ‘collar’ and releases the 
clathrin-coated vesicle.  The vesicle is subsequently 
uncoated, so the constituents can be recycled. (Image 
sourced from Conner and Schmid, 2003 85) 
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 1.5.2 Caveo lae-mediated Endocytos i s  
Caveolae-mediated endocytosis poses as the second form of receptor-mediated endocytic 
process employed for cellular entry.  Caveolae are flask-shaped invaginations in the plasma membrane, 
composed of the integral membrane protein cavelin-1 and 2 86,87.  The process of caveolae-mediated 
endocytosis is similar to that of clathrin-dependent endocytic processing, and is first driven by the 
clustering of receptors on the membrane surface with the ligand 88, thereby, inducing the 
polymerization of caveolin-1 and 2, which is a ATP-, GTP- and Mg2+-dependent process 87.  The 
caveolae flask-shaped pit is then budded off by dynamin 89.  The caveolae vesicles are then transported 
into the cell, but are not uncoated 88.  The still coated vesicles are processed through two pathways, 
either fusing with endosomes, or form with structured called caveosomes, which appear to have 
distinct properties from endosomes, including a neutral pH 88 (Figure 1.6). 
Figure 1.6 – Caveolae-mediated Endocytos is  
Complex binds to and is assumed to cluster membrane-
bound receptors in the caveolae-coated pit, resulting in 
the activation of Giα and Src kinases, thereby 
triggering endocytosis. (Sourced from Connor and 
Schmid, 2003 85) 
 
 
 
 
 1.5.3 Macropinocy tos i s  
Macropinocytosis is a clathrin- and receptor-independent endocytic pathway, which was first 
described morphologically in 1931 90. Actin-mediated membrane ruffling of the plasma membrane 
drives macropinocytosis.  Most of the lamellipodia formed by the ruffling retract back into the cell.  
However, some of the lamellipodia may fold back onto themselves and fuse with the membrane 
creating large and irregular-shaped vesicles termed macropinosomes (Figure 1.7) 91.  Macropinosomes 
are distinct from any other endocytic vesicle; they have no apparent coat structures, and are 
heterogeneous in size, however are considered to be larger than 200nm in diameter 92,93, considerably 
larger than clathrin- or caveolae-derived vesicles.  Once formed, macropinosomes undergo a 
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maturation process; however, it is unlikely that the maturation follows a common pathway in all cell 
types 91.  
 
 
 
 
Figure 1.7 – Pathway o f  Macropinocytos is  
Macropinocytosis involves the actin cytoskeleton  
(depicted as black lines). Cytoskeletal  
rearrangement along the plasma membrane leads   
to the formation of membrane ruffles.  These ruffles  
may then fold back on themselves, entrapping  
extracellular solutes in macropinosomes. The macropinosomes, which are  
typically larger than 0.2µm in diameter and have an irregular shape, are processed  
by the cell most likely in a cell-specific manner. One such way is the tabulation of early  
macropinosomes, resulting in mature macropinosomes, which are either recycled back to  
the plasma membrane, or digested by early endosome or lysosomes. (Sourced from Lim and Gleeson, 2011 91) 
 
Evidently, there is no single internalisation pathway for a delivery vector (Table 1), it would 
appear a number of factors are involved in the process, such as the properties of the vector complex, 
including the size, charge, composition, and stability of the complex, and the cell type targeted 15.  
Complex size has been known to have an impact on the ability to cross plasma membranes, with 
smaller complexes repeatedly demonstrating to better penetrate cells 94-96. Larger complexes (up to 500 
nm) generally enter the cell through receptor- and clathrin-independent endocytosis, whereas, smaller 
complexes (<200 nm) are internalised through receptor dependent endocytosis, such as clathrin- and 
caveolae-mediated endocytosis 97.  Other studies however, have concluded that the charge or ζ-
potential has a greater influence over internalization efficiencies than size 61,98.  Farrell et al. (2007) had 
demonstrated a 30- to 50-fold greater uptake of PEI polyplexes compared to PPL polyplexes with 
similar size distributions, indicating that composition is a critical aspect of internalization 99.   
However, a contradicting study demonstrated the uptake of particles was not governed by 
particle size, charge, or composition of polyplexes in a BHK-21 cell line 100.  Therefore, the cell type 
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must also play a pivotal role in which internalization pathway is undertaken by nucleic acid sequence 
delivery vectors.  Douglas et al. (2006) demonstrated that chitosan polyplexes (~150 nm) were 
internalized via clathrin- and caveolae-dependent pathways in kidney embryonic (293T) and fibroblast 
(COS-7) cells, however were internalized strictly via caveolae-mediated pathways in ovarian (CHO) 
cells 101. 
Like synthetic non-viral vectors, viral vectors are believed to enter the cell through either fusion 
or endocytic processes.  Direct entry, or fusion, is thought to be reserved to non-enveloped viruses, 
however, accumulating evidence is showing that even non-enveloped viruses are capable of entering 
the cell through the same endocytic processes as enveloped viruses 69,72.  The process of endocytosis 
employed by viral vectors differs between clathrin- 71-73 or caveolae-mediated 76, and also 
macropinocytosis 80 (Table 1).  
The cellular penetration of physical vectors on the other hand is entirely dependent on the 
approach undertaken.  For example, microinjection involves the direct injection of the nucleic acid into 
the site of interest within the cell, thereby, completely bypassing the plasma membrane 102.  Whereas, 
electroporation disrupts the integrity of the plasma membrane, and through the electric current created, 
the nucleic acids travel into the cell, without the assistance of the cell in any way 103.  
 1.6 Endosome 
Efficient gene delivery by vectors internalized through clathrin-, caveolae-mediated and 
macropinocytosis endocytosis requires the escape of the vector from membrane-bound compartments 
into the cytosol 15.  These vesicles may eventually form endosomes (in most cases), containing ATPase 
proton pumps, which lower the pH from 7.4 to ~5.0.  In the later stages of endosome processing, they 
fuse with lysosomes (the main degradative compartments of the cell), which also maintain the lumen at 
low pH, and contains high concentrations of nucleases 104.  As a consequence, the failure to escape 
from endosomal compartments results in the nucleic acid sequences becoming transfection-
incompetent through vesicle entrapment, or lysosomal degradation 15.   
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The transfer to and degradation in lysosomes has been proposed as one of the most significant 
barriers in non-viral gene delivery 65.  Confocal microscopy studies demonstrated the gradual change of 
punctate fluorescence patterns, indicative of entrapped fluorescently-labelled complexes, to diffuse 
homogenous fluorescence throughout the cytoplasm, providing evidence of escape from endosomal 
compartments 101,105.  Other studies observed the fluorescence colocalisation decrease over time 
between labelled complexes, and an early endosomal marker, suggested that the complexes had escaped 
from the vesicles 106,107.   
Although the exact mechanisms of endosomal release have eluded research efforts to-date, a 
number of theories have been developed, which support these and studies 15. The release processes 
appear to be dependent on the vector type utilized; lipoplexes escape through a flip-flop or membrane 
destabilization process, whereas, polyplexes may utilize a mechanism termed the “proton-sponge 
escape” theory 15,108.  Of note, the mechanisms involved in complex escape from caveosomes, or 
macropinosomes has yet to be determined, however, if these compartments acidify the mechanism 
should follow the same principles.      
 1.6.1 The Fl ip-Flop Theory 
Zelphati and Szoka (1996) proposed a theory of lipoplex release from endosomal 
compartments, wherein: Electrostatic interactions between the cationic lipids of the lipoplex and 
anionic phospholipids of the endosomal membrane results in the spontaneous release of the naked 
DNA into the cytoplasm after the disruption of the endosomal membrane 109.  With the stability of 
lipoplexes based on the electrostatic interactions between cationic lipids and anionic nucleic acids, the 
disruption of this interaction may release the nucleic acids from these complexes 110.  The release of the 
nucleic acids into the cytoplasm is then further enhanced through lipid: lipid interactions causing a flip-
flop effect of the lipids, ultimately leading to a cascade effect 111, eventually disrupting the endosomal 
membrane integrity and releasing the naked nucleic acid sequences (Figure 1.8).  
Fluorescence studies to date support this theory by demonstrating that the combination of ion-
pairing and hydrophobic interactions between cationic and anionic lipids is stronger than the 
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electrostatic forces maintaining lipoplexes intact 112.  In vitro studies also demonstrate that the cationic 
and anionic lipids together form inverted hexagonal phases when combined 113-115 (Refer back to Figure 
1.4C).  Inverted hexagonal phases are known to disrupt the barrier properties of membranes 116, and 
may also be instructional for the release of naked DNA from the lipoplex and into the cytoplasm 117-119. 
Figure 1.8 – The Flip- f lop Theory 
The flip-flop mechanism first requires the endocytosis of the 
lipoplex. The interaction lipoplex and endosomal membrane is 
lead by the electrostatic charge of cationic lipids (red) and anionic 
lipids (black) (1). Destabilisation of the endosomal membrane is 
caused by the flipping of anionic lipids from the cytoplasmic face 
to the endosomal lumen (2). The anionic lipids then form charge 
neutral ion pairs with the cationic lipids of the lipoplex (3), thus 
displacing the DNA and releasing it free into the cytoplasm (4). 
(Sourced from Medina-Kauwe at al., 2005 56) 
 
 
 
 
The membrane disruption and nucleic acid release from lipoplexes appears to occur within 
endosomal compartments rather than the cell surface.  It has been suggested that the flip-flop theory is 
pH independent 120.  The selective interaction with endosomal membranes rather than the plasma 
membrane may be due to differences in composition.  It has been reported that endosomal membranes 
contain twice as much phosphatidylserine than the plasma membrane 121.  Phosphatidylserine lipids 
have a negative charge, the interaction of the cationic lipoplex with another membrane may be critically 
dependent on the fraction of anionic lipids within the other membrane 122.  
 1.6.2 The “Proton-Sponge” Theory 
The Proton Sponge hypothesis was first proposed by Pollard et al. (1998) to explain the 
endosomal escape of PEI-based polyplexes 123.  According to this theory, 1-6 nitrogen atoms of the 
polymer are protonated at physiological pH. Upon the acidification of the endosomal compartment, an 
increase in the proportion of protonated nitrogens occurs, buffering the pH of endosomal 
compartments. The generation of a charge gradient induces the influx of protons and chloride ion (Cl-).  
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The induced charge also results in a water influx into the compartment, ultimately causing the swelling 
and eventual rupture of the endosome 108,124 (Figure 1.9). 
Figure 1.9 – The Proton-sponge 
Theory 
The proton sponge theory involves the 
acidification of the endosomal space 
containing polyplexes.  This acidification 
causes a buffering effect, during which a 
charge is generated, leading to a scavenging of 
Cl- and H+ ions.  The influx of charged ions 
into the endosomal compartment drives a 
water influx also, ultimately causing the 
swelling and rupture of the endosome. 
(Sourced from Varkouhi et al., 2011 125) 
 
 
Evidence and support of this theory derives from several studies, including the observation of 
decelerated acidification, elevated chloride concentration and a 140% increase in the relative volume of 
endosomes containing PEI complexes 126.  In addition, the transfection efficiency of PEI-polyplexes 
was reduced 20-fold with the removal of protonatable amine groups 127.  
This theory cannot fully explain the endosomal escape of many polyplexes.  Therefore, more 
work must be conducted on the molecular mechanisms of polyplex behaviour within the endosomal 
milieu 124.  
 1.6.3 Viral  Release  f rom Endosomes 
Viral vectors on the other hand, are believed to escape from endosomal compartments through 
the use of fusogenic peptides, which constitute part of the viral capsid.  Many enveloped viruses fuse 
their membrane envelope with the endosomal membrane after the exposure of a fusogenic peptide, 
induced by acidification 128.  On the other hand, the Hepatitis B virus is trafficked through the cell to 
lysosomes, where membranes are destabilized by the proteolytic cleavage of surface proteins, releasing 
the virus into the cytoplasm 74.  Non-enveloped viral vectors however, expose hydrophobic domains to 
the endosomal membrane upon acidification due to conformation changes, thereby, destabilizing the 
membrane and releasing the virus 73,129   
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 1.7 Cytoplasm 
Once released from endosomal compartments the nucleic acid sequences, either naked or still 
associated to its vector, face the cytoplasmic milieu.  During this stage of gene delivery two major 
obstacles are faced by the nucleic acid sequence: (i) the exposure to cytoplasmic nucleases, and (ii) 
limited mobility. 
 1.7.1 Cytoplasmic  Degradat ion 
The presence of calcium-sensitive cytosolic nucleases pose the next barrier to non-viral gene 
delivery 130,131.  Pollard et al. (2001) demonstrated that the half-life of free DNA within the cytoplasm is 
50-90 min due to the rate of degradation.  Several studies reported results supporting the rate and 
nature of degradation that occurs. However, still much is not known, including the mechanisms (i.e. the 
nuclease) involved and exactly where the degradation occurs within the cytoplasm. 
Through the application of Fluorescent in situ Hybridization (FISH), Lechardeur et al. (1999) 
have shown that the disappearance of microinjected DNA occurs in a time dependent manner.  The 
analysis of decay kinetics demonstrated that 50% of the FISH signal was eliminated within 1-2h in 
HeLa (cervical) and COS-1 (kidney) cells 131, and 4h in C2C12 (myoblast) and myotube cells 132.  This 
rapid metabolism of free DNA was independent of a number of factors, including the copy number 
(1,000 – 10,000 plasmids/cell), and the conformation of the DNA (whether linearized or supercoiled, 
and single- or double-stranded) 108.  The disappearance of the plasmid DNA could not be attributed to 
cell division, since the degradation was observed in cell cycle arrested cells 131. 
Although the metabolic instability of DNA within the cytoplasm has been studied, the actual 
mechanisms are yet to be uncovered and the extent of degradations that occurs during synthetic vector 
delivery is unknown.  A number of cellular endonucleases and exonucleases have been recognized as 
potentially involved; however, their functions and subcellular localization are still poorly understood 133-
136.  A recent study applied FCS to identify the mechanisms behind degradation, suggested that 
exonucleases pose the degradative barrier to gene delivery as opposed to other nucleases (DNase I and 
BAL31) within the cytoplasm of cells 137.  The role of DNases has been suggested to be unlikely, due to 
CHAPTER ONE: INTRODUCTION 
 
INTRODUCTION  21 
their cellular function and location 137.  This nuclease has been identified to play a role in chromosomal 
DNA degradation during apoptosis, localizing to the nucleus 138,139.  Therefore, DNases are unlikely to 
translocate between the cytoplasm and nucleus to target cytosolic DNA 131.  The digestion of plasmid 
DNA with purified cytoplasm had also demonstrated to be divalent-cation dependent, and 
thermosensitive.  The activation and inactivation patterns were distinctly different from those of 
apoptotic nucleases, and DNases I and II 130.  
 1.7.2 Dif fus ion Proper t i e s  o f  Nucle i c  Acids  
Once within the cytoplasm, nucleic acids also face mobility challenges. Fragments of DNA of 
250bp and 2000bp diffuse 17- and >100-times slower, respectively, than in water 140.  Lukacs et al. 
(2000) had set the foundations of DNA diffusion within the cytoplasm and nucleus.  In this study, a 
number of DNA fragments were assessed, including 21-, 50-, 100-, 250-, 1000-, 1200-, 2000-, 3000- 
and 6000-bp, through a technique termed Fluorescence Recovery After Photobleaching (FRAP).  
These DNA fragments were fluorescently labeled and microinjected. Then using FRAP, a region where 
the DNA was contained was photobleached through a pulse of high laser power and the recovery of 
fluorescence observed, resulting in semi-quantitative information on the diffusion rate 140.  This study 
concluded that DNA fragments <250bp were able to freely diffuse though the cell and into the 
nucleus, whereas particles >2000bp are virtually immobile.  The decreased mobility of the DNA 
fragments were partially attributed to molecular crowding of the plasmid, but also  due to the increased 
viscosity of the cytoplasm compared to water 140. However, provided that transfections do occur, the 
delivered DNA must be mobile to an extent. The FRAP approach applied does not enable the study of 
single particles, rather only the regional fluorescence. Additionally, the microinjection technique applied 
deposits all of the DNA load into a single location of the cell, therefore immobility could be a result of 
molecular crowding of the DNA or because the cell does not process the DNA. As a consequence, the 
2000 Lukacs’ study does not represent the cellular processing or mobility of DNA when delivered 
through lipofection; a more relevant approach of nucleic acid delivery than microinjection.  
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 1.8 Microtubules 
Larger DNA fragments (>2000bp) appear to have low mobility within the cytoplasm, which 
suggests an active mechanism must be employed to transport DNA into the peri-nuclear region for 
transfections to be successful.  It has since been established that this is achieved through the 
exploitation of the microtubule network 14.  Through a study undertaken by Vaughan and Dean (2006), 
who applied spin-down assays and confocal microscopy, the relationship between DNA plasmids with 
the microtubule network, dynein and adaptor proteins was shown. This study had concluded that DNA 
plasmids transport through the cytoplasm along the microtubule network; a cytoskeletal meshwork, via 
active transport. Dynein, the ATP driven motor protein, linked to the dynein proteins through adaptor 
proteins appears to the involved in trafficking DNA 14.  
The study undertaken by Vaughan and Dean (2006) has since been supported by a number of 
later publications. For example, Drake and Pack (2008) observed decreases in PEI-DNA delivery 
efficiency ranging from 50-98% as a result of inhibition of either actin or microtubule polymerization, 
or dynein or kinesin activity 141.  Further, the notion that DNA is trafficking along the cytoskeleton, via 
active transportation, has been supported by studies applying Two-Dimensional (2D) Single Particle 
Tracking (SPT). In which case the trajectory of particles within the cytoplasm were indicative of active 
transportation through Mean Square Displacement (MSD) calculations 142 which displayed reduced 
mobility when cytoskeletal polymerization is inhibited 143. 
Viral vectors are also well known to utilize the cellular cytoskeleton to traffic throughout the 
cell.  For example, reports have documented HIV-1 virus first engages in early trafficking along the 
actin network when the virus first enters the cell 144-146.  Followed by processing of the virus within the 
cytoplasm, the HIV-1 virus then traffics through the cell via the microtubule network utilizing the 
dynein motor protein 147.  Viruses including the HSV 148, Human Cytomegalovirus 149, Adenoviruses 150, 
Parvoviruses 151 and Simian Virus 40 (SV40) 152, traffic along the microtubule network powered by 
either dynein or kinesin motor proteins 153. 
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 1.9 Nuclear Translocation 
Following the transportation of the nucleic acid into the cell, through the plasma membrane, 
escape from endosomal compartments, and trafficking through the cytoplasm, the nucleic acid enters 
the peri-nuclear region in order to enter the nucleus, defined as the ultimate obstacle for gene delivery.  
Studies on the comparison of transfection efficiency demonstrated that no more than 0.1-0.001% of 
cytosolically injected plasmid DNA entered the nucleus 154.  Additionally, studies applying confocal and 
electron microscopy demonstrated only 20% of cells contained PEI polyplexes within the cytoplasm 
had expressed the reporter gene of interest 155.  Similarly, a study utilizing bone marrow stromal cells 
revealed that approximately 75% of cells contained the PEI or PLL vector, but less than 10% of these 
cells actually contained DNA within the nucleus 99. 
Although the processes of nuclear translocation have been extensively studied, the exact 
processes involved are still not clearly understood.  However, it is apparent that the nuclear 
translocation of DNA complexes is dependent on a number of biological aspects, including the phase 
of the cell cycle, cell type, nucleic acid sequence and the vector applied.  For example, it has been 
demonstrated that the translocation efficiency of single-stranded DNA is about 10-fold greater than 
that of double-stranded DNA 156.  In regards to the vector applied, one study reported that chitosan 
polyplexes enter the nucleus as early as 4h post-treatment, while PPL complexes had not reached the 
nucleus at all 157.  In a similar study, de Semir et al. (2002) had compared a number of commercialized 
lipoplexes, with finding demonstrating that only one achieved nuclear localization of the DNA 158.  Also 
the size of the DNA fragment plays a critical role in the nuclear translocation of the complex.  
Fragments <250bp have the ability to diffuse freely through the cytoplasm and into the nucleus 140.  
Leonetti et al. (1991) showed that the translocation of small DNA fragments (<100bp) is independent 
of the temperature, cytosolic ATP and concentration of DNA 159. 
Although the exact processes involved in nuclear translocation still remain unclear, there are 
two likely means of this occurrence: either (i) the nucleic acid complex enters the nuclear region during 
cell division, or (ii) enters through Nuclear Pore Complexes (NPC) of the Nuclear Envelope (NE). 
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 1.9.1 Entry dur ing Cel l  Divis ion  
One potential process in which introduced nucleic acids can enter the nucleus is while the cell is 
dividing, and the NE no longer poses a physical barrier 160,161.  Several studies indicate that by blocking 
the cell cycle in the G1 phase, a dramatic decrease in reporter gene expression occurs in lipofection and 
increases as cells pass through mitosis 56,161-164.  A key study on the increased efficiency of gene transfer 
in cells transfected in S or G2 phases versus the G1 phase compared the efficiency of lipoplexes 
(Lipofectamine), polyplexes (PEI and PLL) and adenoviruses.  While cell populations were dividing a 
minor four-fold increase was observed in adenoviral gene delivery.  However, a 500-fold increase was 
noted in lipoplex and polyplex transfection, suggesting that these vectors may have a dependence on 
mitosis 160. 
On the contrary, while cell division does appear to have an influence in delivery efficiency of 
non-viral vectors, some studies suggested that the dependence on cell division is cell specific.  For 
example, Dowty et al. (1995) had shown that microinjected DNA readily migrated into the nucleus 
from the cytoplasm in rat myotubes.  Through the co-injection of Wheat Germ Agglutinin (WGA) (a 
lectin which binds to N-acetylglucosamine residues on NPC proteins, thereby effectively blocking NPC 
translocation 165) a 20-fold decrease in gene transfer was observed, indicating that the plasmids were 
entering the nuclei via the NPC 166. 
 1.9.2 Entry through NPCs 
The passage of nucleic acids must occur through means other than just entering the nuclear 
space during cell division.  Dowty et al. (1995) indicated that gene expression of a reporter gene was 
detected when the plasmid DNA was injected into the cytoplasm of primary myoblasts, implying that 
the plasmid DNA is able to enter post-mitotic nuclei 166.  In the same study, Dowty et al. (1995) 
visualized gold-labelled plasmids in close proximity with NPC, and inside the nucleus through electron 
microscopy. This early work was then supported in 1999, when the translocation of plasmid DNA into 
the nucleus was identified to be temperature-sensitive, energy-dependent and inhibited by WGA 167. 
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The NPCs are cylindrical supramolecular structures, each composed of a central cylinder 
anchored to the NE surrounded by spoke-ring complexes 168,169, termed the luminal domain (Figure 
1.10).  They are composed of ~50 proteins, forming aqueous channels through the NE, are about 
130nm in diameter and 70nm thick, and are collectively known as nucleoporins 168.  Cytoplasmic and 
intranuclear filaments (fibrils) extend out 50-100nm into their associated compartments, and is 
expected to interact with incoming and outgoing receptor complexes 170,171. 
Figure 1.10 – The Nuclear 
Pore Complex 
The NPC is composed of two 
regions: the luminal domain 
containing the central framework 
(yellow) and forms the channel 
through the nucleoporin, the 
cytoplasmic ring moiety (blue) 
containing the cytoplasmic fibrils, 
which extend into the cytoplasm, 
and the nuclear ring moiety (red) 
composed of the nuclear basket and 
intranuclear fibrils, extending out 
into the nuclear space. (Sourced 
from Fahrenkrog and Aebi, 2003 
172) 
 
 
Molecules smaller than ~40kDa can passively diffuse through the channel.  However, 
macromolecules larger than 60kDa must either contain a Nuclear Localizing Signal (NLS) or associate 
with other polypeptide(s) incorporating NLS to traverse the NPC in an energy dependent manner 173. 
The diameter of the NPC channel reaches a maximum of 25nm during active transportation, but has a 
cross section of 9nm when engaged in passive transport.  The conformation change may explain the 
ability of NPCs to permit passage of molecules as large as 25-50MDa 174,175.  During active 
transportation, the NLS of the cargo is recognized by the importin-α adapter, which then complexes 
with importin-β via the importin-β binding domain, forming a pore targeting complex 176,177.  The pore 
targeting complex docks to the NPC by associating with the protruding fibrils, it is then believed the 
conformation change occurs as a response to calcium changes 178.  The complex and cargo then passes 
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through the NPC channel.  Following the translocation, the association with Ran-GTP initiates the 
release of the imported cargo from the importins 177.  
Without association with a NLS, or if NPC-dependent active transportation is blocked, DNA 
can be excluded from the nucleus 179.  Due to the potential size of DNA constructs, the introduced 
DNA appears to be undergoing active transport into the nucleus.  A number of approaches have been 
employed to enhance this process.  One such example is the attachment of NLS either covalently, or 
non-covalently 110.  Peptides including SV40 T-antigen 180, TAT 181, Vp22 182 and µ 183 have been 
successfully tested to enhance nuclear translocation.  Another emerging approach is the incorporation 
of DNA targeting sequences into the sequence of the DNA plasmid, such as the 72bp enhancer 
sequence from the SV40 virus 184.  The addition of such a sequence renders the plasmid nucleophilic, 
since the enhancer sequence offers the ability to bind to various transcription factors.  The nuclear 
import of the plasmid is then facilitated since the transcriptional factors have their own NLS 110.	   
 1.9.3 Viral  Entry o f  the  Nucleus 
Like non-viral vectors, viral-based gene delivery also appear to be hampered by the NE. Viral 
vectors generally show greater nuclear translocation compared to non-viral vectors, due to their 
incorporated NLS domains.  However, their ability to penetrate the nucleus is not significantly greater 
than non-viral nuclear translocation 15.  For example, Hama et al. (2006) reported that the nuclear entry 
of adenoviruses was only 2.5 times greater than that of lipoplex delivery 185. 
The NE is also a rate limiting step in viral transduction for other viruses, including AAV 186.  
However, in the case of the MLV retrovirus, early experiments indicate that this virus is only able to 
enter the nucleus during cell division 187,188, thus explaining why the MLV vectors cannot infect non-
dividing cells as the NE is a complete barrier.  In contrast, Lentiviruses, including HIV-1, have the 
mechanisms to infect both dividing and non-dividing cells.  This implies these viruses can pass through 
NPCs in non-dividing cells 189.  This ability has been attributed to the abundant presence of viral NLSs 
190.  Recent studies suggest other factors are involved in lentiviral nuclear import, including the central 
DNA flap structure 191, the CA protein 192, the cellular importin 7 193 and nucleoporin proteins 194. 
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 1.10 Nuclear Architecture 
In many studies on nucleic acid sequence delivery, the cytoplasm has been the major research 
focus, resulting in the nucleus becoming a ‘black box’ to gene delivery. The nucleus is a complex 
organelle composed of several sub-compartments, which are likely to play a role in the fate of 
introduced nucleic acid sequences.  Although it is still not fully understood, it is clear that eukaryotic 
nuclei are dynamics structures, well organized and consist of several distinct non-membrane bound 
compartments 195-197 (Figure 1.11).   
The arrangement of compartments inside the nuclear space is termed the nuclear architecture 
197.  These nuclear compartments can be readily visualized using light and electron microscopy 195 and 
consist of specific resident proteins 195,197.  A prominent compartment of the nucleus is the nucleolus 
(Figure 11B), which is the site of ribosomal RNA transcription and RNA processing.  Other 
compartments include nuclear speckles (Figure 1.11A), the splicing factor compartment, Cajal bodies 
(Figure 1.11C), sites for small nuclear ribonucleoprotein assembly, and Promyelocytic Leukemia bodies 
(PML) (Figure 1.11D), believed to play a role in cellular processes including transcription and cell cycle 
progression, as well as apoptosis and DNA repair 198.   
The genomic DNA, which is packed in the form of chromatin composed of DNA, histones 
and additional architectural proteins 199.  The histones condensing the DNA are subject to a large 
variety of post-translational modifications that regulate the chromatin accessibility and ultimately gene 
expression 197.  Within the compartments chromatin is well organized; it appears that gene-rich regions 
tend to be found in the nuclear interior, and transcriptionally active regions are usually kept as 
decondensed euchromatin.  Whereas, regions of transient gene expression and silenced genes tend to 
be found towards the periphery and if generally inactive, kept as more condensed heterochromatin 
196,197.  Chromosomes themselves are also organized into distinct sub-volumes of the nuclear space, 
termed Chromosome Territories (CTs) 200 (Figure 1.11E, F).  The positions of each gene locus is also 
subject to strict regulation, and CTs, are non- random, tissue, cell-type and developmental-stage specific 
201.   In a study undertaken by Cremer et al. (2003), multiple normal cells were compared to their 
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malignant equivalents, showing a change in nuclear architecture with alterations in CT and gene loci 
positions. 
Figure 1.11 -  Nuclear Archi tec ture and Chromosomal Terr i tor ies  
The centre schematic diagram indicates where the compartments are relative to each other, with fluorescent images 
surrounding the schematic diagram to show how they appear in a eukaryotic cell during interphase.  The surrounding 
images include nuclear speckles (A), nucleolus (B), Cajal bodies (C), PML bodies (D) and mouse chromosomes 13 
(blue), 14 (red) and 15 (green) during metaphase (E) and during interphase in clear chromosome territories (F).  
(Schematic diagram obtained from Lanctôt et al. 2007 196, Images modified from Dundr & Misteli, 2001 195). 
  
 1.11 Nuclear Environment  
Due to the complexity of the nucleus, it is not expected that the delivery nucleic acid sequences 
will simply enter the nucleus and be expressed by the cellular machinery.  Several factors must be 
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addressed and elucidated, including: (i) whether the nucleic acid sequence dissociates from the vector 
complex in order to be transcribed, (ii) where the nucleic acid sequence localizes, (iii) how long the 
nucleic acid sequence is retained within the nucleus, and (iv) how the cell homeostasis is affected by the 
transfection process.  
 1.11.1 Vector  Dissoc iat ion 
It still remains unclear whether the nucleic acid sequence dissociates from the vector to 
function within the nucleus.  However, evidence suggests that free DNA is required 15,108.  Studies show 
that the transfection efficiency of linear PEI polyplexes is higher than branched PEI polyplexes 106.  It 
has also been suggested that lower molecular weight polyplexes result in a high transfection efficiency 
128,202.  The higher transfection efficiency can be contributed to the easier dissociation of the nucleic acid 
from the vector, making it readily available to be transcribed.  Similarly, lipoplexes with a higher charge 
ratio have been reported to reduce transfection efficiency, although internalisation and destabilization 
of endosomes is increased.  The higher charge ratio is thought to reduce DNA release, thereby 
reducing transcription 203,204.  Although the mechanisms of vector dissociation remains unclear, it has 
been suggested that anionic proteins or the large amount of DNA and RNA within the nucleus may 
cause the displacement of the vector from the introduced nucleic acid 106,205,206.  Such propositions 
involving endogenous RNA have been supported by observations where PEI accumulates near the 
nucleoli, but does not interact with chromosomal DNA 155,208. 
Figure 1.12 – Local i sat ion o f  Plasmid DNA 
in Mammalian Nucle i  
Plasmid DNA localises into specific sub- compartments of 
the nucleus. COS7 (fibroblast-like) cells were transfected 
with SAF-A (A), hFibrillarin (B), highlighting the 
nucleolus, and PML (C). After overnight incubation, 
plasmid DNA signals had demonstrated a exclusion from 
the nucleolus (B) and PML (C) compartments, whereas, 
distribution was very similar to the SAF-A (A) scaffolding 
protein. (Sourced from Mearini et al. 2004 207) 
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 1.11.2 Nuclear Local i sat ion 
Within the nucleus, plasmid DNA has been reported to localize in specific nuclear regions. 
Mearini et al. (2004) identified plasmid DNA displays a heterogeneous distribution within the nucleus, 
including nucleoli exclusion (Figure 1.12B) and PML bodies (Figure 1.12C).  Mearini’s study also 
demonstrated the distribution of plasmid DNA was similar to the nuclear scaffolding protein (SAF-A) 
(Figure 1.12A). However, following further experimentation, no association was identified.  The study 
concluded that plasmid DNA has a rapid association with nuclear substructures, which dramatically 
reduce mobility and render the DNA resistant to treatment with detergents and elevated salt 
concentrations 207.  A prior study had similar results, where SV40 viral DNA was observed within the 
nucleus in a similar pattern, being excluded from the nucleoli and other nuclear sub-compartments 209.  
        
Figure 1.13 -  Nuclear Local i sat ion o f  HSV-1 Vector 
The uninfected nucleus of human fibroblast cell shows the typical distribution of PML bodies (red) and little activity of 
γH2AX (blue), a DNA damage response protein. One the contrary, the HSV-1 infected nucleus (right) shows a 
redistribution of the PML bodies that closely associate to the viral genome, indicated by the viral transcriptional activator 
ICP4 (green). A DNA repair response resulted from the presence of the viral vector, indicated by the increased in 
γH2AX in regions close to the viral genome. (Sourced from Everett, 2013 210) 
 
Nuclear localization of some viral vectors demonstrate a different trend, for example, the large 
genomes of the HSV vector, which have a limited mobility within the nucleus, have been observed to 
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localize along the periphery of the nucleus where they would have entered through NPCs 211,212. 
Following nuclear entry, the HSV vector displayed strong association to PML bodies and the activation 
of DNA repair pathways 210 (Figure 1.13). 
 1.11.3 Nuclear Retent ion 
One aspect of non-viral gene delivery is the maintenance and retention of the introduced 
nucleic acid, especially when it remains episomal.  Gasiorowski and Dean (2005) investigated this issue 
through the introduction of plasmid DNA with different modifications.  When the DNA was imaged 
using a FISH approach or the use of Protein-Nucleic Acid (PNA)-fluorescence labelling, the DNA was 
observed within daughter cells (Figure 1.14A).  However, when the DNA was imaged using covalent 
labelling kits, the DNA was excluded from the nucleus following cell division (Figure 1.14B, C) 213.  
Gasiorowski et al. (2005) demonstrated that the modification of nucleic acids could have an effect on 
the overall lifetime of transgene expression. 
Figure 1.14 – Nuclear Retent ion o f  
Fluorescent ly  Label l ed Plasmid DNA 
Unmodified naked DNA was injected in the 
nucleus of HeLa cells and observed 12-18 hours 
later once the cells had divided, demonstrating 
that the introduced DNA remained within the 
nucleus (A). Comparatively, when the plasmid 
DNA was labelled with Texas Red Fast Tag 
(green)  (B) or a mixture of Cy5 Label IT 
(green) and Cy3-PNA (red) (C), the DNA 
labelled with Texas Red Fast Tag and Cy5 
Label IT (C) were not retained in the nucleus 
following cell division. (Sourced from 
Gasiorowski and Dean, 2005 213) 
 
 1.11.4 Cel lu lar Responses  
Until recently few studies have addressed cellular responses at the molecular level in response 
of non-viral gene delivery. Recently, Plautz et al. (2011) had applied microarray analysis to identify 
alternations in gene expression, in response to trafficking lipoplexes in two different cell types: human 
embryonic epithelial kidney cell and mouse fibroblast cells.  In Plautz’s study, cells containing 
lipoplexes were separated into two populations, based on whether (GFP+) or not (GFP-) the Green 
Fluorescent Protein (GFP) reporter gene was expressed, and compared these and a non-treated control 
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214.  The expression patterns of GFP+ and GFP- populations revealed three genes that were statistically 
different: RAP1A, HSP70B’ and PVT1 (a non-protein coding oncogene), all up regulated in GFP+ 
populations.  Additionally, the GFP+ population exhibited statistically significant expression levels in 
19 genes compared to the control. Up regulated genes of interest in the GFP+ population included the 
activating transcription factor 3 (ATF3), damage-specific DNA binding protein 2 (DDB2) (which 
facilitates responses to DNA damage) and a death effector domain-containing gene (PEA15) 214. 
The RAP1A gene was up regulated in GFP+ and GFP- populations (compared to controls), 
therefore, it may play a role in the internalisation of DNA complexes 214.  The gene encodes a GTPase 
involved in a range of cell proceses, including integrin-mediated adhesion 215.  The up regulation of this 
gene was explained as the link between the ECM and non-viral gene delivery, since ECM molecules 
have been demonstrated to enhance non-viral gene delivery strategies 216,217, where the plasmid is 
immobilized to the surface supporting the cell, and internalized while promoting cell adhesion 214,218. 
The HSP70B’ gene, encodes for a heat shock protein, a chaperone involved in protein folding 
and stabilization, which is strictly induced by various cellular stress 219. HSP70B’ is usually silenced in 
many cell types 220, and is important in maintaining cell viability 219 and cytoprotection 221.  Therefore, 
the expression of this gene may be important for maintaining cell viability during transfection 214.  It has 
also been identified that HSP70B’ has a role in and enhances nuclear localization of viral particles 222, 
and therefore, may promote nuclear entry of non-viral vectors 214. 
Finally, the ATF3 gene was up regulated in transfected cells.  This inducible gene alters gene 
expression to adjust for various intra- and extra-cellular stresses and stimuli, including the induction of 
apoptosis 223.  Whether the expression of this gene is protective or detrimental is dependent on the 
stimuli and cell type 223.  The up-regulation of this gene indicates that a survival response was triggered, 
which correlates with the up-regulation of other genes involved in apoptosis 214. 
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2 Characterisation of the Molecular 
Mechanisms of Exogenous DNA Mobility 
 
 2.1 Introduction 
Within a biological system a fundamental question that is frequently raised is at what rate a 
particle or compound moves, and how it does so. Over time a number of bioimaging tools and 
approaches have been developed to achieve such an insight into the real-time dynamics occurring in 
live cells. 
One such example that is commonly applied is the FRAP approach. This technique involves 
the photobleaching of a fluorescent population through a pulse of high-powered laser, followed by the 
observation and calculation of how fast the unbleached population moves into the bleached region 224. 
Although this approach is commonly utilised, it is highly invasive due to the energy that must be 
exerted onto the cell in order to achieve photobleaching, therefore the approach can influence the 
mobility of particles through local heating and cellular damage. Additionally, FRAP is not sensitive 
enough to observe small fluctuations and will only capture events within the small region selected.  
FCS on the other hand (as discussed earlier), offers a means to observe the fluctuations at a 
single-particle level. The FCS approach is not invasive and enables the absolute quantification of 
particle mobility and dynamics. However like FRAP, FCS is limited to the observation of a single small 
area, and events occurring outside of this Region-of-Interest (ROI) will be missed. Therefore, the FCS 
approach has been extended to several techniques, including Raster Image Correlation Spectroscopy 
(RICS) and image-based Means Square Displacement (iMSD); enabling entire frames and images to be 
CHAPTER 2 
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correlated, thus extracting quantitative information of particle dynamics, including mobility, binding-
events and mechanisms of motion 225,226.  
 2.1.1 Raster  Image Corre lat ion Spec troscopy 
The RICS approach applies a raster scan to obtain dynamic information of fluorescently 
labelled particles, including diffusion and mobility, binding and concentration over time and space. In 
the raster scan the laser starts at one point (Point A, Figure 2.1) and scans across the sample acquiring 
pixels and collecting intensity information to form a line (to Point B, Figure 2.1). The laser then 
retraces to the beginning of the next line, then scans, and so on to acquire an entire image, after which 
it retraces back to the beginning (Point A, Figure 2.1) to obtain consecutive images as required. During 
the scanning, the pixel time, line time and retracing times must be taken into account 227. 
Figure 2.1 – The Raster  Scan 
In a raster scan the laser starts from point A and scans across the 
sample acquiring pixels to Point B (scanning indicated by the solid 
yellow lines). The laser retraces down to the next line (indicated by the 
dashed lines) and continues until an entire image has been acquired. 
The laser then retraces back to the beginning of the sample, point A 
(indicated by the dotted line) to acquire consecutive images as required. 
(Image obtained from previous unpublished data) 
 
 
 
 
 
 
 
 
During the raster scan, every pixel acquired contains fluctuation information that can be used to 
extract the dynamics of particles within the sample. Spatial correlation of diffusing/moving particles is 
dependent on the overlap of adjacent pixels, and therefore, the sample must be sampled in such a way 
that the PSF of each pixel slightly overlaps 225. As the raster scan acquires an image, the intensity of a 
single pixel is measured for a very brief time, then immediately after the neighbouring pixel’s intensity 
will be measured. If a particle moves from the first pixel to the second, the intensity fluctuations will be 
correlated with a certain time delay. The scale of this correlation will be dependent on the rate of 
mobility of the given particle/s and may involve several neighbouring pixels 228. On the other hand, in 
CHAPTER TWO: LIPOPLEX DYNAMICS 
 
LIPOPLEX DYNAMICS      35 
the case that the particle is moving very slowly and remains within a location for a long period of time, 
there would be little or no transfer of fluctuations amongst adjacent pixels. Therefore, the spatial 
correlation will have a different distribution compared to the case of faster mobility 228.  
In the case of slower moving particles, the fluctuations particles have a higher probability of 
being detected in nearby pixels, but in a smaller number of pixels (for example, in pixels 1-3 in Figure 
2.2A). When these pixels are correlated a strong correlation amongst adjacent pixels is obtained but the 
correlation will decay as the particles are no longer seen (Figure 2.2C). On the contrary, faster moving 
particles have a lower probability of being detected in adjacent pixels, but will be observed much 
further in time (Figure 2.2B). Due to this characteristic of faster moving particles the ACF will broaden 
(Figure 2.2C) 225. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 – Temporal  Information within the Raster  Scan 
During the raster scan the pixels must be overlapped for the RICS approach. In the case of a slow moving particle, 
fluctuations have a higher probability of being detected in nearby pixels but over a lesser number of pixels (A). Whereas, a 
faster moving particle has a lesser probability of being detected in neighbouring pixels, but will be detected in further pixels 
(B). The colour code represents time evolution of the trajectory. In these cases, the ACF will take on a characteristic 
broadening for faster moving particles since fluctuations are observed much further. However, the ACF will decay much 
faster in the case of slower moving particles as the fluctuations of particles will be detected in less pixels. (Image sourced 
from Digman, 2010 229) 
 
The SCAF and mobility co-efficient are calculated through a few mathematical algorithms. 
Firstly, the image must be divided into four quadrants (for example, an image of 256x256 pixels is 
divided into four equal fractions of 128x128 pixels). Each quadrant is shifted by a single pixel in the x 
direction and then multiplied by its unshifted equivalent, with each pixel providing a point for the 
SACF. The calculation is performed on each pixel of an image and then performed again with a shift in 
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the y direction to obtain the full SACF (Figure 2.3). This operation is repeated for each frame over a 
stake and the SACF of each frame is finally averaged 6.  
 
 
 
 
 
 
Figure 2.3 – Calculat ion o f  the Spat ial  Auto-Corre lat ion Funct ion 
In order to calculate the SACF an image is divided into four equal quadrants.  Each quadrant is shifted in the x 
direction by a single pixel and then multiplied by its original quadrant.  Each pixel contributes to a point of the SACF.  
This operation is repeated with a shift in the y direction.  The calculation is performed on all pixels of each quadrant in 
order to obtain a full SACF. (Image sourced from Digman and Gratton, 2011 6 
 
Mathematically, the 2D SACF is calculated where temporal information is taken into account: 
𝐺𝐺???? =   
𝐼𝐼 𝑥𝑥,𝑦𝑦   𝐼𝐼 𝑥𝑥 +   𝜉𝜉,𝑦𝑦 +   𝜓𝜓
𝐼𝐼 𝑥𝑥,𝑦𝑦 ?
 
Equation 2 -  RICS 2D SACF  
where the variables 𝜉𝜉 and 𝜓𝜓 represent the spatial increments in the x and y directions, respectively 225.  
The equation states that for each pixel, the intensity (I) is multiplied by its shifted equivalent and 
divided by its squared self.  The Fast Fourier Transform (FFT) method is applied in order for these 
calculations to be computed efficiently 228. 
The diffusion coefficient can be determined through the RICS approach: 
𝐺𝐺???? 𝜉𝜉,𝜓𝜓 = 𝑆𝑆 𝜉𝜉,𝜓𝜓   ×  𝐺𝐺 𝜉𝜉,𝜓𝜓  
Equation 3 -  RICS Dif fus ion Coef f i c i ent  
 
A molecule moves independently of whether or not the sample is being scanned.  Therefore, 
the SACF is the product of two terms: (i) the scanning parameters (S), and (ii) the diffusion/movement 
of the particle (G) 1.  Considering the process of diffusion, the diffusion kernel is described by: 
𝑃𝑃 𝑟𝑟, 𝑡𝑡 =   
1
4𝜋𝜋𝜋𝜋𝜋𝜋 ?/?
  𝑒𝑒𝑒𝑒𝑒𝑒 −
𝑟𝑟?
4𝐷𝐷𝐷𝐷
 
Equation 4 -  RICS Dif fus ion Kernel  
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where P is the probability of finding the molecule in the distance r in the given time t.  This expression 
is composed of two parts: (i) the temporal term, which describes the amplitude of the SACF, and (ii) 
the spatial Gaussian term, which is dependent on time.  In the case of a fast time scale, the diffusion 
kernel broadens as the width of the Gaussian increases and the amplitude decreases as a function of 
time 225. 
A 3D fit can be obtained to determine space and time relationships.  This is calculated with a 
3D Gaussian equation (similar to one used for single point FCS): 
𝐺𝐺 𝜉𝜉,𝜓𝜓 =   
𝛾𝛾
𝑁𝑁
1+
4𝐷𝐷 𝜏𝜏?𝜉𝜉 + 𝜏𝜏?𝜓𝜓
𝜔𝜔?
?
??
1+
4𝐷𝐷 𝜏𝜏?𝜉𝜉 + 𝜏𝜏?𝜓𝜓
𝜔𝜔??
?? ?
 
Equation 5 -  RICS 3D SACF Fit 
which takes the pixel time (𝜏𝜏?) and the line time (𝜏𝜏?) into account.  The geometrical factors or the waist 
of the beam path are represented by the acronym 𝜔𝜔 228. 
A common problem with many FCS techniques is cellular artefacts and especially for RICS, 
immobile fractions. Nonetheless, the RICS approach applies a basic concept in order to remove 
artefacts in order to only correlate fluctuations due to mobile particles. An average of the image series 
can be applied by calculating the average intensity of each pixel of an overall image series,  𝐼𝐼 𝑥𝑥,𝑦𝑦 . This 
average is then subtracted from the frames over the data series isolating the fluctuations of only the 
mobile particles. However, this yields some negative values, therefore, a scalar must be added, 𝑎𝑎 =    𝐼𝐼 
229.  This operation is expressed as below: 
𝐹𝐹? 𝑥𝑥,𝑦𝑦 =    𝐼𝐼? 𝑥𝑥,𝑦𝑦 −   𝐼𝐼 𝑥𝑥,𝑦𝑦 + 𝑎𝑎 
Equation 6 -  Average Subtract ion in RICS 
However, the operation detailed above does not remove artefacts including bright or very slow 
moving structures, such as organelles of the cell. Therefore, a moving average can be applied to isolate 
and extract the fluctuations of the particles of interest in the presence to slow moving artefacts. As the 
frames are correlated, the set of frames that are averaged move accordingly 229.  For example, in a 
moving average of 10, the average intensity of frames 1-10 is calculated.  The correlation calculation 
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starts from frame 5 and removes the average intensity of frames 1-10.  As the calculation processes 
correlate pixels of frame 6 the intensity average of frames 2-11 is removed and so on.  As a result, 
slowly moving components are filtered out and the fluctuations of much faster components are 
obtained 229. 
 2.1.2 Image Means Square Displacement 
The Means Square Displacement (MSD) is a common approach to determine particle trajectory 
over time. The analysis provides information on the directionality and motion of a particle 230. 
Consequently, the MSD can determine the possible mechanism of motion based on the nearest-
neighbour algorithm 230-232. MSD analysis is typically performed from Single Particle Tracking (SPT), 
however SPT typically requires specialized equipment, such as circular scanning capabilities 143. 
However, an image-based MSD (iMSD) approach has recently been developed 226. Similar to single 
particle approaches, the iMSD approach provides a value of MSD providing an insight into the directed 
motion, flows, directionality of particles, within a 2D image series using correlation functions 226. A 
range of mechanisms or means of motion can be determined through this technique, including 
Random Diffusion (RD), Active Transport (AT), Transient Confinement (TC), Anomalous 
Subdiffusion (AS), Confined or Corralled Diffusion (CD) and Binding-Unbinding events; Figure 2.4 
presents the expected iMSD curves for the mechanisms of motion outlined.  
The iMSD function is calculated as follows: 
𝐺𝐺 𝜉𝜉,𝜒𝜒, 𝜏𝜏 =   𝑔𝑔 𝜏𝜏 ∙ exp −
𝜉𝜉? + 𝜒𝜒?
𝜎𝜎?? τ
+   𝑔𝑔?(𝜏𝜏) 
Equation 7 -  iMSD Funct ion 
which takes into account three components, the temporal correlation function, iMSD component 
(where the variance is of the spatial G term) and constant offset. The spatial and temporal correlation 
function is the same of that for the STICS approach: 
  𝐺𝐺 𝜉𝜉,𝜒𝜒, 𝜏𝜏 =   
𝐼𝐼 𝑥𝑥,𝑦𝑦  , 𝑡𝑡 ∙   𝐼𝐼 𝑥𝑥 +   𝜉𝜉,𝑦𝑦 +   𝜒𝜒, 𝜏𝜏 + 𝑡𝑡
𝐼𝐼 𝑥𝑥,𝑦𝑦, 𝑡𝑡 ?
− 1 
Equation 8 -  iMSD Spatial  and Temporal  Corre lat ion Funct ion 
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The 3D Fast Fourier Transform (FFT) algorithm is used to calculate the correlation function: 
𝐺𝐺 𝜉𝜉,𝜒𝜒, 𝜏𝜏 =   𝑔𝑔? ∙ 𝑝𝑝 𝜉𝜉,𝜒𝜒, 𝜏𝜏 ⊗𝑊𝑊 𝜉𝜉,𝜒𝜒    
Equation 9 -  iMSD Corre lat ion Funct ion 
where g0 is the usual G(0) of FCS and it depends on the number of particle, P depends on the physics 
of the motion and W is the point spread function. 
The iMSD component takes into the account the Fick’s Law: 
𝑝𝑝 𝜉𝜉,𝜒𝜒, 𝜏𝜏 =   
1
𝜋𝜋4𝐷𝐷𝐷𝐷
𝑒𝑒𝑒𝑒𝑒𝑒 −
𝜉𝜉? + 𝜒𝜒?
4𝐷𝐷𝐷𝐷
 
Equation 10 -  iMSD Fick's Law 
 
 
 
 
 
 
 
 
Figure 2.4 – Examples o f  MSD Curves 
Expected iMSD curves for the variety of different mechanisms of motion with pictorial representations of the motion in 
smaller boxes at the right of each curve. Means of motion include random diffusion (A), active transport (B), anomalous 
subdiffusion (C), confined diffusion (D), transient confinement (E) and binding unbinding (F). (Image created based on 
Levi & Gratton, 2008 233) 
 
 2.1.3 Lipoplex Dynamics  
The mobility and dynamics of delivered DNA has long been in the spotlight since these 
properties play a critical role in the success of this therapeutic approach. As a result, a number of 
approaches to study the delivery process have been applied. During the processing of lipoplexes (the 
complex formed between DNA and transfection lipids), a number of barriers and obstacles are faced, 
potentially impeding mobility of the DNA complexes (as discussed in Chapter 1). 
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The free diffusion of DNA of varying lengths has been established in previously published 
work. Lukacs et al. (2000), for instance demonstrated the rate of motion of DNA fragments ranging 
from 21bp-6kbp through microinjection. The study identified that DNA >1000bp were immobile 
within the cytoplasm, and all sizes were immobile when delivered directly to the nucleus when analysed 
through the application of FRAP. However, the reduced mobility in the cytoplasm could possibly be 
due to molecular crowding as a result of the microinjection delivery approach, as accounted for by 
Lukacs et al. 140. 
Since the DNA was microinjected in the study by Lukacs et al. (2000), it is also likely that the 
DNA was immobile since it would not interact or be processed by the cell compared to the lipofection 
process. Following entry into the cell, lipoplexes are expected to be trapped in endocytic vesicles and 
therefore, must escape these cellular organelles 185. Within the cytoplasm, the nucleic acid is required to 
be trafficked towards the nucleus, and does so along the microtubule network facilitated by motor 
proteins 14. Commonly described as the ultimate obstacle of gene delivery 184,234, the delivered DNA 
most likely enter the nucleus through nuclear pore complexes 235, or by associating with chromatin 
during cell division 161,236. 
Coppola et al. (2013) on the other hand applied a SPT approach to lock onto and track 
individual lipoplexes over time 143. Coppola’s study enabled the analysis of the rate of motion and 
mechanisms behind the motion (i.e. random diffusion or active transport) at a single compound level, 
however it is limited to a single particle. The behaviour of the delivered lipoplexes in Coppola et al.’s 
study was similar to a study undertaken by Ruthardt and Brauchle (2010) who applied SPT to track 
polyplexes 237. In both studies, the delivered DNA compound demonstrated a similar behaviour as viral 
vectors, where confined and anomalous diffusion was observed along the periphery of the cell followed 
by active transportation throughout the cytoplasm.  
Although the processing of lipoplexes has been well documented, no study has yet to 
characterize the mobility of lipoplexes formed from a range of different fluorescently labelled DNA 
(flDNA) sizes within the cellular milieu, specifically addressing the rates and means of motion 
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throughout locations of the cell simultaneously. Therefore, the research effort presented in this thesis 
applied the two techniques, RICS and iMSD; enabling the quantification and identification of the rates 
and means of motion of single flDNA particles from a range of sizes (21bp-5.5kbp) when delivered 
through lipofection.  
 2.2 Materials and Methods 
 2.2.1 Product ion o f  DNA Fragments  
The 5485bp fragment was obtained by labelling PCI-Neo mammalian vectors (Promega, 
Madison WI) with Alexa Fluor 488 through a UYLSIS nucleic acid labelling kit (Molecular Probes, 
Eugene OR). The labelled plasmid was either kept circular or linearized by digesting with BgI II.  
The Alexa Fluor488 labelled 21bp oligonucleotide (5’-AF488-
TCAATATTGGCCATTAGCCAT-3’) was synthesised by Integrated DNA Technologies (Coralville, 
IA) and used as a forward primer to produce 120, 240, 495, 1000 and 1985bp fragments (reverse 
primers: 5’-GGACATGAGCCAATATAAATGTACA-3’, 5’-GGGCCATTTACCGTAAGTTATG-3’, 
5’-ACGTAGATGTACTGCCAAGTAGGA-3’, 5’-GATGTCAGTAAGACCAATAGGTGC-3’, 5’-
GTGTGAAATACCGCACAGATG-3’, respectively) using PCI-Neo plasmids as template (refer to SI-
3 for sequences). DNA fragment lengths were confirmed through agarose electrophoresis, using TAE 
buffer and 1.5% agarose gels. 
Mobility of flDNA and flDNA lipoplexes was characterized at a 50ng/100uL concentration. 
Lipoplexes were formed and data acquired and analysed as detailed below. 
 2.2.2 Cel l  Culture  and Trans fe c t ion 
Rat L6 myoblast cells were cultured and maintained in Dulbecco’s Modified Eagle Medium 
(DMEM) (Gibco, UK) supplemented with Fetal Bovine Serum (FBS) (10% v/v), 
Penicillin/Streptomycin, Amphostat-B and β-Mercaptoethanol at 37°C in a humidified atmosphere of 
5% CO2.   Trypsinized cells (1x10
4) were seeded onto glass chamber slides (Thermo Fisher Scientific, 
Australia) in antibiotic- and phenol red-free DMEM (10% v/v FBS) 24h prior to transfections. 
CHAPTER TWO: LIPOPLEX DYNAMICS 
 
LIPOPLEX DYNAMICS      42 
The cells were transfected by the DNA fragments using X-Treme Gene 9 (Roche, Germany), 
according to the manufactures’ guidelines.  For each well, 100ng of the flDNA was mixed with 0.3 µL 
of transfection reagent (1:3 DNA:lipid ratio) in antibiotic- and FBS-free DMEM. The lipoplex solution 
was added directly to the cell cultures within chamber slides. For cytoplasmic measurements, the cells 
were imaged between 4-8hr after introduction of the lipoplexes, whereas, nuclear measurements were 
imaged after 36hr. Cell nucleic were counterstained with Hoechst 33342 (1µg/mL) when required. 
 2.2.3 Image Acquis i t ion and Data Analys i s  
Confocal, RICS, iMSD and N&B data was acquired using a Leica True Confocal Scanner – 
Spectro-Photometer 5 (TCS-SP5) inverted confocal microscope (Leica Microsystems, Germany). RICS, 
iMSD and N&B data was acquired using Avalanche Photodiodes (APDs) (Leica Microsystems, 
Germany) through an ISS Vista Becker and Hickl FCS card and software (Becker & Hickl, Germany). 
Images and data were collected using a 63X (1.4 NA) water immersion objective. The Argon 
laser with the 488 laser line activated was set to 4%, 1%, 2% or 0.2% maximum power for either 21-
1985bp fragments and lipoplexes in solution, plasmid in solution, 21-1985bp fragments in cells or 
plasmids in cells, respectively. APDs were fitted with a 500-550nm filter. 256x256 format and pixel 
dwell speed of 32 µs. 633nm laser was used for transmission images, and a 405nm laser for Hoechst 
33342. A heated stage was set at 37°C during imaging. 
RICS, N&B and iMSD data was analysed using the Globals software package, SimFCS 2.0, 
developed at the Laboratory for Fluorescence Dynamics (University of California, Irvine) 
(www.lfd.uci.edu/globals). The PSF waist was determined with eGFP as previously described 227. All 
statistical analyses were performed with Microsoft excel using an unpaired, two-tailed student’s t-test. 
 2.3 Results 
 2.3.1 Character i sat ion o f  DNA fragments  and Lipoplexes 
DNA fragments (120-1985bp) were amplified through PCR. To ensure sample purify and 
product lengths, samples where run through agarose gel electrophoresis (Figure 2.5). All samples  
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Figure 2.5 – Elec trophores i s  o f  DNA Fragments 
PCR products ranging from 120bp to 1985 and the PCI-Neo plasmid in 
its linear and circular form were run through a 1.5% agarose gel to ensure 
sample purify and product lengths. 
 
 
 
 
 
 
 
 
 
 
 
 
 
showed a single band at the appropriate length compared to the molecular weight marker. The PCI-
Neo expression vector was also loaded to the gel in its linear and circular form, the circular form had 
shown two bands demonstrating this plasmids tendency of supercoiling. 
The diffusion of flDNA either complexed or uncomplexed with lipids was determined through 
the RICS. The range of flDNA sizes assessed (21-5485bp) had demonstrated a size dependent mobility 
regardless of whether the flDNA was alone or complexed as lipoplexes (Figure 2.6, Table 2). The DNA 
lipoplexes had demonstrated to be between 60-80% slower than that of the DNA alone. However, the 
circular form of PCI-Neo was faster as a lipoplex, most likely due to the packaging of the flDNA into 
the lipoplex that could have caused further compaction of the supercoiled construct. The circular DNA  
Figure 2.6 – DNA Fragment 
and Lipoplex Dif fus ion 
The free diffusion of the DNA 
fragments, 21bp, 120bp, 240bp, 
495bp, 1kbp, 2kbp and 5.5kbp 
(linear and circular) and lipoplexes 
composed of these fragments demonstrate 
a size dependent mobility. A summary 
of the values obtained has been 
presented in Table 2. 
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plasmid had also demonstrated a faster diffusion compared to the linearized form, although the base 
pair sequences were the same, PCI-Neo is known to supercoil, which can be avoided by linearising the 
plasmid (Figure 2.5).  
Table 2 – Summary for  the Dif fus ion o f  DNA Fragments and Lipoplexes  
DNA Size (bp) Fragment Diffusion (µm2/s) Lipoplex Diffusion (µm2/s) 
21 55.11±0.94 18.65±3.30 
120 20.86±0.48 4.37±0.55 
240 13.16±0.50 2.94±0.27 
495 6.01±0.32 1.96±0.16 
1,000 3.43±0.10 1.26±0.05 
1,985 2.80±0.10 1.10±0.10 
5485 (Linear) 1.23±0.02 0.89±0.05 
5485 (Circular) 1.83±0.03 3.71±0.10 
#refer to SI-4 for complete data series 
 2.3.2 Cytoplasmic  Mobi l i ty  and Dynamics 
In order to elucidate DNA lipoplex mobility properties a global cytoplasmic analysis was 
performed, in which the entire cytoplasm of transfected cells were analysed through RICS. This global 
analysis provided spatial correlations that fit a two species model, a faster species demonstrating a size 
dependent decay in mobility as the flDNA size increased, and a slower species, which was size 
independent (Figure 2.7A and SI 5A).  
Statistical analysis demonstrated that the differences in the fast species were statistically 
significant using the T test, however most of the slow species were statistically insignificant (Figure SI 
5C). The population of cells transfected with different sized flDNA constructs exhibited a large range 
of mobility especially in the slower species, this resulted in a large variance and standard deviation, 
therefore skewing statistical analysis (Figure SI 5A). 
As a result a more detailed analysis approach was employed termed ROI analysis, where small 
discrete areas were analysed (Figure 2.7B and Table 3). Through this approach, only the slower species 
was isolated, as the fast species moved through the ROI too rapidly to be correlated, in which case the 
spatial correlation fit a single species. The ROI analysis provided an average range of motion between 
0.66 µm2/s (21bp) to 0.31 µm2/s (linear plasmid) and did demonstrate a size dependency in motion 
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Figure 2.7 – Cytoplasmic Mobi l i ty  o f  DNA 
(A) The entire cytoplasm of transfected cells was first analysed through the RICS approach providing a global view on the 
mobility of the delivered DNA. Two species were isolated, a slow species exhibiting statistically insignificant differences, 
and a fast species with a size dependent decay in mobility that was between 3.5-8-fold faster than the slow species (n = 
27-51 cells). (B) Small areas of the cells (about 2x2µm in size) in the ROI analysis. The DNA within the cytoplasm 
demonstrated a large range of mobility across all DNA fragments. DNA sizes exhibited a mobility rate that was size 
dependent however a large variance was observed. Additionally, besides the 21bp and circular plasmid, all demonstrated a 
similar maximum rate of motion. All DNA size exhibited complete immobility except for the 21bp indicated by *. 
(minimum cell number = 15, minimum number of values = 83) (^Column was shifted to the right for the circular 
plasmid as it overlapped and covered the graph for the linear plasmid). #, ¶, §, Ω indicate statistically insignificant pairs. 
(diamond in graphs represents circular plasmid) (All values and statistical analysis have been presented in SI 5) 
 
 (Figure SI 5A,B). The ROI analysis resulted in a large range of mobility, the largest being the 21bp 
fragment, 0.02-3.92 µm2/s. In addition, the 21bp lipoplex was the only flDNA sequence that did not 
demonstrate complete immobility (Figure 2.7B). Due to the large range of motion a relatively large 
variance factor was calculated, ranging from 0.37 to 0.06 (21bp and 495bp, respectively) (Figure S1 5A). 
Comparing the two plasmids, the circular conformation had demonstrated a faster rate of 
motion compared to its linearized counterpart even though the base pair size was the same. The 
circular plasmid was on average 40% faster (0.44 µm2/s and 0.31 µm2/s, circular to linear respectively). 
In addition, the circular conformation had shown a maximum rate of motion 2-fold faster than the 
linear (3.39 µm2/s compared to 1.88 µm2/s) (Figure 2.7B).  
Since the ROI analysis involves small areas of the cell the signals obtained and analysed in the 
ROIs can be categorised to address how certain factors that influence the mobility of the flDNA, such 
as the location within the cell (Figure 2.8A SI 5D) and the size of flDNA clusters (Figure 2.8B and SI 
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5D,E). Firstly, the flDNA signal obtained in the cytoplasm was sorted to provide information on how 
the cellular milieu affects mobility along the cell extremity, in the cytoplasm, and the peri-nuclear area. 
Table 3 -  Summary o f  Cytoplasmic Local i sed DNA Part i c l es  
Fragment Location Average Min Max Std Dev Cytoplasmic Avg 
 
21mer 
Extracellular 29.787 13.214 55.045 14.857  
Diffuse 0.674 0.089 1.397 0.462 
0.662 Small 0.827 0.130 3.917 0.755 
Large 0.549 0.025 1.888 0.478 
120bp 
Extracellular 4.064 4.064 4.064   
Diffuse 0.781 0.119 1.113 0.288 
0.484 Small 0.559 0.058 1.667 0.347 
Large 0.272 0.000 0.752 0.210 
240bp 
Extracellular 3.170 2.586 3.753 0.825  
Diffuse 0.489 0.033 1.421 0.364 
0.433 Small 0.462 0.000 1.788 0.340 
Large 0.349 0.000 1.094 0.281 
495bp 
Extracellular 2.070 1.132 2.654 0.657  
Diffuse 0.602 0.165 1.119 0.341 
0.482 Small 0.470 0.128 1.052 0.197 
Large 0.373 0.000 1.062 0.247 
1,000bp 
Extracellular 1.330 1.234 1.422 0.133  
Diffuse 0.480 0.000 0.862 0.261 
0.424 Small 0.406 0.010 0.973 0.240 
Large 0.387 0.000 1.297 0.318 
1,985bp 
Extracellular 1.185 0.846 1.630 0.317  
Diffuse 0.511 0.000 1.940 0.461 
0.361 Small 0.352 0.000 1.667 0.301 
Large 0.218 0.000 0.640 0.189 
Linear 
Plasmid 
Extracellular 1.119 0.793 1.626 0.284  
Diffuse 0.317 0.077 0.962 0.286 
0.302 Small 0.380 0.000 1.889 0.324 
Large 0.243 0.000 0.880 0.222 
Circular 
Plasmid 
Extracellular 2.759 1.608 3.950 0.782  
Diffuse 0.658 0.000 3.392 0.708 
0.447 Small 0.480 0.000 1.827 0.428 
Large 0.337 0.000 1.537 0.317 
*mobility units = µm2/s 
Within the cell, the cytoplasm exhibited faster mobility and the extremity of the cell the slowest. 
These three locations all demonstrated a size dependent reduction in mobility; however, the cell 
extremity had a greater decay where the plasmid demonstrated a 55% decrease in mobility, comparing 
the linear plasmid to the 21bp. Whereas, the cytoplasm and peri-nuclear area displayed decreases of 
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30% and 37%, respectively. In all three areas, the circular plasmid demonstrated a faster mobility 
compared to the linear. 
The ROI analysis also enabled the discrimination between flDNA based on the cluster size 
(Figure 2.8B). Here the flDNA signal was sorted based on whether it was not clustered (diffuse), or as 
small (<500nm diameter) or large (>500nm diameter) clusters. Besides the linear plasmid, all diffuse 
linear DNA had demonstrated to be faster than when it clusters and, large clusters were the slowest. As 
previously observed, the circular DNA had demonstrated to be faster than its linear equivalent. 
The ROI analysis demonstrated that the mobility of flDNA was influenced by the location in the cell 
and the cluster size. Across the flDNA sizes assessed, a similar rate and range of motion was found 
between 120-5472bp, most of which were found to be statistically significant. Due to the large variance 
in mobility it was clear that there is no standard rate of motion in the flDNA. Therefore, the 
mechanisms behind the motion were investigated through the utilisation of the iMSD approach. 
  
Figure 2.8 – Inf luence o f  Cel l  Locat ion and Cluster  s ize 
on Mobi l i ty  
(A) The ROI analysis performed also highlighted that the position 
of the DNA influenced the rate of the motion, as DNA within the 
cytoplasm exhibited the faster rate of motion, followed by the peri-
nuclear then cell extremity regions. (B) ROI analysis enabled the 
separation of the delivered DNA based on the size of the cluster it was 
contained in. Either non-clustered (diffuse), small aggregates 
(<500nm) or large aggregates (>500nm) were selected and all 
exhibited a size dependent mobility. Additionally, the size of the 
clusters influenced the rate of motion as the non-clustered DNA was 
the fastest, followed by the small and then large aggregates. (diamond in 
graphs represents circular plasmid) 
(B)  
 
  
 
 2.3.3 Determining the Mechanica l  Processes  behind DNA Mobi l i ty  
The iMSD approach was applied to further characterize the mobility of lipoplex delivered 
flDNA, of various sizes, by distinguishing between the different mechanisms that could have occurred 
within the cell. The iMSD analysis was able to discriminate between a variety of different mechanisms 
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including random diffusion, active transport, subdiffusion, confined diffusion, transient confinement 
and binding-unbinding events (Figure 2.9 and SI 6). Random diffusion was observed to be the slowest 
mechanism and with a reduction in mobility as the flDNA increased in size (Figure 2.9A and SI 6A). By 
contrast, active transport had been the fastest mechanism observed, and did not appear to have a size 
dependent trend.  
 
Figure 2.9 – iMSD Analys is  o f  Lipoplex DNA 
iMSD analysis demonstrated that DNA size did not influence all means of motion. Motion through AT, CD and AS 
did not demonstrate size dependency additionally these other means of motion had a higher mobility rate than that of RD 
(A-C). Whereas, motion through RD and TC had demonstrated a size dependency across the DNA sizes assessed (D). 
A summary of the values obtained has been presented in Table 4. 
 
The mechanism of confined diffusion had demonstrated no significant differences between the 
21-1000bp range, until the 1985bp and plasmids, which had shown a 30% reduction in mobility (Figure 
2.9A and S6D). Anomalous subdiffusion has shown an inconsistent range of motion across the flDNA 
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sizes, which has shown an almost horizontal linear trend. Transient confinement is defined as a 
temporary entrapment of the particle being observed, which is released during the observation. This 
mechanism of motion displayed a similar size dependent trend as random diffusion, however, was on 
average 2-fold faster. The binding-unbinding events on the other hand had a similar trend to active 
transport, however had a reduced rate of motion of around 25% across the flDNA sizes.  
By including the mechanism of motion in the study of flDNA mobility, the variance in the 
populations was greatly reduced. In the ROI analysis (Figure SI 5A) the average variance in the 
populations was 0.14 ranging from 0.06-0.37 (495bp and 21bp, respectively), whereas the average 
variance determined from the iMSD analysis was 0.05 and ranged from 3.3-6-0.16 (240bp random 
diffusion and 495bp transient confinement, respectively) (Figure SI 6A-F).  
Table 4 – DNA Transport  Mechanism vs .  Mobi l i ty  Rate  
 
 DNA Fragment (bp) 
Means of Motion 21 120 240 495 1000 1985 
5485 
(Linear) 
5485 
(Circular) 
Random Diffusion NA 0.398 0.450 0.340 0.222 0.118 0.125 0.126 
Active Transport 0.711 0.648 0.543 0.503 0.598 0.533 0.533 0.676 
Anomalous Subdiffusion 0.509 0.213 0.619 0.317 0.283 0.402 0.260 0.422 
Confined Diffusion 0.384 0.429 0.399 0.449 0.457 0.437 0.306 0.259 
Transient Confinement 0.727 0.635 0.519 0.492 0.387 0.237 0.350 0.327 
Binding-Unbinding 0.741 0.459 0.468 0.450 0.319 0.368 0.356 0.493 
*mobility units = µm2/s 
#refer to SI-6 for complete data series 
 
In addition, the iMSD approach also demonstrated a spatially distributed trend in the 
mechanisms of motion observed (Figure 2.10). Along the cell extremity, more non-active mechanisms 
were detected including; confined diffusion and subdiffusion, as well as transient confinement, which 
may have been the release of the DNA lipoplexes from endosomes. Binding-unbinding events typically 
attributed to 25-30% of events regardless of the location. Motion within the cytoplasm on the other 
hand was mostly attributed to active transportation. Once within the peri-nuclear region, the flDNA 
motion was mostly due to non-active mechanisms again (i.e. confined diffusion and subdiffusion). 
Finally in the nucleus, only confined diffusion and subdiffusion was exclusively observed. Across the 
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flDNA sizes this trend was observed regardless of the size delivered. The only major difference 
between fragments was an increase in immobility as the flDNA increased in size (charts for all DNA 
sizes are shown in Figure SI 6G).  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10 – Locat ion-spec i f i c  Distr ibut ion o f  Transport  Mechanisms 
The mechanisms of motion were sorted based on the location within the cell as being either along the extremities of the cell, 
within the cytoplasm, in the peri-nuclear area or within the nucleus. In this figure the cell populations transfected with the 
240bp and 1985bp fragments have been presented. The 1985bp population had demonstrated a greater distribution of 
immobility compared to the 240bp. Along the cell extremities and in the peri-nuclear region, a greater amount of AS, 
CD and TC was present compared to the mobility within the cytoplasm which had a greater distribution of AT. Within 
the nucleus, only AS and CD was observed. Pie charts for all DNA sizes have been presented in SI 6G. 
 
Within a cellular system there is expected to be variability, which was observed and presented in 
Figure 26, showing cells transfected with the 120bp, 1000bp, 1985bp or linearized 5485bp plasmid 
fragments (A-D, respectively). In Figure 2.11, each cell is presented with ROI’s each relevant to a 
specific iMSD curve example. The expected iMSD curve of each mechanism of motion has been 
previously presented (Figure 2.4). Additionally, for each cell the number of each mechanism of motion 
and range of motion has been shown. Within the single cell a range of mobility was observed, in some 
cases ranging 10-fold (Figure 2.11D). The range of mobility has been attributed to the variety of 
mechanisms of motion that are involved in the mobility of the flDNA. Each cell analysed and those 
presented here contain a range of different means of transport mechanisms, including RD, AT, AS, 
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CD, TC and binding-unbinding events. Across the cell populations acquired and analysed this was 
observed for all DNA constructs. Additional examples have been provided in SI 7. 
 
Figure 2.11 – Examples o f  DNA dynamics o f  vary ing s izes 
Example of RICS and iMSD analysis on cells transfected by 120, 1000, 1985 and linear 5.5kbp fragments (A-D) 
demonstrate that within a single cell a range of different means of motion and rates of mobility can be identified examples 
of. For the individual cells the occurrence of each means of motions has been tabulated, as well as the range of mobility 
observed. The mechanism of motion have been selected for each cell showing RD (Blue), AT (Red), AS (Green), CD 
(orange) and Binding-unbinding (Black). Size of is 16.5x16.5um. 
 
 2.3.4 Nuclear Dynamics  
Finally the dynamics of the flDNA within the nucleus was explored (Figure 2.12 and SI 8). 
These events were less frequently observed (approximately 25% of cells containing cytoplasmic 
flDNA), however RICS analysis had demonstrated a rapid mobility in the nucleus compared to the 
cytoplasm that had fit a single species model. Within the nucleus, the flDNA had shown a 3.4- to 6.5-
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fold (120 and 1000, respectively) increase compared to the cytoplasm. The overall trend in mobility had 
shown a size dependence, however the 120-495bp fragments had anomalous values from this trend.  
In addition to the mobility being explored, the extent of nuclear localisation was explored by 
quantifying the flDNA through Number and Molecular Brightness (N&B) analysis. Through the 
number (N) component of the approach, it was found that the 240bp fragment had accumulated in the 
nucleus the most (Figure 2.12B and C). The amount of nuclear localisation of flDNA decreased as the 
fragment size increased. The two plasmids appeared to have the lowest amount of flDNA (120bp 
fragment N = 2.2 compared to N=0.44 and 0.18 in the linear and circular plasmids, respectively). The 
flDNA ≤1985bp had shown a diffuse distribution in the nucleus, whereas the linear and circular 
plasmid were maintained in clusters, mostly along the edge of the nucleus. 
 
 
 
 
 
 
Figure 2.12 – Nuclear Local i sed DNA/Lipoplex 
Nuclear Dynamics and Particle Number of Delivered DNA. (A) Size dependent mobility and (B) DNA particle 
number (N) in cells transfected with a range of DNA sizes. (C) N&B analysis provides the number calculation with an 
N map showing the DNA particle number within the nucleus after 36h. All images are to the small scale. (n = 10 (21-
1985bp) and 8 (plasmids)) (images 16.5x16.5µm) (diamond in graphs represents circular plasmid) 
 2.4 Discussion and Conclusion 
Characterisation of the different DNA fragments ranging between 21bp-5.5kbp demonstrated a 
mobility rate and size dependent diffusion consistent to previously published studies 140. Except for the 
495bp fragment and 5.5kbp linear fragment, in which case the mobility rates were 2-fold and 1.5-fold 
faster than Lukacs et al. (2000), respectively. However, the study undertaken by Roberston et al. 2006, 
who quantified DNA diffusion by tracking Brownian motion identified a similar mobility rate for a 
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5.9kbp fragment, and additionally demonstrated that circular DNA has a faster mobility rate than 
linear, consistent with to the work presented here using RICS 238. 
The rate of motion throughout the cytoplasm had a significant range of mobility, in some cases 
having a range of 10- to 100-fold in a single cell, which has been demonstrated in a previous study 239. 
However, the rate of mobility identified through RICS was considerably different to other studies also, 
such as the one carried out by Lukacs et al. (2000) monitoring DNA diffusion through FRAP. The 
study reported by Suh, et al. 2004 240, had shown a similar range of mobility in a DNA fragment of 
2kbp but with an average rate 2-fold less than the results reported in study. This inconsistency in 
mobility rates supports the notion that the mobility of DNA lipoplexes is the combination of cell type, 
DNA specific and delivery-mode dependent nature of lipoplex gene delivery but could also be 
influenced by the approach of analysis applied.  
Nonetheless, the rates of mobility reported in this thesis are similar to those expected within the 
cell. Given that the DNA lipoplexes are anticipated to be entrapped within endosomes after cellular 
entry 185, the mobility of the DNA lipoplexes should reflect the transport properties of endosomes. The 
rate of motion of retrograde acidified compartments at 37°C has been identified to be at 0.45 um2/s 241 
and dynein-mediated transport estimated to reach up to 0.7 um2/s 242, these rates match the 
approximate range of active transport observed within the cytoplasm of this study. 
The biophysical mechanisms behind the flDNA mobility demonstrated a similar course of a 
virus (influenza) 243 and PEI-DNA complex 142, which follows a 3 phase process; (i) slow directed into 
the cell, (ii) confined motion along the edge of the cell, followed by (iii) fast directed motion along 
microtubules.  RICS and iMSD analysis of lipoplex delivered flDNA demonstrate further phases of 
mobility including: non-active motion within the peri-nuclear area, and then confined- and sub-
diffusion in the nucleus.   
Suh et al. (2004) identified that approximately 80% of DNA/PEI complexes displayed AS and 
immobile transport characteristics, which would include CD, in half of their observations. This 
however, has not been the case in this study, which demonstrates one third of the observations 
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accounting for AT and a combination of CD, TC, RD and AS responsible for another third of the 
observations. The final third of iMSD observations demonstrated a binding-unbinding signature and 
had a similar mobility rate as the AT events. This phenomenon is most likely due to binding and 
unbinding events of the DNA with microtubules and other cellular structures and/or components 240, 
possibly due to the on-off kinetics of endosomes along microtubules 244,245.  
It was noted that an increase in immobility was observed as the DNA size increased, which was 
expected, as the larger particles would be restricted in how fast they can diffuse within the cytoplasm. 
However, since the occurrence of immobility was the only means of motion influenced by the DNA 
size it can be concluded that DNA, up to 5.5kbp does not influence the mechanisms of motion 
involved in the cell. A series of further studies could have been utilised to support this statement for 
this project such as reducing temperatures, ATP reduction experiments or microtubule 
depolymerisation through drugs such as nocodazole, however these experiments have already been 
performed by others 50,143,217,239. These studies demonstrate that by inhibiting or reduction active 
transportation the rate of motion is reduced in gene delivery or the expression of the transgene is either 
reduced or completely inhibited.  
Entry into the nucleus creates a bottleneck in the cytoplasm, resulting in the accumulation of 
the flDNA in the peri-nuclear region, consistent with the study by Suh et al. (2004), who also found 
that the main means of motion in this area is AS and CD.   
Once within the nucleus, the flDNA in this study demonstrated a very different mobility to 
previous reports. Lukacs et al. (2000) identified a rapid accumulation from the cytoplasm into the 
nucleus of only a 21bp fragment, while larger DNA fragments were also assessed in their study. When 
microinjected directly to the nucleus all DNA fragments were found to be immobile 140. In contrast, 
Shimizu et al. (2005) demonstrated that microinjected DNA <400bp rapidly diffused throughout the 
nucleus, however the mobility rate was not recorded in the study 102. Nevertheless, studies addressing 
the nuclear dynamics of other macromolecules have shown a similar range to that observed here for 
flDNA. Politz et al. (1998) found the mobility of oligonucleotides to be 9 um2/s 246.  Further, 
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endogenous intranuclear mRNA, appeared to move at an average rate of 0.6 um2/s 247, transcription 
factors ranging from 0.34 – 1.99 um2/s 248 and nuclear proteins, HMG17, SF2/ASF and Fibrillarin 
diffuse at 0.45, 0.24 and 0.53 um2/s 199, respectively. The mobility values of flDNA analysed via RICS 
and iMSD are consistent with the nuclear dynamics of other macromolecules reported above. 
Within the nucleus, the flDNA analysed here, demonstrated only two forms of motion, either 
CD or AS. This occurrence fits the model of nuclear dynamics of macromolecules around chromatin 
structures presented by Hinde et al. (2011). Hinde et al. (2011) demonstrated that chromatin poses as 
either a complete barrier or a penetrable barrier where eGFP was able to pass through the structure 249. 
It is likely AS would be due to the chromatin and intra-nuclear DNA and other structures acting as a 
barrier and crowding the space, whereas the confined diffusion could be a result of either crowding 
within the area or as a result of the delivered DNA passing through less dense chromatin. 
The distribution of nuclear localized flDNA in our study had shown a similar pattern to a 
previous study. Mearini et al. (2004) had shown that 3000bp DNA plasmid delivered in the nucleus is 
excluded from specific nuclear compartments including the nucleolus and PML bodies but had a 
similar distribution, to but no association with the SAF-A nuclear scaffolding protein 207. In the results 
presented here, the flDNA between 21bp-2kbp had shown a similar pattern within the nucleus as 
Mearini et al. (2004), but the largest flDNA fragment (5.5kpb) did not. However, it has been identified 
that some DNA viral vectors move very little within the nucleus from their site of entry, resulting in 
accumulation of the viral vector genome along the periphery of the nucleus 210. 
In summary, the application of RICS and iMSD to characterise the mobility of different flDNA 
particle sizes, delivered to live cells, has enabled the quantification and the mechanics of the motion of 
these lipoplexes.  The goal of the study was to assess how the DNA size influences the dynamics and 
mechanics of motion throughout the cell in real time. Further, this model can be applied to track any 
form of nucleotide, such as RNA and lncRNA, or other macromolecules that can be fluorescently 
labelled. In addition, the study has demonstrated the potential of the RICS and iMSD approaches for 
future investigations into the dynamics of delivered macromolecules.  
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3 Live Cell Characterisation of DNA 
Aggregation Delivered through Lipofection 
 
 3.1 Introduction 
Molecular aggregation within the live cell can have a significant biological, pathological and 
clinical impact, however it has received limited attention to date. Several examples of aggregation 
significance includes the necessary aggregation of proteins in adhesion complexes 4, aggregation of 
proteins in disease states such as Huntington’s Disease 250 and Alzheimer’s Disease 251, which can 
influence disease progression, and aggregation nanoparticles in therapeutic delivery that can hamper 
drug delivery 252.  
A likely reason for this lack of research efforts has been a limitation in quantifying aggregation 
within the live cell. It is possible to observe cluster formation and determine cluster size, however 
quantifying aggregation states appears to be a difficult task at this juncture. Nevertheless, the FCS-
based Number and Brightness (N&B), more recently developed, enables the real-time quantification of 
aggregation in live cell samples by acquiring the number and brightness (aggregation) of mobile 
particles within a sample 2,253.   
 3.1.1 Number and Molecular Brightness  Approach 
Before the development of N&B, a common and challenging problem was determining the 
average number and brightness of molecules within fluorescence microscopy images 2. A common 
practice that was widely applied to estimate the number of molecules within a pixel was to calibrate the 
fluorescence intensity with a fluorescent solution of a known concentration.  However, even though 
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this practice provides the total number of fluorophores, it does not provide any information on the 
state of aggregation of the fluorophores as a few bright aggregates can show the same fluorescence 
intensity as many dim molecules 2. 
It is possible to obtain the brightness of a particle separately from the number of particles using 
FCS in a given sample. FCS has been used to determine the degree of aggregation of fluorescent 
proteins within a solution as the occupation number of particles in an open volume follows a Poisson 
distribution 2.  
Moment analysis was then proposed by Qian and Elson (1990), which involved the application 
of FCS to determine the number of particles by calculating the ratio of the variance to the square of the 
average intensity, which is proportional to 1/N (where N is the number of particles in an open volume) 
254.  The brightness of fluorescent particles is then obtained by calculating the ratio of the average 
intensity to the number of particles.  However, the approach can only be applied to homogenous 
systems, as multiple species of different brightness cannot be resolved 2.  
A recently proposed approach, known as Photon Counting Histogram (PCH) analysis, is 
capable of resolving multiple species of brightness in a homogenous solution.  The PCH analysis 
considers the entire distribution of photon counts rather than only the first and second moments 
(moment analysis) in a given solution 2,12.  However, the PCH method is computationally slow for live 
cell analysis as it requires a relatively large number of observations at each pixel 2. 
Moment analysis, PCH and correlation methods are all capable of determining the number and 
state of aggregation to an extent.  The N&B approach, is a combination and extension of these 
methods, and is capable of determining the number and degree of aggregation of multiple species of 
molecules within a live cell in real time 2,253.   
In order to obtain the number and brightness of particles at each pixel of an image, the first and 
second moments of intensity must be calculated to determine the variance factors of the fluctuations 2.  
This is performed by the following equations: 
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𝒌𝒌 =   
𝒌𝒌𝒊𝒊𝒊𝒊
𝑲𝑲
 
 
Equation 11 -  N&B First  Moment – Average 
 
 
𝝈𝝈𝟐𝟐 =   
𝒌𝒌𝒊𝒊 − 𝒌𝒌𝒊𝒊
𝟐𝟐
𝑲𝑲
 
Equation 12 -  N&B Second Moment -  Variance 
where K equals the number of frames, which should be 2 when using consecutive images and 𝑘𝑘? is the 
intensity at a given pixel.   
Following Figure 3.1, there are two examples, pixel k that contains very large aggregates and 
pixel j, which contains a pool of many monomeric particles. Following the first moment calculation the 
same average of the fluctuations over time is obtained, demonstrating that confocal microscopy cannot 
distinguish between aggregative states. However, following the second moment calculation, the 
variance of the frequency can be used to distinguish between the states of aggregation. The variance of 
intensity measurements can be led by a combination of two terms, variance due to occupation number 
(σn
2) and variance due to the count statistics (or shot noise) of detectors (σd
2); other intensity changes to 
pixels, such as bleaching and cell movement are also corrected.  
Figure 3.1 – N&B First  and 
Second Moments 
In this schematic two examples have been 
presented, pixel k containing few large 
aggregates and pixel j containing many 
monomeric particles. In both examples 
the average intensity is the same (black 
line in top graph), however over time 
pixel k has larger fluctuations. This 
critical difference results in pixel k 
having a greater and broader variance σ 
than pixel j (lower graphs). Thereby 
enabling the aggregative state to be 
determined. (Image courtesy of Dr 
Michelle A. Digman) 
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The values obtained in the first and second moment calculations are then used to determine the 
aggregative state and particle number using additional algorithms.  The molecular brightness (𝜀𝜀) is 
defined as “the number of photons emitted per second per molecule when the molecule is in the centre 
of the illumination volume” and is represented as the units counts/second/molecule (cpsm), reflecting 
the cluster or aggregation of fluorophores, and n indicates “the average number of molecules in the 
illuminated volume” 2.  
The apparent brightness (B) for each pixel is defined as “the ratio of the variance to the average 
intensity” and the apparent number of particles (N) is defined as “the ratio of the total intensity of B”.  
These values are calculated by the following equations: 
𝐵𝐵 =   
𝜎𝜎?
𝑘𝑘
=   
𝜎𝜎??
𝑘𝑘
+   
𝜎𝜎?
?
𝑘𝑘
=   
𝜀𝜀?𝑛𝑛
𝜀𝜀𝜀𝜀
+
𝜎𝜎?
?
𝑘𝑘
=   𝜀𝜀 + 1   
Equation 13 -  N&B Apparent Brightness B 
 
 
𝑵𝑵 =   
𝒌𝒌 𝟐𝟐
𝝈𝝈𝟐𝟐
=   
𝜺𝜺𝜺𝜺
𝜺𝜺+ 𝟏𝟏
 
Equation 14 -  N&B Apparent Number N 
 
An important note to take in these calculations is that the value of B is related to the brightness 
of particles (𝜀𝜀) but independent to the number of particles, and the value N is directly proportional to 
the number of particles (n).  The equations for Apparent N and B are rewritten to give a value for the 
true number of molecules (n) and the true molecule brightness (𝜀𝜀), as expressed below: 
𝜀𝜀 =   
𝜎𝜎? −    𝑘𝑘
𝑘𝑘
 
Equation 15 -  N&B True Molecular Brightness  
 
𝑛𝑛 =   
𝑘𝑘 ?
𝜎𝜎? −    𝑘𝑘
 
Equation 16 -  N&B True Part i c l e  Number 
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The variation due to the occupation number is proportional to the square of the molecular 
brightness and variance due to the detector being equal to the average intensity.  The variations seen 
can be defined by the following equations: 
𝜎𝜎?? =    𝜀𝜀?𝑛𝑛 
Equation 17 -  N&B Variance due to Part i c l e  Number Fluctuat ions 
stating that the variance is due to the number fluctuations depending on the particle brightness squared.  
𝜎𝜎?
? =   𝜀𝜀𝜀𝜀 
Equation 18 -  N&B Variance due to Detec tor  Shot Noise 
stating that the detector variance is equal to the intensity.  
𝑘𝑘 =   𝜀𝜀𝜀𝜀 
Equation 19 -  N&B Average Intensi ty  
stating that the average intensity is due to the molecular brightness times the average particle number.  
At present the N&B approach has been applied to quantify aggregation of proteins, which are 
fluorescently labelled, in which sequences encoding for the protein of interest is tagged to a fluorescent 
protein by way of a fusion gene. Through this process a number of significant studies have resulted 
including the quantification of the huntington protein in Huntington’s Disease 250, oligomerization of 
the LRRK2 protein, which is relevant in Parkinson’s Disease 255, and aggregation of the VP40 protein in 
Ebola virus  infections, a protein that has biological significance in the virus’ lifecycle including viral 
transcriptional morphogenesis, packaging and budding of mature virions 256. These noted studies 
address processes involved with endogenous proteins, rather than the delivery of components of 
therapeutic interest including lipoplexes, carbon nanoparticles and drugs, which are likely to interact 
with the cell differently than endogenous or gene-encoded introduced proteins.  
 3.1.2 DNA Lipoplexes as an Aggregat ion Model  
The aggregation of DNA complexed with cationic lipids forming lipoplexes for gene delivery 
has not been fully characterised or quantified within live cells. The aggregation of lipid-based gene 
delivery is of interest given that it has previously been noted as being a major barrier to gene delivery 50, 
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but the phenomena has yet to be addressed in live cells. Once aggregated, the delivery of DNA may be 
hampered for a number of reasons, such as an increase in size causing reduced mobility (as seen in the 
Chapter 2). However, aggregation of lipoplexes has yet to be assessed in the live cell and real time.  
The aggregation of DNA complexed with (non-viral) delivery vectors has been addressed in 
several studies, including the potential mechanisms of aggregation 257 however, these were not cell-
based studies 258,259. To our knowledge no study has identified the location, state, nature or amount of 
aggregation that occurs within the cytoplasm or nucleus of live cells.  
Some studies have addressed the aggregation of polyplex aggregation in solutions; for example, 
Sharma et al. (2005) determined that the aggregation of PEI complexes is reduced in decreased pH and 
higher viscosity (amongst other factors) 257. A study undertaken by Escriou et al. (1998), assessed the 
effects of serum of gene delivery using DNA/lipopolyamine complexes and noted in the presence of 
serum the DNA complexes accumulate in many small masses, whereas in the absence of serum, the 
DNA was found in few but large bodies throughout the cytoplasm 260. However, Escriou’s research 
effort was unable to quantify the aggregation that may have occurred.  
Through the application of the N&B approach a model for flDNA delivery in live cells has 
been presented to quantify intracellular aggregation. Aggregation in the delivery of such compounds 
poses as a significant barrier, in which case large aggregates may not be able to traffic through the cell. 
Additionally, the extent of delivered molecules that do not aggregate would be of interest as these could 
be therapeutically significant. Therefore, in this model the application of the N&B approach to 
characterise flDNA aggregation in live cells is presented. 
 3.2 Materials and Methods 
 3.2.1 DNA Fragments  and Lipoplex formation 
The PCI-Neo plasmid (5472bps) (Promega, Madison, WI) was labelled with Alexa Fluor®488 
using the ULYSIS Nucleic Acid Labelling Kit (Molecular Probes, Eugene, OR) according to the 
manufacturers’ guidelines: 1µg of the plasmid was denatured at 95°C for 5 minutes. The Alexa 
CHAPTER THREE: LIPOPLEX AGGREGATION 
 
LIPOPLEX AGGREGATION      62 
Fluor®488 ULYSIS labelling reagent stock solution was added and the reaction was incubated at 80°C 
for 15 minutes, then stopped on ice. The labelled plasmid was either kept circular or linearized by 
digesting with BgI II. 
Varying sizes of DNA were produced through PCR using an Alexa Fluor488 labeled 21bp 
oligonucleotide (5’-AF488-TCAATATTGGCCATTAGCCAT-3’) (synthesised by Integrated DNA 
Technologies (Coralville, IA)) as a forward primer to produce 120, 240, 495, 1000 and 1985bp 
fragments (reverse primers: 5’-GGACATGAGCCAATATAAATGTACA-3’, 5’-
GGGCCATTTACCGTAAGTTATG-3’, 5’-ACGTAGATGTACTGCCAAGTAGGA-3’, 5’-
GATGTCAGTAAGACCAATAGGTGC-3’, 5’-GTGTGAAATACCGCACAGATG-3’, respectively) 
using PCI-Neo mammalian vectors (Promega, Madison WI) as template.  
Lipoplexes were formed using X-Treme Gene 9 (Roche, Germany) according to the 
manufactures’ guidelines with a DNA:Lipid ratio of 1:3. Lipoplexes were formed and either transfected 
or imaged in Dulbecco’s Modified Eagle Medium (DMEM) (0% FBS). Briefly, for each well 150ng of 
the labelled DNA was mixed with 0.45 µL of transfection reagent in antibiotic- and FBS-free DMEM 
and incubated for 20min before being used immediately.  
 3.2.2 Cel l  Culture  
Rat L6 myoblast cells were cultured in DMEM supplemented with FBS (10% v/v), 
Penicillin/Streptomycin, Amphostat- B and β-Mercaptoethanol at 37°C in a humidified atmosphere of 
5% CO2. Trypsinized cells (1x10
5) were seeded onto 35mm diameter dishes with optic glass (MatTek, 
Ashland, MA) coated with poly-L-lysine (Invitrogen, Carlsband, CA) in antibiotic-free DMEM (10% 
v/v FBS) 24h prior to transfections. 
 3.2.3 Microscope Conf igurat ion for  N&B and RICS Analys i s   
Data was collected on either a FluoView 1000 (FV1000) (Olympus, Japan) or a True Confocal 
Scanner – Spectro-Photometer 5 (TCS-SP5) (Leica Microsystems, Germany): 
The FV1000 system was fitted with a 60X (1.2 NA) water immersion objective lens. Images 
were collected using a 505-525nm-bandwidth filter and a 488/543/633 dichroic mirror. The 488nm 
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laser pathway was activated and set to 0.5% power. Data acquisition was initiated through the SimFCS 
software. The TCS-SP5 was coupled with ISS Vista Becker and Hickl software (Becker & Hickl 
GmbH, Germany). Avalanche photodiodes (APDs) (Leica Microsystems, Germany) were utilised with 
a 500-550nm filter. The microscope was fitted with a 63X (1.4 NA) water immersion objective. The 
Argon laser with the 488-laser line activated. Data acquisition was initiated through the ISS Vista 
Becker and Hickl software. Both systems were set to acquire a pixel resolution of 256x256 or 512x512, 
with a pixel size of 50nm and pixel dwell time 32 µs, respectively. Sampling time was set to capture 100 
frames. 
Aggregation of DNA plasmids and lipoplexes were characterized at a 50ng/µL concentration 
(total volume: 300 µL, 150ng DNA) in DMEM without FBS. 
To observe cellular entry and cytoplasmic localized lipoplexes the cells were imaged 
immediately after the introduction of the DNA and then continuously for 8 hours. In order to observe 
the lipoplex/DNA within the nucleus, cells were incubated between 24-48h in the presence of the 
lipoplex solution prior to imaging. In order to identify the positioning of the nucleus, cells were 
counterstained with Hoechst 33342 (1µg/mL) and imaged with a 405nm diode laser. The N&B and 
RICS data were analysed using the Globals software package, SimFCS, developed at the Laboratory for 
Fluorescence Dynamics at the University of California, Irvine (www.lfd.uci.edu/globals). For the N&B 
analysis data sets were detrended and a moving average of 10 frames was used for RICS analysis. The 
waist of the PSF was determined with (30nM) fluorescein for the RICS analysis. 
 3.3 Results 
 3.3.1 Solut ion Character i sat ion 
In order to quantify aggregation the N&B approach presents a histogram known as a B vs. 
Intensity plot. In this plot every pixel of the image series has been processed through the algorithms 
presented earlier, as a result each pixel has it’s own B value, which is used to calculate the aggregative 
state. Since B (the apparent brightness) is equal to the true brightness (ε) + 1, and ε is represented as 
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counts/second/molecule (cpsm), values can be substituted to obtain the true brightness of particles, 
which is used to determine the aggregative state of particles as a dimer (aggregate of 2) will be 2-fold 
brighter than a monomer (non-aggregated particle). The true brightness will increase magnitudes 
greater than that of the monomer depending on the aggregative state. 
The N&B approach demonstrated flDNA alone in solution did not aggregate whereas flDNA 
and lipoplex do aggregate. However, once complexed with lipids forming lipoplexes the flDNA had 
demonstrated a substantial extent of aggregation with an 8-fold increase in the highest B values 
obtained (Figure 3.2A-C).  The flDNA and lipoplexes in solution appeared to have average B values 
similar to the naked flDNA (a homogenous solution), whereas the lipoplexes had formed few but large 
aggregates. As a consequence, a majority of analysed area contained no signal, resulting in a lower 
average (Figure 3.2D). 
 
Figure 3.2 – Intr ins i c  Aggregat ion o f  DNA Plasmid and Lipoplexes  
The aggregation of either naked (A) or lipid-complexed  (C) DNA was explored through the application of the N&B 
approach. The N&B approach provides information through a B vs Intensity plot, where each pixel is allocated a 
location based on these values, a series of maps including a B map (providing a pictorial presentation of aggregation) (A, 
C) and histograms (B).  The N&B approach had demonstrated that the DNA alone did not aggregate, whereas once 
complexed with lipids forming lipoplexes, large aggregates were observed in solution.  The maximum extend of aggregation 
was 8-fold greater in the lipoplexes, whereas the average B was similar (D). The similar average B was attributed to the 
naked DNA being a homogenous solution, whereas the lipoplex solution only contained few but large aggregates. (**** p 
<0.0001) ) (graphs depict mean ± se) 
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 3.3.2 Character i s ing Live  Cel l  Aggregat ion o f  Lipoplexes  
During the characterisation of flDNA lipoplex aggregation in the model myoblast cell line, 
lipoplexes were formed with the flDNA plasmid. Once administered, the cells were imaged at various 
time points in order to elucidate aggregation at different times and processes. Initially, data acquisition 
and analysis was conducted, upon addition of the lipoplexes until 4h, internalisation of the lipoplexes. 
An internalisation event was identified when the fluorescence signal (the flDNA coupled with 
lipids) had accumulated along the extracellular side of the membrane. When the event was identified 
images were collected over 1 hr or until the lipoplex was completely internalised (additional 
observations displayed in SI 8). The complete internalisation process of a single event is presented in 
Figure 3.3 (and more examples provided in SI 9).  
During the internalisation of lipoplexes, the lipoplexes first accumulated along the plasma 
membrane where a membrane invagination was located (Column A). At the 5 min time point, the 
membrane invagination is clearly observed in the intensity image as the flDNA enters the forming pit 
(Ai). The N map (Aii) shows a small number of particles within the pit (N = 2.9), and both the B map 
(Aiii) and N&B analysis (Aiv, v) demonstrate average aggregation of B=1.4, within the invagination but 
along the membrane. After 5 min (Column B), the accumulated flDNA in the pit increased in intensity 
(Bi), number (Bii) and aggregation (Biii-v). By 20 min (Column C), the invagination of the membrane 
was very clear (Ci, ii) and the aggregation (B = 1.6) and particle number (N = 5.5) had increased, 
however the aggregation that appeared along the membrane, adjacent to the invagination dissipated or 
entered the invagination (Ciii-v). At the 30 min time point (Column D), the internalised flDNA within 
the pit shows a clear single aggregation (Di), that is both greater in number (Dii) (N = 5.8) and 
aggregative state (Diii-v) (B = 1.8) compared to previous time points. Finally, after an hour of imaging 
(Column E), the flDNA appeared to have pulled away from the membrane (Ei) and the N&B analysis 
had demonstrated the largest amount to aggregation. 
Signal for the flDNA was observed throughout the cell cytoplasm 6h after the administration of 
the flDNA lipoplexes (Figure 3.4A). The N&B analysis, which provides a series of maps enabled an  
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Figure 3.3 – Aggregat ion o f  DNA Lipoplexes during Internal i sat ion 
The internalisation process was observed over a one hour time period and presented at 5, 10, 20, 30 and 60min time 
points (Columns A-E). The intensity (Int) maps (Row i) show the fluorescence images (scale: Low  
High). Pictorial representation of the N and B values provides maps for both values (Rows ii and iii) (N scale: 0 
 100) (B scale: 0  10).  The B vs. Intensity plots (Row iv) and Selection (Sel) 
maps (Row v) enabled the identification of the aggregative state. Through N&B analysis the pit had firstly contained 
mostly monomeric DNA particles (red, 330 cpsm) with the lesser aggregative state of 44 DNA particles forming within 
the pit (green, 14 670 cpsm).  As the internalisation process continued, the aggregative amount and state present 
increased, which included aggregation of 110 DNA particles (blue, 37 670 cpsm). The combination of the B, N and 
selection maps demonstrate the aggregation of the DNA increasing as the lipoplexes accumulate within the pit during the 
internalisation process. The data sets were collected on the Olympus FV1000 system. 100 frames were used for these 
measurements. Ex and Cy represent the extracellular and cytoplasmic locations, respectively. Images are 5.4µm x 5.4µm. 
 
Ex 
 
              Cy 
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insight into the particle number within the cell, which appeared as an accumulation of the flDNA along 
the extremity of the cell, and the presence of flDNA throughout the rest of the cytoplasm (Figure 
3.4B). In the cell presented, an extent of aggregation was found throughout the cell wherever the 
flDNA was present. Aggregate ‘hotspots’ were found primarily along the extremity of the cell, and in 
the peri-nuclear area. The highest aggregative state found in the cell was aggregates containing up to 
124 flDNA particles (124mer) found in the peri-nuclear area (Figure 3.4 C, D). 
Figure 3.4 – Determining Aggregat ion 
in the Live Cel l  
Myoblast cells were transfected with an Alexa 
Fluor488 labelled DNA plasmid facilitated by 
lipofection. After 6h, the N&B analysis had 
demonstrated DNA distributed through the cell 
cytoplasm that had demonstrated extensive 
aggregation through the cell in an intensity map (A) 
and N map (B). The aggregative analysis 
demonstrated aggregation through the cytoplasm 
with a maximum aggregative state of 124 DNA 
particles, which were located in clusters and hotpots 
mostly in the peri-nucelar region and extremity of 
the cell (C, D). 
 
 
 
 
 
 
Region-of-Interest (ROI) analysis was performed on the population of cells transfected with the 
plasmid DNA between 4-8h providing details on small areas within the cell. The N&B analysis had 
demonstrated a trend in the aggregation and particle number based on the location in the cell (Figure 
3.5). The greatest extent of aggregation was generally observed along the cell extremity, followed by the 
peri-nuclear region and between these locations listed, the least amount of aggregation was identified in 
the core of the cytoplasm (Figure 3.5B). In addition, the N&B analysis provided details on the particle 
number of flDNA in these areas, showing that the extremity of the cell also contained the largest 
amount of flDNA. The particle number had decreased the further the flDNA traversed into the cell, as 
the peri-nuclear region had exhibited the lowest amount of flDNA (Figure 3.5C).  
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Figure 3.5 – Spatial  Aggregat ion and Part i c l e  Number 
A ROI analysis was performed highlighting the cell edge (circles), cytoplasm (squares) and peri-nuclear region (triangles) of 
the average B (A), maximum B (B) and particle number (C). The red line in the box represents the mean. (Data values 
presented in SI 10) (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) (graphs depict mean ± se) 
 
Once with the cell a range of aggregation was observed resulting in a large variance between 
cells, and at different locations within a single cell (Figure 3.5). As seen in Figure 3.4, the flDNA within 
the cytoplasm is maintained in clusters containing different extents or degrees of aggregation. 
Therefore, the flDNA is not maintained at a single aggregative state, resulting in the wide variance 
observed.  
During the ROI analysis, the Raster Image Correlation Spectroscopy (RICS) approach was also 
applied, providing a quantitative insight into the mobility of the areas addressed. Through this 
approach, it was demonstrated that the flDNA aggregation influenced the mobility of the flDNA. As 
the aggregation increased, the rate of motion had decreased in the three areas of the cell assessed 
(Figure 3.6). This trend was most apparent in the cytoplasm where all flDNA with a B value greater 
than 6, an aggregative state of approximately 50 flDNA particles, did not exceed a mobility rate of 0.25 
um2/s. On the contrary, the fastest rate of motion observed was 0.79 um2/s in the region containing an  
Figure 3.6 – Inf luence o f  Aggregat ive  
States  on DNA Mobil i ty  
The addition of the RICS approach 
demonstrated that the ROIs selected had 
demonstrated a trend where the smaller 
aggregative states had a faster mobility rate (n 
= 12 cells, total of 81 ROIs). (Data values 
presented in SI 10) 
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aggregation of 20 flDNA particles (about 60% greater than the lowest aggregative state observed in the 
ROI analysis of 12 flDNA particles). 
Following an incubation of 36h, the aggregation of the flDNA was observed within the nucleus 
(Figure 3.7). Cells were counterstained with Hoechst 33342 in order to identify the position of the 
nucleus demonstrating the localisation of flDNA within the nucleus (Figure 3.7A). Within the nucleus, 
flDNA aggregates up to 58 particles were maintained in small clusters around the periphery of the 
nucleus, and a larger cluster in the centre (Figure 3.7B, C). In addition to flDNA localised to the 
nucleus, an extensive extent of aggregation was also observed within the peri-nuclear area along the 
nuclear envelope. Comparing the aggregation and particle number between the nucleus and cytoplasm 
(Figure 3.7D), the N&B analysis demonstrated that the aggregative state was 3-fold lower in the 
nucleus. In addition, the particle number within the nucleus was shown to be 90% less than the 
cytoplasm.  
 
Figure 3.7 – Aggregat ion o f  Del ivered DNA within the Nucleus 
Cells were incubated in the presence of the lipoplex for 36h to ensure nuclear localisation shown in a 3D image with 
orthogonal views (A). The N&B analysis had demonstrated aggregation within the nucleus and extensive aggregation in 
the peri-nuclear region (B, C). The aggregation and particle number were compared between the nucleus and cytoplasm 
(D). (n = 4 cells, in the graphs 43 ROIs were selected). (*** p ≤ 0.001) (graphs depict mean ± se) 
 3.3.3 Effe c t s  o f  Serum Concentrat ion on DNA Lipoplex Aggregat ion 
The effect of serum concentrations (2.5, 10 and 20%) on the intracellular aggregation of DNA 
and lipoplexes was also explored. A Region-of-Interest (ROI) analysis demonstrates a similar trend in 
the control cell population as before (Figure 3.5).  The delivered DNA was distributed throughout the 
cell (Figure 3.8D), with the greatest extent of aggregation observed along the cell cytoplasmic edge and 
the lowest amount of aggregation in the cytoplasm (Figure 3.8B, circles).  The DNA particle number  
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Figure 3.8 – Effec t s  o f  Serum Concentrat ion on DNA Lipoplex Aggregat ion 
The L6 myoblasts were maintained and transfected in different serum (FBS) (2.5, 10 or 20% v/v) concentrations to 
explore to effects on cytoplasmic aggregation. ROI analysis was performed highlighting the cell edge (circles), cytoplasm 
(squares) and peri-nuclear region (triangles) of the average B (A), maximum B (D) and particle number (C) (n = 22 
cells, each condition). (C) Cells transfected and maintained in 2.5% (C), 10% (D) and 20% (F) serum showing DNA 
localization and aggregation. Aggregation is presented at 5 extents: monomers, 2- 12mers, 12-25mers, 25-40mers and 
40-58mers (red, green, blue, orange and yellow, respectively). Each cell has been presented with a confocal image and 
associated N&B analysis. Each example has been presented with a confocal image and associated N&B analysis. 
(image size 12.8x12.8 µm) (ns = no significantly difference, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p 
<0.0001) (graphs depict mean ± se) (Data values presented in SI 11). 
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was also the greatest along the cell extremity (N = 2.5), which had dropped by 28% in the cytoplasm 
(N = 1.8) and was half within the peri-nuclear area compared to the cell edge (N = 1.3) (Fig 3.8C, 
circles). 
When starved and maintained in 2.5% serum, a decrease in aggregation was observed in all 
three locations compared to the control (Figure 3.8E).  In the average brightness, the most significant 
change occurred along the edge of the cell with a decrease of 28% (Figure 3.8A, B, squares).  Within 
the peri-nuclear region however, the highest extent of aggregation observed was 50% higher than the 
control (B = 14.3 compared to 9.8) (Figure 3.8B, squares).  When starved, the DNA particle number 
demonstrated the least amount of DNA along the cell edge, and the greatest particle number in the 
peri-nuclear region. Within the cytoplasm a similar amount was observed compared to the control 
(Figure 3.8C, squares). The distribution of DNA particle number in the starved condition was opposite 
to the control.   
The cells maintained in 20% serum demonstrated fewer but larger clusters within the cell 
(Figure 3.8F).  Through N&B analysis, the cell edge showed a significant increase (80%) in the highest 
state of aggregation observed and a 63% increase in the average B compared to the control (Figure 
3.8A, B, triangles).  Significant increases in aggregation were also determined in the cytoplasm and peri-
nuclear areas, which demonstrated 70% and 97% increases in the average aggregation, respectively 
(Figure 3.8B, triangles).  Compared to the controls, these cells exhibited a decrease of about 50 % in 
the particle number along the cell edge.  The cytoplasm and peri-nuclear region however, showed 
increased averages of 16% and 49% compared to the controls, respectively (Fig 3.8C, triangles).  
 3.3.4 Size-Dependent  Aggregat ion 
The effects of DNA size on aggregation was investigated through the use of flDNA fragments 
ranging from 120bp to 2kbp, as well as the PCI-Neo plasmid in a linear and circular conformation.  
The aggregation of the lipoplexes was first characterised in solution (Figure 3.9).  
The flDNA sizes assessed ranged from 120-5485bp (120-1985bp displayed in Figure 3.9) 
demonstrated a size dependent aggregation. However, the size or length of the flDNA did not only 
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influence the extent of aggregation amongst these lipoplexes, it was also observed that the physical size 
of the lipoplex aggregates influences the number of lipoplexes that formed. For example, the 500 bp 
lipoplex had a relatively low extent of aggregation (20% lower than 1985 bp lipoplex) but with the 
highest B average (60% higher than 1985 bp lipoplex). The aggregation was not greater than the larger 
fragments, but due to the number of lipoplexes present in each frame, the B average was higher than 
the larger fragments (Figure 3.9B-E). Additionally, the linear plasmid appeared to aggregate slightly less 
(by 10%) than the circular plasmid. However, the results are not presented in Figure 3.9 since the 
labelling techniques applied differed (see data presented in SI 12). 
 
Figure 3.9 – Size Dependent Aggregat ion o f  DNA Lipoplexes 
Aggregation of DNA was determined to be size dependent within solution. Through the application of N&B analysis, 
the average and highest extent of aggregation was extracted from 8 samples of each (A). As the DNA size increased so 
did the maximum extent of aggregation, the average B value however was found to decrease. Examples of the B vs 
Intensity histograms have been presented for DNA samples of 500, 1000 and 1985 bp (B-E). The B histograms 
obtained during the analysis were collated for these DNA sizes (C), demonstrating that although the maximum extent of 
aggregation increased as the DNA size did, the average B value decreased. In the collated B histogram, the orders of 
aggregation selected in the B vs Intensity histograms (B-E) have been identified along the top of the graph. (Data values 
presented in SI 12) 
 
Once transfected into live cells, the lipoplexes formed from varying lengths of flDNA, and all 
exhibited cytoplasmic aggregation to some extent. Through the application of the N&B approach, the 
extent of aggregation and particle number were quantified within the cytoplasm of at least 8 cells 
transfected with the varying lengths of flDNA and imaged at 8h and 24h time points following the 
addition of the lipoplex (Figure 3.10).  
The N&B results indicate that the aggregation of the flDNA occurred in a size dependent 
manner, where the cells transfected with the smaller DNA constructs exhibited a higher extent of 
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aggregation (Figure 3.10A-C). However through the Number component of the N&B analysis, the 
particle number was lower within the cytoplasm of those cells compared to the larger flDNA 
constructs (Figure 3.10D).  
In addition, it was also found that the conformation of the flDNA influenced the aggregative state of 
the flDNA. Populations of cells were transfected with the PCI-Neo plasmid (the same plasmid used 
previously), but was either kept circular or linearised through a restriction enzyme digest. Through this 
approach, the N&B analysis demonstrated that the circular form of the flDNA aggregated significantly 
more (on average 4-fold more) than it’s linear counterpart (Figure 3.10A-C). This analysis also 
demonstrates that over the first 8 hours, the particle number and therefore, gene delivery efficiency was 
lower for the circular form of the plasmid. By 24h, the linear and circular plasmid had demonstrated a 
similar particle number of the plasmid within the cytoplasm (Figure 3.10D). 
 Figure 3.10 – Size Dependent Aggregat ion within the Cytoplasm 
Myoblast cells were transfected with DNA of varying sizes (120bp to 5.5kbp), and plasmid DNA that was either 
circular or linear, and imaged at 8h and 24h time points. The application of N&B analysis provided an average B value 
(A), maximum extent of aggregation (B), range of the highest extent of aggregation (C), and the average particle number, 
N (D) for these samples. The values obtained for between 8-12 cells were averaged and graphed, refer to SI-15 for values. 
(Data values presented in SI 13) 
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Finally, this experiment demonstrates that the aggregation of flDNA was time dependent. 
Across the DNA sizes assessed, the flDNA had demonstrated a reduced extent of aggregation but 
increased particle number over time (Figure 3.10D). For example, Figure 3.11 presented two cells 
transfected with the 1985bp flDNA fragment that were imaged after 8h (Figure 3.11A-D), and 24h 
(Figure 3.11E-H). At the first time point, aggregation was observed and calculated throughout the 
cytoplasm ranging from a monomeric state (coloured blue) up to aggregates containing 246 flDNA 
particles (coloured in orange) (Figure 3.11A-C). However 16h later, the highest order to aggregation 
observed were 5 fold lower containing aggregates of up to 52 flDNA particles (coloured in green) 
(Figure 3.11E-G). As previously noted, the flDNA particle number within the cytoplasm increased over 
time (Figure 3.11D, H).  
Figure 3.11 – Size Dependent Cytoplasmic 
Aggregat ion 
Two cells transfected with the 1985bp DNA have been 
presented as examples for time related changes in DNA 
aggregation and particle number. The cells presented were 
imaged 8h (top A-D) and 24h (bottom E-H) after the 
addition of lipoplexes. In the B vs Intensity plots (A, E) 
pixels representing monomeric DNA (blue), 52mers 
(green), 141mer (purple), 246mer (orange) and 382mer 
(red) were selected. The fluorescence images provide 
orientation of the cell to be identified and the selection map 
is colored based on the pixels selected in the B vs Intensity 
plots (B, F). B histograms have been colored based on the 
B vs Intensity plots (C, G) and N histograms enable the 
delivered DNA particle number to be determined (D H). 
Scale bar equals 7.5µm. 
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 3.4 Discussions and Conclusion 
This study appears to be the first to address and quantify the extent of aggregation that occurs 
during the processing of lipoplexes in live cells. In this study, the N&B approach was applied to 
determine aggregation in real time at key points during the lipoplex gene delivery, including the 
internalisation along the cell plasma membrane, within the cytoplasm and nucleus. Additionally, a 
number of other factors were addressed including the influence of DNA size, conformation, and time 
has on the DNA aggregation. 
The observed internalisation event appeared to be endocytosis (supported by several studies 
64,65,68,83,261), leading to the conclusion that the internalisation of lipoplexes is predominately through 
endocytosis and most likely clathrin-mediated 162,262. Regardless, the aggregation of lipoplexes was 
observed numerous times (n = 10), at different time points over the first 4 hours of introducing the 
DNA. As a consequence, it would appear that the aggregation of lipoplexes along the plasma 
membrane is a phenomena involved in lipoplex uptake. The aggregation could be due to a number of 
possibilities. It may be possible the aggregation of lipoplexes along the plasma membrane induces 
endocytic processes 263. Alternatively, the aggregation may be due to the accumulation onto membrane 
receptors, bringing them into closer proximity causing aggregation via hydrophobic interactions 56.  
Interestingly, during a study using atomic force microscopy, Marty et al. (2009) noted that 
lipoplexes in solution aggregate in the presence of high lipid content. It could therefore, also be 
possible that the aggregation of lipoplexes during this event could be due to the interactions of the 
lipoplexes and plasma membrane. Thereby, causing the lipoplexes to aggregate 259. 
Additionally, Fumoto et al. (2004) studied the aggregation of lipoplexes in different ionic 
conditions. Their findings show that lipoplexes going from non-ionic to high salt conditions result in 
aggregate formations 264. Hence, the ionic change from the extracellular space to the cell is a probable 
cause to the aggregation of lipoplexes during internalisation observed in the work presented here.   
Regardless of the mechanism involved, whether the aggregation is caused by one of the 
possibilities presented or a combination, the observed event is not a random event. Given that there is 
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a 30 min delay between the initiation of the event and the final internalisation of the DNA material the 
event is most likely dependent on cellular machinery. 
Once within the cytoplasm of the cell, extensive aggregation of flDNA was observed. Through 
the combination of the N&B and RICS, it was found that as the aggregative state increased, while the 
rate of motion had decreased. This observation is also supported in the work presented in Chapter 2, 
where larger clusters of flDNA had a reduced mobility across varying sizes of DNA. Therefore, the 
aggregation of lipoplexes and delivered DNA presents a physical barrier to successful gene delivery.  
At present, several publications have addressed the aggregation of the cationic polymer 
polyethylenimine (PEI) polyplexes in solution 257,258. Although these two delivery vectors cannot be 
directly compared as the mechanisms of aggregation may be different, it was worth noting that research 
presented here of lipoplex aggregation within the cell, contradict those obtained of PEI complexes in 
solution. Sharma et al. (2005) identified that the aggregation of PEI complexes reduces in decreased pH 
and higher viscosity (amongst other factors) 257. However, in this study, given that the lipoplexes were 
internalized through endocytic processes, it is expected that the lipoplexes would be enclosed within 
endosomes and possibly lysosomes, which may eventually acidify 56. As a consequence, the pH would 
decrease, however an increase in aggregation when the lipoplexes/DNA were contained within distinct 
bodies within the cytoplasm was observed.  
Currently, no other study has documented the aggregation of delivered DNA within the 
nucleus. In this study, the flDNA was distributed throughout the nucleus but does appear to be in 
distinct regions within the organelle, which has been recorded in viral transfections 210. Given the lack 
of work published on this aspect, the aggregation of DNA within the nucleus cannot be attributed to 
any known process or characteristic. It is interesting, that an extensive amount of aggregation occurs 
within the peri-nuclear region, however flDNA still enters the nucleus. Therefore, further work must 
be undertaken to determine whether the aggregation of delivered DNA is detrimental to the gene 
delivery process, or if it facilitates certain events. 
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The size dependent aggregation has been attributed to the charge of the DNA, given that 
shorter DNA fragments has a lower net charge compared to their larger counterparts. The formation 
of lipoplexes is a random event, which relies on the electrostatic interactions between the negatively 
charge DNA backbone and positively charged (cationic) lipids. Therefore, it would appear that larger 
DNA fragments with a greater charge form larger lipoplexes. 
The aggregation of delivered DNA and lipoplexes within the cytoplasm has been previously 
noted to occur and present as a barrier to non-viral gene delivery, however very little work has 
addressed these events within the cell. At present, most studies addressing lipoplex aggregation have 
focused on aggregation in vitro prior to delivery into cells. For example, Ross and Hui (1999) found a 
correlation between lipoplex size and transfection efficiency, larger lipoplexes result in greater efficiency 
265. A similar pattern was observed in our study in which the larger fragments resulted in greater 
aggregation in vitro and a larger particle number, following entry into live cells. 
Recently, we had demonstrated that the N&B approach has the potential to quantify lipoplex 
aggregation in live cells and real time. In this study a circular form of DNA demonstrated to 
aggregation immediately upon cellular entry, which appeared to have occurred through endocytosis. 
After a period of time (>4h), extensive aggregation of the plasmid-lipoplex was observed throughout 
the cytoplasm of the cell.  
The aggregation of lipoplexes may be a necessary phenomenon to an extent, in order to achieve 
successful gene delivery.  Additional to noting that aggregation of lipoplexes leads to greater gene 
delivery efficiency, Ross and Hui (1999) found that serum has varying effects on lipoplex formation, 
including the reduction of lipoplex size resulting in reduced delivery efficiency. This suggests that 
aggregation to an extent facilitates lipoplex processing. It would be expected at a certain point, lipoplex 
aggregation would be unfavourable, and through the approach presented in this thesis such an 
understanding could be resolved.    
This study demonstrates that the N&B approach is a valuable tool in the study of lipoplex 
delivery and is capable of quantifying the aggregation of delivered DNA. It appears that lipoplexes 
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aggregate the moment they start to interact with the cell, during internalisation, and from there the 
aggregative state of the DNA increases. Within the nucleus, the aggregation of the DNA decreases 
however it is still apparent. This study also demonstrates that larger DNA fragments aggregate less than 
their smaller counterparts and that DNA conformation and time play a role in the cytoplasmic 
aggregation. The aggregation of DNA and lipoplexes within cells may possibly be cell, lipid and DNA 
sequence dependent, however this study provides a powerful model that could be applied to further 
elucidate the mechanisms or factors causing aggregation. 
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4 Quantifying the Real-time Degradation of 
intracellular DNA Lipoplexes 
   
 4.1 Introduction 
 4.1.1 DNA Degradat ion 
Efficient delivery in gene therapy still remains a challenge. During the delivery process, the 
DNA and vector complex face a number of obstacles. One such barrier that has not been extensively 
studied is the stability of delivered DNA or vector complexes within the cytoplasm. It has been 
suggested that enzymatic activity and breakdown of delivered DNA in lysosomes within the cytoplasm, 
poses as a significant hurdle to successful nuclear translocation and nuclear uptake of therapeutic 
nucleic acids 131,137. A key limitation in current literature is the lack of studies addressing the real time 
degradation of DNA delivered through viral or synthetic vector approaches, such as lipofection. It 
would appear that the focus has been on the microinjection of DNA 130,131. Such an approach of DNA 
delivery results in many of the processes of delivery being by-passed, including cellular uptake and 
endosomal release that many other non-viral or viral vectors will be exposed to. Additionally, through 
the by-pass of such key steps of gene delivery, the injection into the cytoplasm could possibly result in 
the direct exposure of the DNA to cytoplasmic nucleases, which may have contributed to the short-
half life of 50-90min for the DNA 131. 
To date the studies that have investigated DNA degradation have had limited tools to do so. 
For example, Lechardeur et al. (1999) and Pollard et al. (2001) applied a combination of studying 
nuclease activity on DNA (from cell extracts using gel electrophoresis); observing the disappearance of 
CHAPTER 4 
CHAPTER FOUR: REAL-TIME DNA DEGRADATION 
 
REAL-TIME DNA DEGRADATION      80 
delivered DNA through Fluorescence in situ Hybridisation (FISH); visualisation of DNA 
fragmentation using Terminal Deoxynucleotidyl Transferase-mediated dUTP Nick End Labelling 
(TUNEL) assays; and radiolabeled 32P-release from end-labelled fragmented DNA 130,131. These 
approaches require cell fractions or fixed cells, which may not properly represent the events that occur 
in the live environment. 
Pampinella et al. (2002) and Srinivasan et al. (2009) applied real time and live cell observations of 
DNA degradation through the application of confocal microscopy 132,266. However, confocal 
microscopy lacks the sensitivity required to observe the degradation of single particles of DNA. For 
example in the study undertaken by Srinivasan et al. (2009), the authors developed a novel approach of 
dual labelling DNA plasmids with two different fluorophores. During degradation the DNA cleavage 
results in the separation of the two colours. In the case where both fluorophores were in close 
proximity the authors claimed that the DNA is still intact. However the DNA could have been 
degraded but remained within in the same area and confocal microscopy is not sensitive to detect this 
situation. 
Sasaki and Kinjo (2010) presented a study, which applied the use of dual labelled DNA and two 
colour FCS. In the study the focus was to gain an insight into the type of nucleases that are likely the 
cause of cytoplasmic degradation 137. This type of FCS analysis is limited to small volume of the cell at 
any one time. 
Clearly, a complete understanding of the degradative behaviour of delivered DNA is paramount 
to achieve efficient gene delivery. Therefore, this study presents a model to quantify the degradation of 
DNA delivered through lipofection, both spatially and temporally in live cells through the application 
of two-colour RICS (also known as cross correlated RICS or ccRICS). 
 4.1.2 Cross  Corre lated RICS 
The Raster Image Correlation Spectroscopy (RICS) approach applied in previous sections can 
be extended to study two different fluorophores 3. Through the application of two-colour cross 
correlation the temporal and spatial distribution of focal adhesion kinase (FAK), paxillin and vinculin, 
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along adhesion complexes, has been reported 3,267. Since positive cross correlation will only occur in the 
case that the two particles’ fluctuations align 3, the ccRICS approach offers a non-invasive and highly 
sensitive approach to determine the molecular interactions of particles of a sample. 
 4.2 Materials and Methods 
 4.2.1 Product ion o f  Dual Label l ed DNA 
Fluorescent-labelled primers were bought from Integrated DNA Technologies (Coralville, IA):  
Forward: 5’-AF488-TCAATATTGGCCATTAGCCAT-3’ 
Reverse: 5’-AF594-ACGTAGATGTACTGCCAAGTAGGA-3’ 
Two-coloured DNA fragments were generated by PCR.  The PCR producing a fragment size of 
495bp was performed using PCI-Neo (10ng) (Promega) was used as a template through the use of a 
Platinum Taq PCR kit (Invitrogen, Carlsbad USA). 
For the study of degradation through the RICS G0 ratios, the 5485bp fragment was prepared 
by labelling PCI-Neo mammalian vectors with Alexa Fluor 488 through a UYLSIS nucleic acid labelling 
kit as detailed in previous sections. 
 4.2.2 Ase-I  Degradat ion  
The dual labelled DNA was digested using Ase-I (New England Biolabs) (cutting at base 160). 
The Ase I digestion was performed using a 1:1 ratio of DNA (ug) to Ase-I (U) and incubated at 37°C 
for 1h then heat inactivated at 65°C for 20min. 
The samples were run on 1.5% w/v agarose gels with a 1kbp ladder and undigested DNA 
fragments were run. Two wells of the digested DNA product were run, one containing SYBR Green I 
(SG1) and one without.  
 4.2.3 Cel l  Culture  and DNA Transfe c t ion 
Rat L6 myoblast cells were cultured and maintained in DMEM supplemented with FBS (10% 
v/v), Penicillin/Streptomycin, Amphostat-B and β-Mercaptoethanol at 37°C in a humidified 
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atmosphere of 5% CO2.   Trypsinized cells (1x10
4) were seeded onto glass chamber slides (Thermo 
Fisher Scientific, Australia) in antibiotic- and phenol red-free DMEM (10% v/v FBS) 24h prior to 
transfections. 
The cells were transfected by the DNA fragments using X-Treme Gene 9 (Roche, Germany), 
according to the manufactures’ guidelines. A 1:3 ratio (dual labelled DNA:transfection lipid) was used.. 
The lipoplex solution was added directly to the cell cultures within chamber slides. Cells were imaged 
either immediately or incubated until required in the previously described conditions. To study the 
degradation of DNA in real time, and the mechanical and spatial influence on the degradation, a 150ng 
of DNA amount was introduced to each well of cells. In these studies, the cells were imaged 
immediately once the lipoplexes were introduced up until an 8 h time point, than at 24 and 48hr after 
the introduction of DNA. In the study of the effects of DNA dose, varying amounts of DNA were 
introduced into the cell cultures, including 50, 100, 200 and 400ng of DNA per well. Once transfected, 
these cells were imaged at both 8 and 24h after the introduction of the lipoplexes. In order to 
determine the DNA half life, cells were incubated in the presence of lipoplexes (150ng DNA per well) 
for 5h, then were washed three times in PBS and maintained in DMEM (FBS 10%). Cell nucleic were 
counterstained with Hoechst 33342 (1µg/mL) as required in all experiments. In order to determine the 
half-life of DNA plasmids through the application of RICS G0 ratios, the DNA plasmid was 
transfected into the cells with a 100ng DNA load, and then imaged immediately for 8h. 
 4.2.4 Data Acquis i t ion and Analys i s  
Confocal series were obtained using a Leica TCS-SP5. The fluorescently labelled DNA was 
excited using an Argon Ion laser with the 488nm pathway activated to excite the Alexa Fluor488 and a 
Helium-Neon 594 nm laser to excite the Alexa Fluor594. Hoechst 33342 was excited by a 405nm 
Diode laser and transmission images were obtained using a Helium-Neon 633nm. ccRICS, and iMSD 
data was acquired using APDs through an ISS Vista Becker and Hickl FCS card and software. 256x256 
format and pixel dwell speed of 32 µs were used. Emission bandwidths were detected between 500-
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550nm (channel 1) and 603-687nm (channel 2). The microscope was fitted with a 63X (1.4 NA) water 
immersion objective. All samples were maintained on a stage heated at 37°C.  
The ratio between the G0 of the cross channel and the two individual channels was performed 
to determine the rate of degradation over time: 
𝐺𝐺0  𝑜𝑜𝑜𝑜  𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 − 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴  (𝐺𝐺0  𝑜𝑜𝑜𝑜  𝑐𝑐ℎ𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎  1  𝑎𝑎𝑎𝑎𝑎𝑎  𝑐𝑐ℎ𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎  2)
 
Equation 20 -  Degradat ion o f  dual  labe l l ed DNA 
For half-life study utilising DNA plasmids, a RICS G0 ratio data was acquired with a Zeiss 
LSM710 META laser scanning microscope (Zeiss, Jena, Germany). The Alexa Fluor488 excited using 
an Argon Ion laser with the 488nm pathway activated and Hoechst 33342 was excited by a 405nm 
Diode laser. Signal for the DNA was collected with a 500-550nm bandwidth. Data was collected in a 
256x256 format and pixel dwell speed of 25.61 µs were used. The microscope was fitted with a 63X 
(1.4 NA) water immersion objective. All samples were maintained on a stage heated at 37°C with 5% 
CO2. 
The RICS simulations and RICS, N&B and iMSD data were analysed using the Globals 
software package, SimFCS 2.0, developed at the Laboratory for Fluorescence Dynamics at the 
University of California, Irvine (www.lfd.uci.edu/globals). The waist of the PSF was determined with 
eGFP as previously described 227 (refer to SI-4 for further details). 
 4.2.5 Nuclear Extrac t ion and PCR Detec t ion 
Cells were cultured within T75 culture flasks and transfected with unlabelled 495bp DNA 
fragment using X-treme Gene 9 transfection reagents. Following either an 8 or 24h incubation the 
cytoplasmic or nuclear factions of the cells were isolated through the use of a nuclear extraction kit 
(Millipore Merck, Sydney, Australia). The isolation was performed based on the manufacturers 
guidelines as detailed below.  
Cells were first washed with warm 1X PBS, and then 0.5% Trypsin-EDTA was added to 
dislodge cells from the culture flasks. They were then transfers to a sterile centrifuge tube and 
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centrifuged at 250g for 5 min at 4°C. The cells were resuspended and washed in fresh 1X ice-cold PBS 
and centrifuged again as before. The supernatant was removed and the cells were suspended in 5 times 
the volume of the cell pellet with ice-cold cytoplasmic lysis buffer containing 0.5mM DTT and 1/1000 
inhibitor Cocktail. Once incubated for 15 min, cell were centrifuged at 250g for 5 min at 4°C. The 
supernatant was discarded and the cells resuspended in two volumes of ice-cold Cytoplasmic Lysis 
Buffer. Cell clumped with broken up via pipetting at this point.  
Cell were then centrifuged again at 8,000g for 20 min at 4°C. The supernatant obtained at this 
step was the cytoplasmic fraction, and the remaining pellet was the nuclear fraction, which was 
resuspended in 1X PBS. Samples were stored immediately at -80°C. This experiment was performed 
three times. 
PCR was performed using a purified 495bp sample as a standard and using the KAPA SYBR 
PCR Master Mix (KAPA Biosciences, Sydney, Australia). The primers presented in section 6.2.1 were 
used to detect the presence of the plasmid in samples and standards but were not labelled. Each PCR 
reaction contained 15 µL 2X PCR master mix, a final concentration of 0.5µM of each primer, 5 µL of 
the cell fraction or the diluted plasmid for standards, and totalled to a volume of 30 µL with nuclease-
free water. PCR reactions were performed on the Rotor Gene-Q real-time PCR machine (Qiagen, 
Sydney, Australia). Reactions were incubated at 95°C for 2 min, followed by 40 cycles of 95°C for 30s, 
50°C for 45s and 72°C for 60s at which point green channel fluorescence was detected, followed by 
72°C for 10 min. High resolution melt analysis was performed in order to check for sample purity and 
product amplification specificity (entire PCR experiment is available in SI-16 including the melt 
analysis) 
 4.3 Results 
 4.3.1 PCR Detec t ion o f  DNA degradat ion  
In order to determine DNA degradation the expected time period that intact DNA could be 
detected in live cells, a PCR detection method was applied. Since PCR can be highly sensitive, it was 
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expected that the DNA will only be detected and PCR amplification occur when the DNA is full intact 
with the cell. Through the application of real-time PCR, this approach was able to both qualitatively 
indicate with the DNA was intake or not, which has been presented in Figure 4.1, or quantify the 
amount of DNA present within the cell fractions at the two specified time points by comparing the cell 
fractions to standards. 
 The results of this experiment were consistent with those obtained through the microscopy-
based approaches previously presented. At the 8 and 24h time points all cytoplasmic samples had 
demonstrated the presence of intact DNA. In all cases, the 24h samples had exhibited more DNA 
present as the real-time PCR curve starts to increase before the 8h sample (Figure 4.1, Table 5). The 
nuclear fractions demonstrated the presence of the intact DNA in some of the samples (1 or 3) in both 
the 8 and 24h time points. Consistent to the cytoplasmic samples, the 24h time point had more DNA 
than the 8h, but both had less compared to the cytoplasmic fractions. The PCR specificity was 
confirmed through high-resolution melt analysis by comparing the standards to the samples (these 
results can be found in SI 15). 
 Figure 4.1 – PCR Detec t ion o f  
DNA in Cel l  Fract ions 
Cytoplasmic and nuclear cell fractions were 
obtained at 8h and 24h from cells 
transfected with a 495bp DNA fragment. 
Real-time PCR demonstrated the presence 
of intact DNA within the cytoplasm at 
both time points and in a single sample 
within the nuclear at both time points. 
Positive PCR amplification was identified 
with the PCR curve increases from the base 
line. Additional data including all of the 
samples and standards are available in SI-
16. 
 
 
Table  5 – Summary o f  PCR Resul ts  
Time Point Location 
Number of 
Samples 
Positive 
Amplification % Positive 
8 Hour Cytoplasm 3 3 100 
Nucleus 3 1 33 
24 Hour 
Cytoplasm 3 3 100 
Nucleus 0.3 1 33 
CHAPTER FOUR: REAL-TIME DNA DEGRADATION 
 
REAL-TIME DNA DEGRADATION      86 
 4.3.2 In Vitro Degradat ion  
In the design and application of the DNA constructs of this section, the concept is that the 
DNA was dual labelled by two different fluorophores. Through the application of ccRICS, the DNA 
will only be determined as being intact when the fluctuations of both fluorophores match perfectly. 
Initially, the dual labelled DNA was first exposed to DNA nucleases and analysed in vitro (Figure 4.2). 
Dual labelled DNA was digested by the Ase-I nuclease, which resulted in the 495bp product 
being cleaved into two differently sized DNA fragments of 160 and 335bp (refer to supplementary 
material SI3 for cleave site). The digested DNA was run through an agarose gel to identify the resulting 
bands (Figure 4.2). In the agarose gel, the intact DNA displayed a clear band at the 500bp marker. In 
the gel, two digested samples were run, one containing SG1 and the other none. The sample containing 
SG1 (lane 3) enabled the observation of both bands (160 and 335bp), whereas the lane without SG1 
(lane 4) only the 160bp fragment was only visible since it was labelled by Alexa Fluor 488.  
 
 
Figure 4.2 – Ase-I degradat ion o f  dual labe l l ed DNA 
(A) Within a single cell it is expected that introduced DNA will be degradation. In this study, the end of the DNA was 
labelled with different coloured probes. Once within the cell regions where DNA is presented are expected to be a 
combination of intact and degraded DNA, which could be present in the same pixel or area. The application of RICS 
will enable to differentiation between intact and degraded DNA as the probes will be required to have correlated 
fluctuations in order to be determined as intact.  (B) The dual labelled DNA was digested by the Ase-I nuclease. DNA 
was run on an agarose gel with a 1kbp ladder (lane 1), intact DNA (lane 2), and the digested DNA, with SG1 (lane 
3) and without SG1 (lane 4). (C) The DNA was than analysed using ccRICS where the intact DNA had 
demonstrated a large amount of cross-correlation. But once digested, the cross signal was 100-fold less than the intact, and 
the green and red channels had demonstrated an increase in mobility, consistent with the DNA fragment sizes. 
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Once it was established that the Ase-I nucleases cleaves the dual labelled DNA into two 
differently sized fragments, ccRICS was applied to confirm the imaging approach is capable of 
characterising DNA degradation in real time. Controls for the bleed through of Alexa Fluor488 into 
the red channel were performed (refer to supplementary material SI 14). When the green primer was 
imaged alone the bleed through into the red channel was 5% of the green signal. However, when the 
two (green and red) primers were imaged together, no cross correlation was detected.  
Through ccRICS, the intact DNA demonstrated a mobility of 8.45 µm2/s (cross) and the two 
green and red channels had similar mobility rates (consistent to section 2 of this thesis). Once digested, 
the cross-correlation had identified a similar mobility rate, however the G0 (intensity) had dropped 100-
fold, demonstrating a significant loss in the cross-correlation of the DNA. The green and red channels 
in the digested DNA however, had demonstrated an increase in the mobility rate consistent with the 
values obtained from section 2, but little change in the G0 (Figure 4.2C). 
 4.3.3 Real-Time Degradat ion 
The dual labelled DNA was then transfected into the myoblast cell model and immediately 
imaged following the addition of the lipoplexes for the first 8h, than at 24 and 48h time points, totalling 
to 98 cells analysed. Through the application of ccRICS, it was determined that two species were 
present within the cells, a slow species ranging from 0 – 0.5 µm2/s and a fast species ranging from 0.68-
5.75 µm2/s. Across this population of cells a global analysis was preformed, typically including parts of 
the cytoplasm and nucleus (Figure 4.3), the analysis demonstrated a cross correlation in every cell. In 
Figure 4.3, three cells have been presented at 3.5, 8 and 24h time points. In these cells, the two mobility 
species have been identified and a positive cross for both species can be identified in all three cells. 
Across the cells observed, the cross-G0 was always lower than the G0 of the green or red 
channels. Since a 100% cross correlation was never observed it is apparent that degradation has always 
occurred within the cells sampled. However, as presented in Figure 4.3, the rate of degradation 
appeared to be a lot slower compared to previously published work (as discussed in section 4.1.1). It is 
apparent in Figure 4.3, as cells even at 8h and 24h demonstrate positive cross correlation in both the 
CHAPTER FOUR: REAL-TIME DNA DEGRADATION 
 
REAL-TIME DNA DEGRADATION      88 
slow and fast species isolated, which do not have a significantly lower amplitude than the earlier time 
point. 
 
Figure 4.3 – Intrace l lu lar  Real-Time Degradat ion 
The dual labelled DNA was transfected into the myoblast cell model to imaged from the immediate addition of the 
lipoplexes up to 8h, then at 24 and 48h time points. Through the application of ccRICS the extent of degradation could 
be determined for the slow and fast species present within the cell in real time. Examples presented in this figure represent 
time points at 3.5, 8 and 24h (A, B and C, respectively). For each cell, channel 1 (i), channel 2 (ii) and the overlap of 
these channels (iii) with the transmission image and Hoechst (blue) enabling the nucleus to be identified; have been shown 
demonstrating that the two probes bound to the DNA are distributed throughout the cell. The ccRICS approach enables 
the study of DNA degradation by correlating the fluctuations of both channels. When the DNA is intact, it is expected 
to be cross-correlated, which adds to the G0 value (peak) of the SCAFs (iv). If the SCAF decreases in the cross-
correlation it is indicative of degradation. Image sizes are 16.5 x 16.5 µm. 
 
CHAPTER FOUR: REAL-TIME DNA DEGRADATION 
 
REAL-TIME DNA DEGRADATION      89 
 
Figure 4.4 – Summary o f  Intrace l lu lar Degradat ion 
In order to study the extent of DNA degradation occurring within the cell population the G0 value of the cross correlation 
was divided by the average of the two channels., thereby providing a ratio of the cross-correlated or intact DNA and the 
overall signal in the two channels. The ccRICS approach enables the differentiation between the two species present, either 
a slow species ranging from 0 – 0.5 µm2/s and a fast species ranging from 0.68-5.75 µm2/s. Over the first 8h of the 
transfection process, the trend of the slow species (green) demonstrated a minor decrease in the cross G0 ratio (A), 
compared to the faster species (purple), which had shown a steeper decrease in the trend line (B). Across the entire 48h 
analysed, the two species had demonstrated a similar trend (C, D), where the cross Go ratio declined more in the fast 
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species than the slow species. Chart D shown a zoomed in view of Chart C, enabling the difference in the slow and fast 
species to be seen more clearly. Over the first 8h of the transfection, the fast species appeared to have the same G0 value, 
whereas the slow species demonstrated a lag of about 4h before the G0 value started to increase (D). Number of cells 
analysed were 98, between 0-8h n = 78, at 24h and 48h n = 10 each. 
 
The cell pollution transfected by the dual labelled DNA between 0-8h (Figure 4.4A, B) 
discriminates both the slow and fast species in order to identify the extent of degradation that occurred 
over the 8h time course. The ratio applied across the cross-correlation resulted in values independent 
of DNA concentration. In these calculations, since the cross channel value is the numerator 
degradation will be observed when the calculated integer decreases over time (i.e as the G0 value of the 
cross-correlation decreases, the denominator (green and red channel) is expected to remain the same, 
therefore the resulting value from these calculations will decrease as degradation occurs).  
In the two mobility species across the 0-8h time course an overall trend indicated that DNA 
degradation occurred indicated by the downward slop of the trend line (Figure 4.4). However, the rate 
of degradation in the slow and fast species was different. In the slower species, a slow rate of 
degradation appeared to occur, whereas the faster species exhibited a steeper decrease in the cross-G0 
ratio over time. When the later time points, 24 and 48h, were included in the calculations the trend in 
degradation demonstrated a similar occurrence to the earlier time points where the faster species 
demonstrated a more rapid degradation or reduced rate of cross correlation than the slower species 
(Figure 4.4B, C). The ratio of the cross-correlation and two individual channels had demonstrated a 
reduction in the 24 and 48h time points for both the slow and fast species compared to the earlier time 
points (0-8h). In all cells analysed (n = 98 cells), every cell demonstrated a positive cross-correlation for 
both the slow and fast species.  
 4.3.4 DNA Dose Dependency on Degradat ion 
The effect of DNA dose on degradation was explored through the administration of different 
amounts of DNA (50, 100, 200 and 400ng; in the previous time series, section 4.3.2, 150ng of DNA 
was delivered). The rate of degradation was observed at 8 and 24h; and the same G0 ratio was 
calculated as previously. It was found that the higher amounts of DNA had resulted in a less amount of 
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degradation compared to the lower DNA doses. Additionally, the slow species (0-0.8µm2/s) 
demonstrated a lesser extent of degradation compared to the fast species (0.9-5.5µm2/s) (Figure 4.5A).  
When comparing the 24h time point to the earlier one, the same trend had occurred; the slower 
species demonstrated a higher G0 ratio compared to the faster, and the larger DNA dose exhibited a 
lower rate of degradation. However, the G0 ratios were lower in the 24h measurements compared to 
the 8h indicating that degradation has occurred over time, which is consistent to the previous study of 
this project.  
In order to provide an explanation into the effect of DNA dose, the N&B approach was 
applied to determine and quantify the extent of aggregation that had occurred in the ranging DNA 
doses and two time points (Figure 4.5B).  The application of N&B had demonstrated that the larger 
DNA dose had resulted in a greater extent of aggregation; for example, the extent of aggregation was 
just over 3-fold higher in the 400ng dose compared to the 50ng dose at 8h. 
Figure 4.5 – Effec t s  o f  DNA dose on 
intrace l lu lar degradat ion 
The dual labelled DNA was transfected into cells at 
varying amounts: 50, 100, 200 and 400ng per well of 
cells, and imaged at 8 and 24h after the addition of the 
lipoplexes. The G0 ratio of cross-correlated over the 
average of channels 1 and 2 was performed for the slow 
and fast species (A). This approach demonstrated that 
the higher DNA doses resulted in less DNA 
degradation over all. Therefore, the N&B approach was 
applied to each channel (1 and 2) for the four DNA 
doses and two time points (B). Channel 1 is listed as 
Green and channel 2 as Red. The N&B approach 
demonstrated that the higher doses of DNA resulted in a 
larger extent of aggregation compared to the lower doses. 
10 cells for each DNA dose and time point were used in 
these calculations. 
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 4.3.5 Determining DNA Half  Li fe  
The application of ccRICS and dual labelled DNA demonstrated that degradation occurred 
across the cell population analysed here. However degradation had not occurred at the rapid rate 
previously reported in other studies, for example Lechardeur et al. (1999) reported a cytoplasmic half-
life of 50-90min for microinjected DNA. When dual labelled DNA was delivered into the cells; 
following a 5h incubation in the presence of the lipoplexes (the optimal time indicated previously in 
Figure 4.4E) the cells were washed thoroughly to remove any superfluous lipoplexes. Given that no 
additional DNA or lipoplexes should be entering the cells the cellular lifetime of the DNA can be able 
to be determined.  
Following the washing of extraneous lipoplexes, the cells were imaged immediately up to 4h 
(Figure 4.6A). Over the 4h time period, the fast and slow species were separated as before and the 
cross ratio calculation performed. The trend of both species, whether a linear average or moving 
average trend line was applied, a drop in the G0 ratio was minor, the slow species had demonstrated a 
13% and fast species a 10% decrease in the G0 ratio. 
The cells were then incubated overnight after the wash enabling measurements to be obtained 
18h after washing the cells (Figure 4.6B). By including the earlier time points, it was found that the 
faster species resulted in a faster decay in the G0 cross ratio compared to the slower species. However, 
positive cross-correlation was still observed in the dual labelled DNA even after 18h. It is worth noting 
however that of the 33 cells measured between 0-4h following the removal of extracellular lipoplexes, 
one single cell did demonstrate a complete lack of cross-correlation between the two channels, and of 
the 5 cells measured at the 18h time point 2 cells presented with a lack of positive cross-correlation.  
By following the tread lines of this study it would be expected that no correlation would occur 
in the slow species by 38h 20min and the fast species by 26h 30min, therefore, the calculated 
cytoplasmic half-life is in the order of 19h and 13h for the slow and fast species, respectively. 
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Figure 4.6 – Determining the DNA hal f - l i f e  
through dual labe l l ed DNA approach 
The dual labelled DNA and ccRICS was applied to 
determine the DNA half-life for this model. The DNA 
was first delivered to the cells, incubated and then washed 
to remove excess lipoplex. Cells were then imaged 
immediately for 4h, which demonstrated very little 
degradation in both the slow (green) and fast (purple) 
species (A). Following a further incubation, cell were than 
imaged 18h after being washed showing that degradation 
had started to occur over this time period (B). Using the 
equation of the trend lines obtained in these charts it was 
calculated that the half-life of the slow species was 19h and 
13h for the fast. In this study, 33 cells were imaged over 
the first 4h, and than 5 cells at 18h. 
 
 
 
 
 
 
 
 
 
A second approach to determine the DNA half-life was applied through the application of a 
DNA plasmid. Through the application of a single channel RICS; the ratio between the slow and fast 
species was applied. This approach is based on the concept that as the DNA plasmid is degraded the 
mobility will increase as the plasmid is fragmented in the cell. 
Across the time 6h series measured the calculated ratio decreased demonstrating an increase in 
the prominence of the faster species. In the earlier time points the slower species was more prominent 
over the faster as displayed in Figure 4.7A, B and E in cells, cells A and B represent time points 2hr and 
3hr 15min respectively. The cells presented in Figure 45, have a G0 value (indicated by a height of peak 
in the SACF) of the slower species was 3-fold and 1.65-fold higher than that of the fast species. On the 
other hand, by 4.5h and 5h 10min (Figure 4.7C, D respectively) the prominent mobility species had 
shifted. In both cells C and D, the fast species had a G0 value 4-fold greater than the slower.  
Additional to the shift in the mobility species distribution, this approach has also found changes 
in the mobility rate over time (Figure 4.7F). Over the time course the slow species had shown little 
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change in the rate of motion, whereas the faster species had demonstrated a consistently increasing rate 
of motion over time, from 4h onwards.  
 
 
Figure 4.7 – Determining DNA hal f - l i f e  through G0 approach 
The half-life of delivery cytoplasmic DNA was determined through a second approach, the used of a randomly labelled 
DNA plasmid and calculation of the ratio difference between the fast and slow species over time. Across all 4 cells 
present, there is a clear trend that the slow species started with a high G0 that steadily declined, whereas, the faster species 
had a G0 that increased. Cells A and B represent early time points at 2h 15min and 3h 15min, respectively. Both cells 
demonstrate a greater dominance of the slow species indicated by the height of the SACF, and the graph over time (E). 
Cells C and D show later time points at 4h 30min and 5h 10min, respectively. On the contrary to cells A and B, the 
fast species is more dominant than the slow in the later time points. In order to determine the DNA half-life, the G0 
value of the slow species was divided by the fast. This ratio of the cell population of 68 cells has been plotted in a graph 
(E) with the positions of cells A-D indicated. Based on the average trend line applied it has been calculated that the 
approximate half-life of the DNA is 4h. The mobility rates of both species, slow green and fast purple; has also been 
plotted over time, demonstrating that the rate of motion in the slow species remained relatively the same whereas the fast 
species had demonstrated an increase in mobility over the 6.5h time course measured. Image sizes are 16.5 x 16.5 µm. 
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Finally, through the application of the slow and fast G0 ratio on a randomly labelled DNA 
plasmid, the DNA half-life could be determined. Although a complete absence of the slow species did 
not occur and is unlikely, following the trend presented in Figure 4.7E, the G0 ratio would meet zero at 
around 8h 10min. Therefore, the approximate half-life of the DNA plasmid in this myoblast cell model 
is approximately 4h. 
 4.3.6 Spat ia l  and Mechanica l  Inf luence  on Degradat ion 
In Chapter 2 it was demonstrated that events are spatially oriented, therefore through the 
application of cursor analysis in ccRICS and iMSD approaches the impact of the location and 
mechanism of motion was explored. Through cursor analysis data files were analysed as 4 sections (100 
frames were collected over 4 min, therefore, each quarter is equivalent to a minute), the iMSD analysis 
enabled the mechanism of motion to be determined and ccRICS allowed the rate of degradation to be 
determined over the 4 min time frame. In this analysis the cursor was moved as required between 
quadrants to ensure that the DNA/lipoplex of interest remained within the centre of the cursor. 
Through the application of the dual labelled cross over channels G0 ratio; three scenarios appeared 
during the time frame analysed; either the ratio decreased indicating degradation, the ratio remained the 
same suggesting that degradation did not occur or the ratio increased, which could be attributed to an 
event such as the accumulation of the DNA or rapid mobility.  
Along the cellular extremities a range of mechanisms of motions were identified including 
confined diffusion (CD), anomalous subdiffusion (AS), transient confinement (TC) and binding-
unbinding (B-UB) events (Figure 4.6, Figure 4.12). Within the example cell (Figure 4.8), CD and TC 
were identified along the extremities of the cell. The CD (ROI 1) in this example follows the pattern 
identified throughout the entire population analysed, which suggested that degradation does not occur 
during CD along the cellular extremities. Over the cells observed, CD identified along the cell edge 
exhibited a lack of degradation in all events isolated, as the cross-G0 ratio either remained unchanged 
or increased over time (Figure 4.12). 
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In the example below, the motion of TC displays an increase in the G0 ratio over the time 
observation (ROI 2). However, TC along the extremities show a variation in degradation across the 
entire population observed, including a combination of the ratio remaining the same, increasing and 
decreasing (Figure 4.12). The TC mechanism only specifies that the particles of interest are entrapped 
for a given period of time during the observation but could involve a variety of different events, as the 
iMSD approach cannot specify exactly what has occurred.  
 
Figure 4.8 – The spat ia l  and mechanical  in f luence on DNA degradat ion – Cel l  Extremit i es  
Dual labelled DNA along the cell extremity was selected and both ccRICS and iMSD analysis was applied. In both 
ROI displayed, the G0 ratio had increased in the presence of CD (ROI 1) and TC (ROI 2). In the graphs displayed the 
G0 ratio between the individual channels and cross-correlation have been displayed in red and are timed in minutes. 
When the ratio increases or remains the same the ratio of un-degraded DNA increases or remains the same, respectively, 
whereas in the occurrence of degradation, this ratio will decrease. In the same graphs, the iMSD has been presented in 
orange. The expected curves for the different mechanisms of motion have previously been detailed. 
 
AS was identified along the extremities of the cell, which demonstrated a decrease in the G0 
ratio and therefore occurrence of degradation in all observation of the event. Binding-unbinding events 
along the cell extremity appeared as a combination of degradation and no degradation (G0 ratio 
decreasing and increasing, respectively). 
Similar to the study on DNA mobility (Chapter 2), only two forms of motion were prominent 
within the cytoplasm in the study of DNA degradation, active transport (AT), and binding-unbinding 
(Figure 4.9, Figure 4.12). Within the cytoplasm AT did not exhibit any evidence of degradation during 
these events, both within the example cell below (ROI 1, Figure 4.9) and across the entire population  
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Figure 4.9 – The spat ia l  and mechanical  in f luence on DNA degradat ion – Cytoplasm 
Dual labelled DNA within the cytoplasm of the cell was selected and both ccRICS and iMSD analysis was applied. 
Within the cytoplasm, the prominent mechanisms of motion were AT and binding-unbinding events so were displayed in 
this figure. ROI 1 exhibited AT, which had demonstrated very little change in the G0 ratio applied. ROI 2 on the other 
hand, had an overall G0 ratio that increased, but over time it increased and then decreased during the B-UB event 
observed. In the graphs displayed the G0 ratio between the individual channels and cross-correlation have been displayed 
in blue and are timed in minutes. When the ratio increases or remains the same the ratio of un-degraded DNA increases 
or remains the same, respectively, whereas in the occurrence of degradation, this ratio will decrease. In the same graphs, the 
iMSD has been presented in orange. The expected curves for the different mechanisms of motion have previously been 
detailed. 
 
measured (Figure 4.12). The G0 ratio, during AT either remained the same or increased. The binding-
unbinding events within the cytoplasm however displayed a similar trend as the same event along the 
cell extremity; the combination of the G0 ratio increasing and decreasing.  
 
 
 
Figure 4.10 – The spat ia l  and mechanical  in f luence on DNA degradat ion -  Per i -nuc lear Area 
Dual labelled DNA within the peri-nuclear region of the cell was selected and both ccRICS and iMSD analysis was 
applied. Within this region, two prominent mechanisms of motion were CD and TC events so were displayed in this 
figure. ROI 1 demonstrated a CD event, which had displayed a decrease in the G0 ratio applied, and therefore, 
degradation had occurred.. ROI 2 on the other hand, had an overall G0 ratio that increased, but over time it increased 
and then decreased during the TC event observed. In the graphs displayed the G0 ratio between the individual channels 
and cross-correlation have been displayed in orange and are timed in minutes. When the ratio increases or remains the 
same the ratio of un-degraded DNA increases or remains the same, respectively, whereas in the occurrence of degradation, 
this ratio will decrease. In the same graphs, the iMSD has been presented in orange. The expected curves for the different 
mechanisms of motion have previously been detailed. 
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At the nuclear membrane, in the peri-nuclear region, transport mechanisms were consistent as 
previously described in Chapter 2, including CD, TC and unbinding-unbinding events. Within this area 
of the cell CD had demonstrated a combination of CD that involved the G0 ratio remaining the same, 
increasing and decreasing (ROI 1 Figure 4.10, Figure 4.12). TC in the peri-nuclear region had shown a 
combination of the G0 ratio increasing (ROI 2 Figure 4.10) and decreasing, however, the decreasing 
ratio was more prominent suggesting degradation (Figure 4.12). The binding-unbinding events however 
had shown the opposite, containing events that had both increased and decreased G0 ratios, the 
increasing ratio was more apparent (Figure 4.12). 
Events in the nucleus were less frequently observed, with two cells across the population of 
cells analysed displaying flDNA within the nucleus, once example being the cell presented in Figure 
4.11. Events identified within the nucleus both display CD through iMSD analysis. It is worth noting, 
one of these cells presented a G0 ratio that trended upwards (Figure 4.11) and the other downwards. 
However, in both cases the average trends over the period observed were nearly horizontal. In Figure 
4.11, the G0 increased over the 4 min observation by 20%, whereas the second observation had 
decreased by 8% over the same period. 
 
Figure 4.11 – The spat ia l  and mechanical  in f luence on DNA degradat ion – Nucleus 
Observations of the dual labelled DNA within the nucleus were rare and therefore only one event was found in this cell 
example. Previously it was established that the mechanisms of motions found within the nucleus of delivered DNA were 
either CD or AS. In the event here where both ccRICS and iMSD analysis were applied, a CD event was isolated. This 
event had demonstrated a very little change in the G0 ratio, therefore, it would appear that degradation did not occur. 
 
Following the ROI analysis of the dual labelled DNA, all cells analysed were collated together 
based on the mechanism of motion determined and whether the G0 ratio increased, decreased or 
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remained the same. The collection of results are presented in Figure 4.12. As previously observed, a 
range of mechanisms of motion were observed along the cell extremity, including CD, AS, TC and B-
UB events. In Figure 4.12, the events have been colour coded based on the G0 ratios observed, where 
those that increased possibility accounting for events where DNA is recruited is in green, when the G0 
ratio remained the same it was coloured yellow, and red presents the G0 ratios that decreased (indicated 
that degradation had occurred). No degradation appeared to have occurred in CD along the cell 
extremity, whereas TC and B-UB observations demonstrated approximately 50% degradation events, 
and AS had shown degradation in all events.  
 
Figure 4.12 – Summary o f  Spat ial  and Mechanical  Degradat ion 
All of the ROI analysis through the combination of ccRICS and iMSD were combined providing an insight into the 
mechanical processes involved in DNA degradation. In the graphs presented in this figure, the four locations isolated; cell 
extremity (A), cytoplasm (B), peri-nuclear (C) and nuclear (D), has been presented showing the mechanisms motion 
analysed and whether degradation was determined or not. In the graphs when the G0 ratio increased it was coloured green, 
when the G0 ratio remained the same it was coloured yellow, and red presents the G0 ratios that decreased likely 
indicated that degradation had occurred. 
 
Within the cytoplasm, only AT and U-UB events were observed, and no degradation was found 
when the DNA is moving via active motion. Once within the peri-nuclear area, the DNA had exhibited 
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CD, TC and B-UB events, all of which exhibited degradation, however TC had shown the most of the 
three mechanisms of motion while studying degradation.  
 4.4 Discussion and Conclusion 
Most studies on DNA degradation used short DNA fragments known as oligonucleotides, 
which are not commonly applied in gene delivery, and have yielded a variety of results. DNA 
degradation has been claimed to occur significantly within 20h and 3h in a single study 159, and within 
6h 235 and 60 min 268 in two others, all of which were performed using different fibroblast cell lines. A 
more relevant study utilised plasmid DNA that was microinjected in the cytoplasm of cells which 
uncovered a DNA half-life of 50-90 min 131. These studies produced significantly different results for 
the most part. A critical disadvantage in the approach undertaken by these studies determined the 
occurrence of degradation on the decrease in fluorescence signals from labelled DNA. Such the 
decrease in fluorescence could be due to other factors including photobleaching, and the release of the 
DNA from cells 269.  
Since the use of fluorescence imaging is not ideal to study DNA degradation other approaches 
are essential, which includes the application of more sensitive and specific tools such as FCS. For 
example, Kinjo et al. (1998) demonstrated that FCS could be applied to study DNA fragmentation, as 
smaller fragments are faster than larger ones. However, Kinjo and colleagues’ study was limited to 
studying DNA degradation in solutions. Additionally, the cellular environment has demonstrated that 
DNA has capacity to move at a range of different speeds, therefore, faster mobility could likely be due 
to active transportation (as per previous sections of this thesis).  
Sasaki and Kinjo (2010) applied a Fluorescence Cross-Correlation Spectroscopy (FCCS) 
approach to study the degradation of a dual labelled DNA fragment, which was delivered through a 
bead loading system. Their approach attempted to identify the likely nucleases responsible for the 
degradation of delivered DNA based in the changes in mobility. The study identified a reduced cross-
correlation amplitude after 45 minutes indicative of degradation 137, however no half-life was presented 
or the point in time where cross correlation was no longer observed.  
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The DNA half-life obtained for the investigations presented here are in the order of 2 to 38 
fold greater in the slower species and 1.3 to 26 greater in the faster species compared to previously 
published studies 159,268. It is this study presents the most comprehensive analysis on DNA degradation 
to date, addressing the spatial and temporal degradation as well a DNA half-life, effects of DNA loads 
and also how the mechanical processes of the cell influences degradation, no study to date has achieved 
this.  
Three major factors may have influenced the differences observed to date; the cell type, delivery 
processes and the DNA utilised. Across these studies a range of cell types have been used, including 
fibroblasts, ovarian cells and kidney cells. As each cell type has different physiology and function, they 
may result in different rates of degradation. Additionally, each study utilised different DNA constructs. 
Ratton et al. (2014) recently utilised a high-throughput sequencing approach to determine the most 
commonly cuts sites of a DNA plasmid during to cytoplasmic and nuclear degradation, demonstrating 
significance that the DNA sequence may have DNA degradation. In this case, Ratton and colleagues 
identified that the most commonly cut sequences were those of foreign regions, including viral 
promoters, antibiotic resistance genes, synthetic poly(A) and the bacterial origin of replication (Ori) 270. 
Therefore, Ratton et al. demonstrate that the DNA sequence must be considered when studying DNA 
degradation.  
The transport mechanisms appeared to have played a critical factor in the occurrence of 
degradation; previously this aspect has never been explored. It is expected that the DNA lipoplexes will 
be contained within endosomes following their uptake into the cell 15, during which the lipids of the 
lipoplex have been suggested to alter the biology of endosomes 109. This phenomenon, and the 
mechanism of confined diffusion may protect the delivered DNA from cytosolic nucleases. Whereas, 
subdiffusion and transient confinement are likely to represent the DNA that has escaped endosomes, 
therefore exposed to nucleases 130 and explain why rapid degradation has been observed in studies 
employing microinjection 131. 
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Within the cytoplasm, the predominate transport mechanism was active transport, which 
exhibited the complete absence of any degradation. Such a process could not otherwise be 
demonstrated through many of the techniques applied to study DNA degradation 130,131. Therefore, this 
observation highlights the requirement for live cell approaches to study such processes. 
Along the peri-nuclear region, this study and others 240 have observed the accumulation of the 
exogenous DNA along the nuclear membrane. This region exhibited the greatest amount of 
degradation, and has previously been demonstrated to have poor mobility (Chapter 2), therefore, it was 
possible that the low mobility and accumulation provided the opportunity to recycle and degradation 
the exogenous DNA. Thereby, explaining the high rate of degradation that occurred within the peri-
nuclear region. 
The data presented in this chapter clearly demonstrates that DNA degradation plays a 
significant role in the efficacy of successful delivery of gene products. The application of ccRICS 
coupled with iMSD analysis has enabled the calculation of degradation and DNA half-life, in live 
myoblast cells. In addition, the approach employed identified that the process the mechanisms of 
motion are related to the rate or occurrence of degradation.  
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5 The Effects of Membrane States on 
Intracellular Lipoplex Dynamics 
  
 5.1 Introduction 
The physiology and state of a cell is a critical factor for successful gene delivery, for example, 
a number of studies have demonstrated that by simply treating cells with agents that destabilise 
cytoskeletal networks gene delivery can be hamper 14,143.  In addition, Ca2+ and ATP depletion have 
demonstrated that these small molecules are critical for gene vector uptake and endosome release 271. 
The cell cycle can also play a pivotal role in successful delivery outcomes, for example some vectors 
such as retroviruses can only target dividing cell populations 15, or cell division can enhance nuclear 
translocation 50.  
It is worth considering the membranes of the cell govern many interactions that a gene 
delivery vector will engage with. For example, the delivery vector such as a lipoplex must first 
interact with the plasma membrane in order to enter the cell, but then may be encapsulated within 
the endosome membrane. The nuclear envelope must also be traversed in order for the exogenous 
DNA to pass into the nucleus. Therefore, this section of the thesis aims to seek how the membrane 
physiology, i.e. the membrane state and composition, has an effect on the behaviour of delivered 
DNA lipoplexes. 
 5.1.1 Cel lu lar Membranes 
In mammalian cells, the plasma membrane defines the cell and separates the intra- and extra-
cellular constituents, but membranes are also found throughout the cell, as membranes define 
CHAPTER 5 
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organelles including the nucleus and vesicles. All membranes are composed of three principal classes 
of lipids, (i) phospholipids, (ii) sphingolipids and (iii) cholesterol. The main building block of 
biomembranes are phospholipids which are composed of two segments, the head group which are 
hydrophilic and interact with the water interfaces, and the tail which are hydrophobic and are 
composed of the fatty acid side chain (Figure 5.1).   
In aqueous environments, phospholipids will spontaneously form one of three structures, 
spherical micelles; liposomes or phospholipid bilayers (Figure 5.1). The bilayers, which form the 
plasma membrane and many others including those of organelles, such as the nuclear membrane and 
mitochondria, are highly specific depending on their location and function, containing different 
compositions of lipids but also proteins, such as transmembrane or lipid-anchored proteins of 
various functions including transport proteins and receptors (Figure 5.1). 
Depending on a number of factors including the lipid composition, distribution of proteins 
and physiological conditions such as temperature and ion concentrations the membrane structure 
can differ. For example, the degree in membrane fluidity depends on the lipid composition, 
structure of phospholipid tails and temperature. Phospholipids containing long, saturated fatty acyl 
chains have a tendency to aggregate, thereby packing tightly together and forming a gel-like state. 
Whereas, short fatty acyl tails, which have less surface area cause fewer van der Waals interactions 
and form more fluid membranes. 
 
Figure 5.1 – Membrane Fluid 
Mosaic  Model  
A bi-lipid layer composed mostly of 
phosolipids forms the membrane of a cell, but 
depending on the function and location of the 
membrane other components can be found 
including cholesterols, membrane bound 
proteins, glycoproteins and carbohydrates. 
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A significant challenge in the study of biomembranes has been the difficulty to monitor and 
observe a number of characteristics of membranes in live cells, such as the state and composition. 
However, a number of bioimaging tools have recently emerged that provide a rapid and simple 
approach to characterise live cell membranes in real time. 
 5.1.2 Spec tra l  Phasor Approach 
The application of phasors to analyse typically difficult data has started to gain momentum in 
the field of bioimaging. One such example is the application of Fluorescence Lifetime Imaging 
Microscopy (FILM) that can be potentially difficult to interpret, however, once the data is converted 
in a phasor a relatively simple, graphical and fit-free analysis can be applied 272.  
However, for the interest of this project the recent development of the spectral phasor 
approach will be the focused here. Cutrale et al. (2013) recently presented the theoretical background 
of translating multi-spectral data obtained from a commercial confocal microscope into a phasor, 
thus enabling the simple analysis of spectral data. 
In the spectral phasor approach (and similar to the FLIM phasor analysis) the data is 
transformed into a phasor plot based on two equations that provide the G and S co-ordinates (x and 
y, respectively). The equations of the two co-ordinates have previously been outlined by Cutrale et al. 
(2013) as follows for each individual image (i): 
𝐺𝐺?   𝜆𝜆 =   
𝐼𝐼  (𝜆𝜆)????  ?? cos(𝑛𝑛𝑛𝑛𝑛𝑛)∆𝜆𝜆
𝐼𝐼   𝜆𝜆   ∆𝜆𝜆????  ??
 
Equation 21 -  G co-ordinate in Spectral  Phasor  
 
𝑆𝑆?   𝜆𝜆 =   
𝐼𝐼  (𝜆𝜆)????  ?? sin(𝑛𝑛𝑛𝑛𝑛𝑛)∆𝜆𝜆
𝐼𝐼   𝜆𝜆   ∆𝜆𝜆????  ??
 
Equation 22 -  S co-ordinate in Spectral  Phasor  
where 𝜆𝜆?  and 𝜆𝜆?  are the starting and final wavelengths of the spectrum respectively, n is the 
harmonic number, and 𝜔𝜔 = 2𝜋𝜋𝜋𝜋  where the frequency 𝑓𝑓 = (𝑛𝑛  ×  𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠  𝑐𝑐ℎ𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎)?? . Once 
translated into the spectral phasor each pixel of an image is distributed within the phasor plot based 
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on its spectral properties within the spectral phasor presented in Figure 5.2. Then through cursor 
analysis, the area of phasor is selected and super-imposed over the imaged acquired.  
Figure 5.2 – Spectral  Phasor 
In the spectral phasor approach the first (A) and second (B) harmonics have been presented where λ represents the 
wavelength and σ the width or distance from the centre. The visual light spectrum is distributed across the phasor 
accordingly in an anti-clockwise manner (blue to red). The distribution of the spectrum has been presented based on a 
32-channel simulation performed by Cutrale et al. (2013). In the simulation three examples have been calculated (C) 
and their perspective positions on the phasor plot identified (A, B). (Image obtained from Cutrale et al. 2013) 
 
 5.1.3 Laurdan and Nile  Red 
With respects to the spectral analysis of biomembranes there are several membrane specific, 
fluorescent dyes that enable the identification of membranes that are well characterised and readily 
available, two such examples are Laurdan and Nile red. 
Laurdan is a useful membrane specific dye that fluoresces once within a lipid-rich 
environment. It has been characterised in several studies to specifically address membrane fluidity 
due to its property to sense the polarity of its environment. Laurdan has the ability to distinguish 
between two classes of bilayer membrane states, either solid-order or lipid-order (i.e. rigid or fluid). 
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As a result two recent studies have demonstrated that this dye has the capacity to characterise 
cellular membranes through the application of both FLIM and spectral phasors 273,274. These two 
studies demonstrated that laurdan shows a shift in both the fluorescence lifetime and spectra 
depending on the fluidity of cellular membranes, which is directly related to the membrane lipid 
composition and water saturation 273.  
Nile red on the other hand, which is also a lipid specific fluorescent dye, has the potential to 
discriminate between the type of lipid present, thereby determining the lipid composition of a 
biomembrane.  In the instance of nile red, exhibits a spectral shift from yellow to red wavelengths, 
in the presence of non-polar lipids such as cholesterol and triglycerides, and polar lipids (including 
phospholipids), respectively 275.  
Therefore, it is expected that the use of both laurdan and nile red are worthwhile stains to 
characterise cellular membranes through the application of the spectral phasor approach. In 
particular providing insight into physiology of cell membranes aimed to further the understanding 
into events that occur in therapeutic strategies such as gene delivery. 
 5.2 Materials and Methods 
 5.2.1 Cel l  Culture ,  Treatments  and Trans fe c t ion 
L6 Rat Myoblast cells were cultured at 37°C in 5% CO2 in DMEM supplemented 0.5% Pen-
Strep, and 2.5mM HEPES. Trypsinized cells were plated onto 8-well Labtek chamber slides. Cells 
were cultured in four conditions: (i) controls, media supplemented with 10% FBS, (ii) starved, media 
supplemented with 2.5% FBS, (iii) supplemented with 20% serum, or (iv) cholesterol treated, media 
supplemented with 10% FBS and a 2-fold increase in media cholesterol using a total cholesterol 
solubilized in ethanol (serum cholesterol was determined to be 0.85mmol/L using a cholesterol 
module of an Abbott Architect ci16200 (Abbott Diagnositics, Australia)). Laurdan (6-dodecanoyl-2-
dimethylamino naphthalene; Invitrogen) was dissolved in dimethylsulfoxide (DMSO) and prepared 
at a 1.8 mM stock solution. Nile Red (9-diethylamino-5-5-benzo-α-phenoxazinone; Invitrogen) was 
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dissolved in acetone and prepared as a 7.8mM stock solution. Dyes were diluted 1:1000 into serum-
free media to a working concentration, then added to the cells, incubated for 40 min at 37°C and 
then washed before imaging. 
In order to determine the gene expression/delivery efficiency cells were transfected with a 
pAcGFP1-Actin (Clontech, USA), whereas DNA behaviour was studied with a 1,000bp DNA 
labeled with Alexa Fluor488 as detailed in Section 2.2.1. Lipoplexes were formed with a 3:1 ratio 
with the X-treme Gene 9 reagent as detailed in Section 2.2.2. Once the lipoplexes were administered 
to cells they were incubated in the above conditions and imaged a 8, 24 and 48h time points. 
 5.2.2 Spec tra Phasor Imaging and Analys i s  
Spectral profile data for both solutions and cells were acquired with a Zeiss LSM710 META 
laser scanning microscope (Zeiss, Jena, Germany) coupled to a 2-photon Ti:Sapphire laser (Mai Tai, 
Spectra Physics, Newport Beach, CA) producing 80-fs pulses at a repetition of 80 MHz. Both 
Laurdan and Nile Red were excited at 780 nm.A 60X (1.4NA) water-immersion objective was used 
for all experiments. The data was acquired in the spectral mode of the Zeiss 710 using 32 channels 
covering the spectrum from 416.32 to 727.65 nm with 9.73 nm bandwidth per channel. All images 
were acquired using a pixel dwell time of 177.32µs and 256 × 256 pixel size frames. A 16-bit integer 
was used for all images. 
RICS, N&B and iMSD data was collected within the Leica SP5 system as previously detailed 
(Section 2.2.3). The Globals software package, SimFCS 3.0 was used to reference and analyse 
spectral phasor data, and RICS, N&B and iMSD data was analysed using the same software. 
 5.3 Results 
 5.3.1 Changes  in membrane phys io logy 
The changes in cell membrane state and composition were first assessed through the 
application of the spectral phasor approach with cells maintained under different conditions with 
either laurdan or nile red.  
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Figure 5.3 – Spectral  dis tr ibut ion o f  Laurdan in ce l l  t reatments  
Examples of spectral phasor images from cells used as controls (10%), were starved (2.5% FBS), or treated with a 2-
fold increase in cholesterol and stained with Laurdan (A-C, respectively). Phasor plots are shown in the left, and cell 
images in the right. Two cursors were used and linked with a colour pellet, which has been superimposed in the phasor 
plot of the cholesterol treated sample (C). Cells are coloured based on their position between the cursors demonstrating 
their membrane fluidity, more rigid membrane are shown in a cream colour, and more fluid in the red colour. The 
phasor positions of specific membranes were isolated and presented in scatter plots identifying the membrane fluidity of 
each culture condition for the plasma membrane, outer and inner cytoplasm, vesicles and nuclear envelope (D-H, 
respectively). Number of cells for each population = 5. 
 
Firstly, laurdan demonstrated the cells maintained in the three conditions, starved in low 
serum and controls in 10% serum and in a 2-fold increase in cholesterol, all exhibited different 
membrane states and fluidity (Figure 5.3). In summary, cells maintained in low serum exhibited 
more fluid membrane, demonstrated by the spectral shift towards to green wavelengths (Figure 
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5.3C) compared to the control cells (Figure 5.3A). The cholesterol-treated cells on the other hand 
showed a shift towards to blue wavelengths, indicative of more rigid membranes (Figure 5.3C). 
The spectral phasor approach enables the analyses of small regions, providing details on 
specific membrane areas, including the plasma membrane, vesicles and nuclear membrane. The 
shifts in the spectral emission have been presented as scatter plots, enabling the discrimination of 
changes for the different conditions (Figure 5.3D-H).  
Across the treatments, laurdan demonstrated changes in the plasma membranes of the cells; in 
particular, those treated with cholesterol exhibited more rigid states compared to the control and 
starved populations, which and shown a similar fluidity state (Figure 5.3D). Within the cytoplasm of 
these cells, the laurdan probe demonstrated that the starved cells were more fluid, whereas the 
cholesterol-treated were more rigid compared to the control cells, with an apparent spectral 
distribution in the centre of the starved and cholesterol-treated conditions (Figure 5.3E, F).  
Vesicles in the cytoplasm and the nuclear envelope (NE) were isolated as they both play 
pivotal roles in gene delivery. Similar to the rest of the areas, the vesicles and NE revealed more 
fluid like behaviour when the cells are starved and more rigid when treated with cholesterol, the 
control cells remained with a distribution in the centre of the two treatments (Figure 5.3G, H).  
When nile red was applied to cells, shifts in the emission spectra were observed, 
demonstrating characteristic changes in the alterations in membranes of the different conditions 
(Figure 5.4). The membranes, when starved, displayed a more polar state, whereas cholesterol 
treated cells appear to exhibit more non-polar membranes (compared to the 10% serum controls).  
The major differences were observed within the extremity of the cytoplasm and vesicles, which 
exhibited a significant shift towards the yellow wavelengths (587-589nm) in the cholesterol-treated 
vesicles, compared to the control (605-611nm) and starved (607-615nm) (Figure 5.4I). Interestingly, 
around the peri-nuclear region and the nucleus envelope the spectral emission of the cholesterol-
treated cells showed a shift indicative of more polar membranes (towards red wavelengths), 
compared to the controls (Figure 5.4H, J). 
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Figure 5.4 – Spectral  dis tr ibut ion o f  Nile  Red in ce l l  t reatments  
Examples of spectral phasor images from cells used as controls (10%), were starved (2.5% FBS), or treated with a 2-
fold increase in cholesterol and stained with Nile red (A-C, respectively). Phasor plots were superimposed in the control 
and starved examples, and due to the tight pixel distribution in the phasor plots, images where the cursor positions 
were adjusted have been also presented. Two cursors were used and linked with a colour pellet, which has been 
superimposed in the phasor plot of the cholesterol treated sample (C). Cells are coloured based on their position between 
the cursors demonstrating lipid polarity and charge; non-polar, neutrally charged lipids including cholesterol and 
triglycerides are shown in purple, and polar, negatively charged lipids such as phospholipids in the red colour. The 
phasor positions of specific membranes were isolated and presented in scatter plots identifying the membrane fluidity of 
each culture condition for the plasma membrane, outer and inner cytoplasm, vesicles and nuclear envelope (D-H, 
respectively). Number of cells for each population = 5. 
 
Cells maintained with 20% serum exhibited similar spectral distributions for both laurdan 
and nile red as the control (10% serum) populations (SI 16). 
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 5.3.2 Effe c t s  on DNA behaviour and express ion 
The effects of different membrane states and compositions were assessed through two 
approaches; the changes in transgene expression, and the behaviour of the flDNA, at a molecular 
level, in an effort to link gene delivery efficiency with the molecular mechanisms and behaviour of 
the flDNA. 
Firstly, cell populations were cultured under different conditions and transfected with an 
expression vector encoding for an Actin-GFP transprotein. At 8, 24 and 48h time points, the 
percentage of cells expressing the fluorescent protein were counted (Figure 5.5). Across all 
conditions, the percentage of cells expressing the protein increased over the 3 time points observed. 
However all treatments; starved (2.5% FBS), stimulated (20% FBS) and cholesterol-treated (2-fold 
increase), exhibited a reduction of transgene expression to different extents.   
 By 48h almost 17% (89 of 534) of control cells had expressed the fluorescent reporter. In 
comparison, the other conditions demonstrated reduced transfection efficiencies; the starved 
population had a transfection rate of 13.5% (31 of 228), which was 80% of the control, the high 
serum at 9% (54 of 575 cells), almost half of the control, and the cholesterol treated having the 
lowest transfection efficiency of 3.8% (7 of 184 cells), being less than a quarter of the control. 
Figure 5.5 – Effec t s  o f  Membrane 
States  on Transgene Express ion 
Transfections with a GFP-actin expression 
vector were performed with cells under different 
conditions. The cells were counted at 8, 24 and 
48h time points. Graph depicts the percentage 
of cells expression the GFP control. Across the 
cell populations an average of 380 cells were 
counted per population, a lower range of 100 
cells and high range of 616 cells. Error bars 
represent the standard deviation.  
 
 
The molecular influences and changes on the altered gene expression were then explored 
through the application of RICS, N&B and iMSD in order to study the variations in flDNA 
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mobility, aggregation and mechanisms of motion, respectively. A global analysis was performed in 
the first instance, providing an insight into changes in the cytoplasm as a whole (Figure 5.6).   
The cells maintained in different conditions were transfected with a 1000bp DNA construct 
and immediately exhibited differences in cluster size and the extent of fluorescence (Figure 5.6A-D). 
The cells maintained in 20% serum, display large clusters within the cytoplasm, and after 24h these 
large clusters localised within the peri-nuclear region (Figure 5.6C).  
Figure 5.6 – Global Effec ts  on DNA Behaviour  
Cells were maintained in four conditions: 2.5% serum (starved), 10% serum (controls), 20% serum or 2-fold increase 
in cholesterol (A-D, respectively) and transfected with a fluorescently labelled 1000bp DNA. The cell populations 
were imaged at 8, 24 and 48h time point. A-D shown cells at the 24h time point showing the delivered DNA 
(green), and the nuclei counterstained by Hoechst 33342 (blue). The inserted images present the DNA channel 
coloured by a visible colour spectrum (blue--green-red) showing the fluorescence intensity and DNA distribution in the 
different conditions. A global cell analysis was then performed using N&B and RICS in order to study the variations 
in DNA aggregation and mobility, respectively. Graphs E and F shown the maximum aggregative states present, and 
average aggregation, respectively. The average particle number (N) is shown in G, and the mobility in H. (Cell images 
are 16.5x16.5 µm) (n = 8-10 cells per population) 
 
The application of N&B analysis demonstrates that the control (10%) cell population 
displayed the largest extent and average of B values, representing aggregation. However, over time 
(24 and 48h) the aggregation within this population had decreased (maximum aggregative states, B = 
16.6 at 8h, and 11.9 and 9.2 at 24 and 48h, respectively), whereas the other treatments had increased. 
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The 20% serum cells had displayed the highest extent of aggregation, whereas the cells treated with a 
2-fold in cholesterol appear to have the lowest amount of aggregation, and generally less than the 
control group (Figure 5.6E, F).  
In addition to aggregation, the N&B approach provides details on the particle number 
present within a sample. In the case of the cells transfected in different conditions, all populations 
demonstrated an increase in particle number within their cytoplasm, over the time course observed.  
After 24h, the starved cells appeared to plateau by 48h. The controls, 20% serum and 
cholesterol-treated conditions demonstrated a constant increase in particle number. Additionally, the 
cells treated with a 2-fold increase in cholesterol demonstrated less flDNA particles (N = 0.25 at 8h) 
compared to other conditions (N = 0.3, 0.32 and 0.87 at 8h in 10%, 2.5% and 20% serum, 
respectively) throughout the time points observed (Figure 5.6G). Finally, by 48h the control cells 
appeared to contain the greatest flDNA particle number (N =2.4, compared to 2.1 in the 2.5% and 
20% serum treated). 
The RICS analysis demonstrated that the cells maintained in 20% serum appeared to have 
the most mobile flDNA. The overall mobility increased between the 8h and 24h observations, and 
then plateaued. The controls however, declined in mobility, which then increased between the 24 
and 48h observations. Both the 2.5% serum and cholesterol-treated populations demonstrated 
slower mobility compared to the controls at all three time points (Figure 5.6H). 
Following global analysis, the RICS, N&B and iMSD approaches were applied to study the 
molecular mechanisms and changes in three specific locations within the cell; the extremity of the 
cell along the plasma membrane (Figure 5.7), within the cytoplasm (Figure 5.8), and in the peri-
nuclear region (Figure 5.9). 
 Cell Extremity 
Along the cell extremity, the flDNA in control cells exhibited a low amount of aggregation at 
8h, which then increased at 24h and then reduced by 20% at 48h (maximum aggregative state, B = 
2.6, 7.6 and 6.1 at 8, 24 and 48h, respectively) (Figure 5.7A). Both the starved and cholesterol-treated 
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populations displayed a similar aggregative state at 8h (compared to the controls), however did not 
exhibit an increase in aggregation at 24h. In the starved populations, the aggregation was unchanged 
until 48h when it doubled (from B=3.6 at 8h, to B=7.6 at 48h). The cholesterol-treated cells 
exhibited a linear increase in aggregation along the cell edge over time, however the aggregation was 
lower than the control at 48h (B = 5.4). The 20% serum treated cells exhibited an aggregative state 
in the flDNA 4-fold greater than the controls at 8h. Over time, the 20% serum treated cells 
displayed a decrease in aggregation, and by 48h the aggregation was 20% less than the 8h time point. 
The N&B approach also provided details on the particle number (Figure 5.7B), where the 
control group displayed an increase of 2-fold between the 8 and 24h points, and a further increase of 
almost 4-fold between the 24 to 48h points. Apart from cells maintained in 20% serum, the other 
populations had a similar particle number within the cell extremity at 8h. The 20% serum group was 
2-fold greater then the rest, which may be related to the increase in observed aggregation. Over the 
time course, the cells maintained in 20% serum, and treated with cholesterol, exhibited the 
 
Figure 5.7 – DNA Behaviour Along the Extremit i es  o f  the Cel l  
ROI analysis along the cell extremity was performed in cells transfected and exposed to different conditions. N&B 
analysis provided information on the aggregative state of the DNA (A) and particle number, N (B) over a 48h time 
course. The mobility of the delivered DNA was ascertained through the application of RICS (C), and the mechanisms 
behind the mobility was determined through iMSD analysis (D) (n = 8-10 cells per population, with each cell 
providing 2-5 values). 
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lowest particle number, only increasing by 4- and 2-fold over the 48h of the experiment. The starved 
cells on the other hand, demonstrated a dramatic increase in the particle number, which then 
declined from N=3 to 2 (between 24 and 48h). As previously observed (Chapter 2), the cells 
maintained in 10% serum (controls) demonstrated a decrease in mobility along the cell extremity 
(mobility was halved between 8 and 48h) (Figure 5.7C), and the majority of motion was identified as 
Confined Diffusion (CD) and Binding-unbinding (B-UB) events. All treated cell populations had 
exhibited changes in both the rates and mechanism of motion. Along the cell extremity, the starved 
cells shown a more rapid rate of motion compared to the control (0.18 µm2/s compared to 0.12 
µm2/s at 8h), which had decreased but was still faster than the control. The iMSD analyses identified 
the presence of Active Transportation (AT), which was not typically observed in the control group. 
In addition, the starved population demonstrated less B-UB events to the control (none at the 48h 
observations).  
The cells maintained in 20% serum, and treated with cholesterol, did not display a rate of 
motion that decreased over time (like the control group). In both the 20% serum-, and cholesterol-
treated cells the rate of motion observed was slower at 8h compared to the control. By 24h, the rates 
of motion were similar to the control, however both groups exhibited more rapid mobility at 48h 
(20% serum: 3-fold and cholesterol-treated: 2-fold greater than the control) (Figure 5.7C). Both 
populations displayed at least double the amount of immobility compared to the control (9% in the 
controls at 24 and 48h, compared to 18% in the cholesterol treated to 48h and 33% in the 20% 
serum at 8h). A reduction in B-UB events was also demonstrated (Figure 5.7D). 
 Cytoplasm 
Within the cytoplasm, the control group was consistent with previously shown studies 
(Chapters 2 and 3), where the aggregative state was relatively low but did increase by about 50% 
over the 48h experiment (Figure 5.8A). The particle number had increased by about 5-fold over the 
same time (Figure 5.8B). Across all populations, a reduced mobility at 24h appeared, however, in the 
control group the rate of motion remained unchanged between the 8 and 48h observations (Figure 
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5.8C). Finally, iMSD analysis demonstrated that the majority of motion was due to AT (42-60%) and 
B-UB (27-38%) (Figure 5.8D). 
Cells that were starved exhibited similar properties as the control group. The aggregative 
states was in the order of 20% higher than the control group, across the time course of the 
experiment, have a significantly higher particle number, almost 2-fold greater at 24h (Figure 5.8A,B). 
The flDNA within this population of cells did have a mobility rate 20% slower than the controls 
(Figure 5.8C), as the iMSD analysis demonstrated the presence of immobility, and reduced rate of 
AT (42% of observations at 8 and 24h). Further, TC and CD was more apparent at the 48h time 
point compared to the control group (Figure 5.8D). 
When cells are maintained in 20% serum, aggregation appeared to increase significantly 
compared to the controls (1.2-fold and 1.8-fold greater at 8 and 48, respectively) and other 
populations (Figure 59A). It should be noted that the particle number started higher than the 
controls (1.4-fold) at 8h, increased at 24h (2-fold greater than the control) but by 48h, had a lower 
particle number than the control cells (Figure 5.8B). At 8h, the mobility of the flDNA was 1.4-fold 
faster than the control, but was slower than the controls at 24h and then increased by 48h (Figure 
5.8C). The occurrence of AT had increased (25%, 36% to 50% over the 8, 24 and 48h observations, 
respectively), and immobility which was present decreased (17%, 14% to 7% over the 8, 24 and 48h 
observations, respectively) (Figure 5.8C). By 48h, the transport mechanisms were almost the same as 
the control population at the same time point. 
The cholesterol-treated cell population demonstrated almost the same aggregative states and 
particle number within the cytoplasm as the control group (Figure 5.8A, B). However, the mobility 
of the flDNA did differ, as the rate of motion was approximately 2-fold less than the control cell 
population (for example, cholesterol treated: 0.13 µm2/s compared to control: 0.25 µm2/s at 8h) 
(Figure 5.8C). The iMSD analysis provided an insight into the causation of the reduced mobility. 
Within the cytoplasm of cholesterol-treated cells, AT appeared to occur less compared to the 
CHAPTER FIVE: MEMBRANE EFFECTS ON LIPOPLEX BEHAVIOUR 
 
MEMBRANE EFFECTS ON LIPOPLEX BEHAVIOUR      118 
controls (20% of events compared to 42-60% events) with increase in CD (Figure 5.8D). It is worth 
noting in the cholesterol-treated cells, large cholesterol deposits appeared throughout the cytoplasm. 
  
 
Figure 5.8 – DNA Behaviour within the Cytoplasm 
ROI analysis within the cytoplasm along the cell extremity was performed in cells transfected and exposed to different 
conditions. N&B analysis provided information on the aggregative state of the DNA (A) and particle number, N 
(B) over a 48h time course. The mobility of the delivered DNA was ascertained through the application of RICS (C), 
and the mechanisms behind the mobility was determined through iMSD analysis (D) (n = 8-10 cells per population, 
with each cell providing 2-5 values). 
 
 Peri-nuclear Region 
 Within the peri-nuclear region, the flDNA delivered to the control population show a small amount 
of aggregation at 8h (B = 3.0), but had increased 4-fold by 24h (B = 13.8) and then decreased at 48h 
(B = 4.8) so that is was about 60% higher than the 8h time point (Figure 5.9A). This same pattern 
was observed along the cell extremity in the control population. Between the 8 and 24h time points, 
the particle number had increased 5-fold, and then plateaued (as did the 2.5% and 20% serum 
treated populations) (Figure 5.9B). The flDNA within this region had demonstrated a decrease in 
mobility over time resulting in a 40% decrease in mobility over the 48h experiment (Figure 5.9C). 
The iMSD analysis demonstrated a variety of transport mechanisms including immobility, AS, CD, 
TC and B-UB events, over the time course the number of B-UB events reduced and the AS events 
increased (Figure 5.9D). 
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Figure 5.9 – DNA Behaviour within the Per i -nuc lear Region 
ROI analysis within the peri-nuclear region of the cell was performed in cells transfected and exposed to different 
conditions. N&B analysis provided information on the aggregative state of the DNA (A) and particle number, N 
(B) over a 48h time course. The mobility of the delivered DNA was ascertained through the application of RICS (C), 
and the mechanisms behind the mobility was determined through iMSD analysis (D) (n = 8-10 cells per population, 
with each cell providing 2-5 values). 
 
In the stared cell population, over the 48h time course, the aggregation was initially the same 
as the control at 8h but gradually increased from B = 2.5 to B = 7.7 over the 48h of observation, 
where it was 2-fold greater than the control (Figure 5.9A). Along with the increase in aggregation, 
the particle number increased (2.4-fold greater than the control by 48h) (Figure 5.9B) and the 
mobility decreased albeit 2.4-fold greater than the control by 48h (Figure 5.9C). In the starved 
population AT was identified in the area, which was not observed in the control group. Additionally, 
the occurrence of AS remained the same over time, unlike the control group, which increased over 
time (Figure 5.9D). 
Cells maintained in 20% serum had demonstrated a greater extent of aggregation within the 
peri-nuclear area, at both 8 and 48h being 2-fold greater than the control (Figure 5.9A). The particle 
number in these cells was higher than the controls at 48h (being 50% higher), and plateaued after 
the 24h observation (Figure 5.9B). The RICS analysis demonstrated that the flDNA was initially 
about 55% faster than the control, however at 24h was the same and just marginally faster by 48h 
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(Figure 5.9C). The drop in mobility appeared to be due to the occurrence of immobility at the 24 
and 48h time points, but AT was also present in peri-nuclear region of this condition. Additionally 
unlike the control cells, the occurrence of AS remained the same over the analysed time points 
(Figure 5.9D). 
Relative to the other treatments within the cholesterol-treated cells aggregation increased by 
about 2-fold, over the 48h (Figure 5.9A). Consistent with the other areas analysed within the cell, the 
cholesterol-treated cells had the least amount of flDNA within the peri-nuclear area up to the 48h 
point, when it was slightly (18%) greater that the control. Particle number did, however, increase by 
6-fold over the course of the experiment (Figure 5.9B). The rate of mobility was similar to the 
control cells (at 8, 24 and 48h, 0.17 µm2/s, 0.06 µm2/s and 0.08 µm2/s, respectively) (Figure 5.9C). 
The cholesterol-treated cells had also shown the highest rate of immobility in the peri-nuclear area, 
with the other prominent mechanism being CD (Figure 5.9D).  
Table 6 – Summary o f  f lDNA Behaviour 
Condition/Position 
Aggregation 
Particle 
Number Mobility Mechanism 
Transgene 
Expression 
C
on
tr
ol
 
Extremity Medium High Low CD, B-UB 
High Cytoplasm Medium Medium High AT 
Peri-nuclear Medium Low Low CD, increasing AS 
St
ar
ve
d 
Extremity Low Medium High CD 
Medium Cytoplasm Medium High Medium AT 
Peri-nuclear High High High CD, AT present 
20
%
 
Se
ru
m
 Extremity High Low High CD, Immobile 
Low Cytoplasm High High High AT (low then high) 
Peri-nuclear High Medium Medium CD, AT present, immobility 
C
ho
le
st
e
ro
l 
Extremity Low Low Medium CD, Immobile 
Low Cytoplasm Medium Medium Low CD 
Peri-nuclear Low Low Low CD, immobility, late AS increase 
 5.4 Discussions and Conclusion 
This chapter explores the effects that serum and cholesterol concentrations have on cellular 
membranes that can then be translated to changes in the behaviour of DNA that is delivered 
through lipofection. The application of the spectral phasor approach enabled the changes in 
membrane fluidity and composition to be determined when cells were maintained in their optimal 
CHAPTER FIVE: MEMBRANE EFFECTS ON LIPOPLEX BEHAVIOUR 
 
MEMBRANE EFFECTS ON LIPOPLEX BEHAVIOUR      121 
condition (10% serum), starved or treated with an increase in serum (20%) or external cholesterol. 
Previously this technique has been applied to study changes in membrane fluidity in response to 
drugs that altered membrane physiology 274.  
Previous studies that utilised the lipoplex reagent used in this project, have applied different 
serum concentrations (including 2.5% 276  5% 277 10% 276), all resulting in transgene expression. 
However, no study found utilised it in higher amounts of serum (i.e. 20%). Based on the 
transfection efficiency at different concentrations, it was found here that the optional condition was 
with 10% serum. Therefore, this condition was considered the control for the most efficient gene 
delivery in the model here. This observation was found in other studies, including Marchini et al. 
(2009) demonstrating that transfections were more efficient in the presence of 10% serum, 
compared to no serum at all. In their study, four different lipoplex regents were used, however in 
the absence of serum, the amount of gene expression was within 10% of populations containing the 
serum 278. It may be plausible that the presence of serum enhances gene delivery, as a study 
undertaken by Yoshikawa et al. (2011) identified that components of serum enhanced in vivo 
transfection of hepatocytes 279. 
Previously published work focusing on the effects of serum on gene delivery mostly 
explored the effects on delivery outcomes and changes in the molecular structure of the lipoplex 
itself, not how the lipoplex behaviours within the cellular environment. Zuhorn et al. (2002) 
provided an interesting insight on how altering the lipoplex’s exposure to serum can have an effect 
on gene delivery. In their study, lipoplexes were formed in the presence or absence of serum, then 
for those prepared in the absence of serum, were delivered to cells (COS-7) with or without serum 
280. It was found that lipoplexes were internalised 3-fold greater when prepared in the presence of 
serum, but transfection efficiency was 5-fold lower compared to those prepared in the absence of 
serum. The higher rate of internalisation could be due to the formation of smaller lipoplex structure 
in the presence of serum 281. Zuhorn et al. (2002) had also found that lipoplexes prepared in the 
presence of serum resulted in the DNA changing from supercoiled to an open form, potentially 
exposing it to nucleases which may explain the low transfection efficiency 280. 
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Cholesterol appears to have an influential role in the gene delivery process, however the only 
studies to-date have addressed how the presence of cholesterol within the lipoplex structure affect 
gene delivery 282. In addition, a study that applied CD (Circular Dichroism) spectroscopy to study the 
complexation of DNA to lipids in the formation of lipoplexes found that the DNA aggregates in the 
presence of high lipid and cholesterol content 259. 
Little to no work to date has explored how changing conditions can affect the behaviour of 
the delivered DNA. Escriou et al. (1998) reported that delivered DNA in cells in the absence of 
serum formed large clusters that were few in number 260. However, their study on aggregation was 
not quantitative, instead based on the intensity of fluorescence and physical size of clusters. In the 
work of this chapter, it was observed that aggregation in the absence of serum resulted in the least 
amount of aggregation. However, Escriou et al. (1998) had used a different cell line, DNA construct 
and lipid delivery approach. 
The work undertaken by Escriou et al. (1998) also highlights an overarching trend in the 
study of gene delivery, which is that differences are observed due to a number of factors that can be 
changed, including the cell line, delivery approach and DNA sequences. This was further 
demonstrated by Mirsa et al. (2013), whose work demonstrated that the composition of the lipids in 
lipoplexes used are pivotal in the successful delivery, under different culture conditions. Mirsa et al. 
manufactured a range of lipoplexes composed of different lipids, with some achieving better 
transfection efficacy with or without serum, some lipoplexes even demonstrating transfection in 
serum concentrations as high as 50% 283. 
In this chapter, the changes in flDNA dynamics and behaviour were explored by altering the 
membrane state and composition through different culture conditions. Through the application of 
the spectral phasor, RICS, N&B and iMSD approaches the work presented here demonstrates that 
changes in serum amounts (2.5%, 10% and 20%) or cholesterol (2-fold) altered the molecular 
behaviour reflecting changes in transfection efficiency. Prior to this study, the molecular dynamics 
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of delivered DNA have not been explored due to changes in culture conditions, and membrane 
physiology.  
 
CHAPTER SIX: CONCLUDING REMARKS 
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6 Concluding Remarks 
 
 
 
Throughout this thesis a number of FCS-based bioimaging approaches were applied in order 
to quantify and study the molecular behaviour of delivered flDNA in live cells. In this work two 
core hypotheses were addressed; firstly, that these bioimaging approaches can be applied to study 
the delivery process of exogenous compounds labelled with small molecular probes, and secondly, 
to gain a deeper understanding of DNA lipoplex dynamics as a model for the prior aim.  
The application of the FCS based bioimaging approaches employed throughout this thesis, 
enabled the molecular mechanisms of individual particles to be investigated of fluorescently labelled 
particles. As the fluorescently labelled particle passes through the focus illumination volume, each 
will provide a signal enabling dynamic information to be exacted for each particle. The correlation of 
the fluctuations over time, gives information on mobility, mechanism of transport, aggregation and 
interactions. To date, these approaches, including RICS, iMSD, N&B and their cross-correlation 
extensions, have been applied to study endogenously encoded proteins, which have been tagged 
with a fluorescent protein, commonly GFP.   
However, there is an interest in gaining an understanding of how exogenous compounds 
behave within cells. As such, the model presented in this thesis demonstrates the application of 
these bioimaging approaches to study live cell processes. In addition, this work utilised the small 
molecular probe, Alexa Fluor 488, which is a fraction of the size of GFP (with approximate 
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molecular weights to 570 and 26,900, respectively). The impact of the reduced flurophore size on 
the behaviour of labelled molecules is less likely to affect the behaviour of the particle of interest. 
  
 
Figure 6.1 -  Final  Overview 
Through the model devised in the thesis, it appeared that the delivered DNA followed a clear, redefined path through 
the cell, during normal physiology. The combination of RICS, N&B and iMSD demonstrated that that a slow 
mobility, and a high extent of aggregation would occur along the cell edge. Additionally, the main transport 
mechanisms included confined diffusion, transient confinement, and subdiffusion, exhibiting low, moderate and rapid 
degradative rates of the DNA, respectively. When within the cytoplasm, rapid, active transport was observed, resulting 
in little aggregation and degradation. Once localised within the peri-nuclear region, confined diffusion, transient 
confinement, and subdiffusion were again observed, however aggregation was lower, but degradation was higher. 
Finally, once within the nucleus only rapid mobility was observed, representing confined diffusion: likely due to the 
delivered DNA interacting within chromatin structures, or subdiffusion, possibly due to chromatin and nuclear 
structures acting as barriers. Within the nucleus, a low extent of aggregation was exhibited.  The combination of these 
techniques provides an insight into the processing of delivered DNA throughout the entire cell simultaneously.  
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The dynamics of the delivered compounds are of great interest, previous studies utilising 
characterization techniques, including FRAP, often lack sensitivity and are potentially disruptive to 
the live cell milieu, or SPT, which is highly sensitive albeit lacking the capacity to investigate events 
of the entire cell. However, the bioimaging tools applied here have provided both spatial and 
temporal information in a non-disruptive approach. The combination of flDNA within lipoplexes 
has been utilised as a model for the delivery of macromolecules, which exhibited a pathway 
predefined by the cell, involving a 5-phase process of (i) slow directed into the cell, (ii) confined 
motion along the edge of the cell, followed by (iii) fast directed motion along microtubules, (iv) non-
active motion within the peri-nuclear area, and then (v) confined- and sub-diffusion in the nucleus.  
This process through the cell appeared to go unchanged when the DNA size was altered between 
the 21bp to 5.5kbp range observed (approximately 12 to 3,300kDa).  
Through this model, certain behaviours and phenomena of the delivered compound are 
expected to occur in specific areas of the cell. For example, along the cell extremity, the flDNA 
exhibited poor mobility contributed to non-active transport mechanisms (including confined- and 
sub-diffusion). In addition, the cell extremity exhibited the greatest extent of aggregation and particle 
number, and a moderate amount of degradation. 
The flDNA within the core of the cytoplasm exhibited different behaviours compared to the 
cell extremity, and therefore, as a model within this area, a rapid mobility due to active transport 
would be expected. Additionally, this region lacked a great extent of aggregation, exhibited a low 
particle number and very little degradation. 
The model presented also demonstrated the importance of the nature of the cell. By 
changing the cellular physiology, changes in the flDNA behaviour were observed throughout the 
cell. Other factors must also be taken into consideration, as outlined throughout this thesis and the 
literature including: the cell type, cell cycle and the nature of the delivered compound (in this case, 
the DNA size) can play a pivotal role in how a delivered macromolecule behaves at the molecular 
scale in a live cell. 
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A process that was not addressed in this study was the differentiation between the DNA 
being processed by gene delivery processes, and the DNA nucleotides that have been degraded and 
being recycled by the cell. In nucleotide metabolism, salvage pathways recover degraded base pairs 
and nucleosides from DNA and RNA, in order to produce nucleotides 286. However, through the 
application of cross-correlation, it appears the DNA molecules labelled with two different probes 
cross correlate, thus enable intact and degraded DNA to be distinguished. Therefore, further work 
must be undertaken to gain a deeper understanding of these processes in live cells, although the 
work presented here sets the ground work to focus on nucleotide recycling.  
In conclusion, the research presented in this thesis presents a model to characterise the 
delivery of macromolecules, which could include DNA lipoplexes, drugs, nanoparticles and other 
nucleic acids such as non-coding RNAs, and micro RNAs. The techniques utilised provided spatial 
and temporal information of the entire live cell, of single, dynamics particles.  
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Supplementary Information 1 (SI 1) – DNA Label l ing Approaches  
Three DNA labelling approaches were explored: the use of an ULYSIS Nucleic Acid Labelling Kit 
(Alexa Fluor488) – this approach was used to label DNA plasmids, and the generation of DNA using 
fluorescently labelled primers, both homemade by labelling primers with an ULYSIS Nucleic Acid 
Labelling Kit, or purchased from Integrated DNA Technologies (IDT). SI-1 presents cells that were 
transfected with a 1000bp fragment. In SI-1A the DNA was generated through PCR and then labelled 
with the ULYSIS Nucleic Acid Labelling Kit, whereas in SI-1B the fragments were amplified with the 
IDT purchased Alexa Fluor488 labelled primer. 
Supplementary Figure 1 -  DNA Label l ing Approach 
As seen in the DNA labelled with the ULYSIS Nucleic Acid Labelling Kit the fluorescence signal was 
very high and while attempting to acquire data for FCS, RICS or N&B it would saturate the APDs. 
Therefore, this approach was not employed for the project. When labelling plasmids more DNA was 
labelled, and less labelling reagent was utilised than the manufacturer’s guidelines had stated.   
Supplementary Information 2 (SI 2) – Transfe c t ion Approaches  
Three different transfection reagents were screened: Lipofectamine 2000 (Invitrogen), X-treme Gene 9 
(Roche) and X-treme Gene HP (Roche). Of these three X-treme Gene 9 had demonstrated the most 
rapid uptake of the fluorescently labelled plasmid. Additionally, the X-treme Gene 9 had shown the 
least amount of cell death and toxicity.  
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Supplementary Figure 2 -  Lipofec t ion Approaches 
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PCI-Neo Vector Map 
 
Supplementary Figure 3 -  PCI-Neo Vector Map 
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PCI-Neo Sequence and Primer Hybridisation Sites 
TCAATATTGGCCATTAGCCATATTATTCATTGGTTATATAGCATAAATCAATATTGGCTATTGGCCATTGCA
TACGTTGTATCTATATCATAATATGTACATTTATATTGGCTCATGTCCAATATGACCGCCATGTTGGCATTG
ATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGTTCCGCGT
TACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGAC
GTATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTG
CCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTCCGCCCCCTATTGACGTCAATGACGGTAAATGG
CCCGCCTGGCATTATGCCCAGTACATGACCTTACGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTC
ATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACACCAATGGGCGTGGATAGCGGTTTGACTCACGGG
GATTTCCAAGTCTCCACCCCATTGACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAA
AATGTCGTAACAACTGCGATCGCCCGCCCCGTTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTC
TATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCACTAGAAGCTTTATTGCGGTAGTTTATCACAGTTA
AATTGCTAACGCAGTCAGTGCTTCTGACACAACAGTCTCGAACTTAAGCTGCAGTGACTCTCTTAAGGTAG
CCTTGCAGAAGTTGGTCGTGAGGCACTGGGCAGGTAAGTATCAAGGTTACAAGACAGGTTTAAGGAGACC
AATAGAAACTGGGCTTGTCGAGACAGAGAAGACTCTTGCGTTTCTGATAGGCACCTATTGGTCTTACTGAC
ATCCACTTTGCCTTTCTCTCCACAGGTGTCCACTCCCAGTTCAATTACAGCTCTTAAGGCTAGAGTACTTAAT
ACGACTCACTATAGGCTAGCCTCGAGAATTCACGCGTGGTACCTCTAGAGTCGACCCGGGCGGCCGCTTCC
CTTTAGTGAGGGTTAATGCTTCGAGCAGACATGATAAGATACATTGATGAGTTTGGACAAACCACAACTAG
AATGCAGTGAAAAAAATGCTTTATTTGTGAAATTTGTGATGCTATTGCTTTATTTGTAACCATTATAAGCTG
CAATAAACAAGTTAACAACAACAATTGCATTCATTTTATGTTTCAGGTTCAGGGGGAGATGTGGGAGGTTT
TTTAAAGCAAGTAAAACCTCTACAAATGTGGTAAAATCCGATAAGGATCGATCCGGGCTGGCGTAATAGCG
AAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGACGCGCCCTGTAGC
GGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGC
CCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGG
GCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTT
CACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGT
GGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTG
CCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTA
ACGCTTACAATTTCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATACGCGGAT
CTGCGCAGCACCATGGCCTGAAATAACCTCTGAAAGAGGAACTTGGTTAGGTACCTTCTGAGGCGGAAAG
AACCAGCTGTGGAATGTGTGTCAGTTAGGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGC
AAAGCATGCATCTCAATTAGTCAGCAACCAGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTAT
GCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAACTCCGCCCATCCCGCCCCTAACTCC
GCCCAGTTCCGCCCATTCTCCGCCCCATGGCTGACTAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTC
GGCCTCTGAGCTATTCCAGAAGTAGTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAAAAGCTTGATT
CTTCTGACACAACAGTCTCGAACTTAAGGCTAGAGCCACCATGATTGAACAAGATGGATTGCACGCAGGTT
CTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGC
CGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGA
ATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCT
CGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTC
ATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATC
CGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGG
TCTTGTCGATCAGGATGATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTC
AAGGCGCGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGG
TGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACAT
AGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTAC
GGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGAGCGGGACTC
TGGGGTTCGAAATGACCGACCAAGCGACGCCCAACCTGCCATCACGATGGCCGCAATAAAATATCTTTATT
TTCATTACATCTGTGTGTTGGTTTTTTGTGTGAATCGATAGCGATAAGGATCCGCGTATGGTGCACTCTCA
GTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGA
CGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGA
GGTTTTCACCGTCATCACCGAAACGCGCGAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAAT
GTCATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTG
TTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATAT
TGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTT
CCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGG
GTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATG
ATGAGCACTTTTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCAACTCGG
TCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATG
GCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCTG
ACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTG
ATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAAT
GGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTG
SUPPLEMENTARY INFORMATION       V 
 
GATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGAT
AAATCTGGAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCC
GTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGAT
AGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAA
ACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGT
GAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTG
CGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCT
ACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTTCTTCTAGTGTAGCC
GTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGT
GGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCG
CAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTG
AGATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCG
GTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTAT
AGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCC
TATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGGCTC
GACAGATCT 
Primer Binding Sites: 
Yellow: FWD Primer 
Green: 120bp REV 
Cyan: 240bp REV 
Red: 492bp REV 
Purple: 1,000bp REV 
Blue: 1,985bp REV 
AseI restriction site highlighted in grey 
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Supplementary Information 4 (SI 4) – RICS Analys i s  o f  DNA in so lut ion 
 
Supplementary Figure 4 -  RICS Analys is  o f  DNA and Lipoplexes in Solut ion 
SI 4A presents the values of the DNA and DNA lipoplex diffusion on solution analysed through RICS. 
The values include the mean, standard deviation and range observed. SI 4B shows a box and whisker 
plot of these values, showing the first and third quartile and the range observed for each fragment as 
naked DNA and lipoplexes.  
SUPPLEMENTARY INFORMATION       VII 
 
Supplementary Information 5 (SI 5) – Cytoplasmic  Values  o f  DNA 
Mobi l i ty  
Supplementary Figure 5 -  Cytoplasmic Mobi l i ty  o f  Transfec ted DNA Lipoplexes  
(A) The mean, standard deviation, variance and upper and lower ranges of the cytoplasmic localised 
DNA has been presented for the global and ROI analysis. (B) The mean mobility obtained in the ROI 
analysis has been plotted in a scatter plot demonstrating the size dependent mobility of the DNA. (C) 
Statistical analysis was performed using a T Test assuming unequal variances showing that the global 
analysis resulted in mobility rates that were statistically insignificant from each other. However, in the 
ROI analysis, the mobility of most fragments was statistically significant. (D) The values obtained in the 
ROI analyses representing the cell position and cluster size have been presented, in addition an example 
of different cluster sizes in a cell (E). 
SUPPLEMENTARY INFORMATION       VIII 
 
Supplementary Information 6 (SI 6) – Mechanisms o f  Motion 
Supplementary Figure 6 -  Values for  the Mechanisms o f  Motion 
The mean, standard deviation, variance and upper and lower range values for the different mechanisms 
of motion including random diffusion (A), active transport (B), anomalous subdiffusion (C), confined 
diffusion (D), transient confinement (E) and binding-unbinding (F). (G) The spatial distribution of the 
mechanisms of motion has been presented for all of the DNA fragment sizes. 
 
SUPPLEMENTARY INFORMATION       IX 
 
Supplementary Information 7 (SI 7) – Examples  o f  Cel l s  
 
Supplementary Figure 7 -  Examples o f  Cel l s  
A cell example for each DNA fragment including 21bp (A), 120bp (B), 240bp (C), 495bp (D), 1000bp 
(E), 1985bp (F) and, linear (G) and circular (H) plasmid has been presented. Each example has ROIs 
selected representative of the different mechanisms of motion identified in each cell. In addition 
summaries of the types of mechanisms found and range of motion observed have been presented. 
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Supplementary Information 8 (SI 8) – Summary o f  Nuclear Dynamics 
 
  
Mobility 
N 
  
Mean 
Mobility 
(um2/s) 
Standard 
Deviation 
Range 
  
Min Max 
D
N
A
 B
as
e 
P
ai
rs
 
21 3.67 3.07 0.28 14.09 1.27 
120 1.63 1.40 0.19 6.01 2.17 
240 2.31 1.81 0.03 7.72 3.17 
495 2.12 1.34 0.18 5.07 1.84 
1000 2.65 2.46 0.08 11.90 1.63 
1985 1.79 2.13 0.11 10.50 1.36 
5485 (Linear) 1.31 1.31 0.07 3.73 0.44 
5485 
(Circular) 2.30 3.79 0.01 14.40 0.18 
 
Supplementary Information 9 (SI 9) – Examples  o f  Internal i sat ion Event 
 
Six different internalisation (in each row) events have been presented at different stages of 
internalisation. Over the event an accumulation of the DNA lipoplex was observed (A), then the DNA 
slowly accumulates into a single cluster (B-E), until a clearly defined cluster/aggregation was seen (F). 
The cluster then further accumulates DNA (G), before being internalised (H). All stages have two 
images, the B map (left) and intensity map (right). 
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Supplementary Information 10 (SI 10) – Spat ia l  Aggregat ion and Dif fus ion 
 
 
Cell Extremity Cytoplasm Peri-nuclear 
 
Max B 
Avg 
B 
Avg 
N D Max B 
Avg 
B 
Avg 
N D Max B 
Avg 
B 
Avg 
N D 
Average 6.491 2.224 2.468 0.077 4.792 1.892 1.795 0.181 5.123 1.774 1.266 0.079 
Std. Dev. 3.301 0.947 2.116 0.067 2.501 0.800 1.315 0.136 2.352 0.553 0.747 0.062 
Min 2.435 1.224 0.347 0.000 2.272 1.208 0.345 0.024 2.074 1.116 0.197 0.000 
Max 15.302 5.513 6.948 0.228 10.063 4.717 7.134 0.795 9.849 2.965 2.746 0.254 
D
at
a 
V
al
ue
s 
2.435 1.224 0.585 0.020 2.485 1.381 0.889 0.281 2.272 1.219 0.409 0.069 
2.747 1.265 0.797 0.228 2.272 1.301 0.590 0.399 2.074 1.161 0.496 0.149 
11.582 5.513 1.412 0.200 3.012 1.564 0.779 0.191 2.239 1.134 0.261 0.188 
7.547 2.327 0.772 0.096 6.410 2.150 0.637 0.153 6.218 1.277 0.227 0.254 
4.626 2.344 1.668 0.099 3.297 1.526 0.689 0.298 3.023 1.116 0.197 0.149 
4.571 1.989 1.196 0.157 3.962 1.318 0.345 0.159 2.680 1.212 0.296 0.016 
13.060 3.740 1.436 0.000 2.549 1.350 1.443 0.135 6.444 1.692 1.563 0.091 
4.835 1.735 0.453 0.072 2.858 1.408 1.572 0.187 4.341 1.628 2.134 0.034 
5.322 1.970 1.489 0.109 8.540 2.581 1.767 0.237 9.727 2.338 0.736 0.092 
5.408 1.980 1.542 0.035 2.599 1.252 0.983 0.164 7.146 2.403 0.762 0.004 
4.535 1.940 1.116 0.062 9.654 3.084 3.012 0.024 4.507 1.562 1.530 0.126 
15.302 2.177 0.347 0.068 3.172 1.505 2.204 0.092 6.169 2.744 2.142 0.061 
5.924 2.163 4.862 0.121 4.507 1.652 1.804 0.138 9.849 2.965 1.354 0.101 
5.055 1.979 6.114 0.067 2.975 1.617 1.519 0.147 5.693 1.925 1.258 0.112 
4.789 2.097 4.588 0.186 3.526 1.596 1.819 0.115 4.066 1.704 1.513 0.005 
7.158 2.305 3.571 0.019 3.851 1.522 2.101 0.107 8.159 2.256 2.029 0.009 
6.861 1.885 6.948 0.047 3.277 1.401 1.102 0.169 3.232 1.323 0.966 0.013 
4.822 1.476 1.916 0.015 8.798 3.134 0.617 0.105 6.412 1.930 1.067 0.049 
10.249 2.183 5.045 0.010 6.400 1.597 2.822 0.179 3.492 1.501 1.891 0.085 
2.760 1.234 6.369 0.015 4.587 1.851 2.017 0.100 7.667 2.866 1.762 0.057 
4.208 1.351 2.876 0.021 4.587 1.830 2.007 0.105 3.671 1.579 0.978 0.070 
7.747 3.157 0.561 0.125 10.063 4.717 0.777 0.250 3.949 1.674 1.327 0.111 
7.761 3.108 1.092 0.000 8.413 3.817 2.270 0.235 2.571 1.381 2.669 0.049 
    
8.797 2.479 2.301 0.073 4.446 1.635 1.325 0.077 
    
6.085 1.811 2.131 0.133 8.039 2.118 2.746 0.000 
    
2.942 1.386 1.631 0.119 
    
    
9.279 2.640 2.355 0.122 
    
    
2.655 1.441 1.241 0.089 
    
    
3.422 1.633 0.867 0.119 
    
    
3.246 1.352 1.651 0.338 
    
    
2.499 1.208 1.249 0.121 
    
    
4.178 1.759 7.134 0.109 
    
    
3.248 1.579 4.920 0.795 
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Supplementary Information 11 (SI 11) – Changes  in Aggregat ion due to  Serum Concentrat ion 
 
 
Starved 10% Serum 20% Serum 
 
Extremity Cytoplasm Perinuclear Extremity Cytoplasm Perinuclear Extremity Cytoplasm Perinuclear 
 
Avg 
B 
Max 
B 
Avg 
N 
Avg 
B 
Max 
B 
Avg 
N 
Avg 
B 
Max 
B 
Avg 
N 
Avg 
B 
Max 
B 
Avg 
N 
Avg 
B 
Max 
B 
Avg 
N 
Avg 
B 
Max 
B 
Avg 
N 
Avg 
B 
Max 
B 
Avg 
N 
Avg 
B 
Max 
B 
Avg 
N 
Avg 
B 
Max 
B 
Avg 
N 
Mean 4.291 1.632 1.666 5.154 1.705 2.086 4.703 1.635 2.775 6.491 2.224 2.468 4.792 1.892 1.795 5.123 1.774 1.266 9.132 2.701 1.324 7.357 2.464 2.084 6.483 2.187 1.884 
Std. 
Dev. 1.844 0.492 1.646 2.329 0.570 1.771 2.995 0.468 2.237 3.301 0.947 2.116 2.501 0.800 1.315 2.352 0.553 0.747 7.273 1.911 0.851 5.354 1.789 2.869 5.336 1.337 1.717 
Min 2.252 1.155 0.148 2.124 1.109 0.107 0.496 1.061 0.094 2.435 1.224 0.347 2.272 1.208 0.345 2.074 1.116 0.197 2.328 1.215 0.296 2.003 1.047 0.190 2.195 1.104 0.419 
Max 9.743 3.201 5.366 10.25 3.753 6.065 14.31 2.964 9.926 15.30 5.513 6.948 10.06 4.717 7.134 9.849 2.965 2.746 27.26 9.013 3.851 22.03 8.096 13.44 25.13 5.845 6.724 
D
at
a 
V
al
ue
s 
3.310 1.386 0.387 9.765 1.919 0.919 3.981 1.304 0.824 2.435 1.224 0.585 2.485 1.381 0.889 2.272 1.219 0.409 21.22 5.969 0.521 3.260 1.179 0.190 2.401 1.104 0.709 
3.618 1.321 0.446 7.282 1.386 1.050 2.023 1.112 0.626 2.747 1.265 0.797 2.272 1.301 0.590 2.074 1.161 0.496 15.51 5.196 0.916 11.23 5.262 0.459 2.722 1.104 0.460 
4.801 1.510 0.148 10.25 3.753 2.756 2.151 1.066 0.405 11.58 5.513 1.412 3.012 1.564 0.779 2.239 1.134 0.261 6.864 2.308 2.918 7.753 1.297 0.260 2.624 1.220 0.575 
4.871 1.770 0.509 2.255 1.160 0.776 2.389 1.147 0.498 7.547 2.327 0.772 6.410 2.150 0.637 6.218 1.277 0.227 21.12 4.423 1.157 2.660 1.075 0.729 2.244 1.179 0.640 
5.028 2.053 0.983 5.799 1.725 1.186 3.012 1.348 0.497 4.626 2.344 1.668 3.297 1.526 0.689 3.023 1.116 0.197 5.583 1.929 1.425 2.921 1.159 0.566 25.13 5.845 1.516 
2.749 1.233 0.407 3.405 1.139 0.458 3.031 1.234 0.506 4.571 1.989 1.196 3.962 1.318 0.345 2.680 1.212 0.296 5.480 1.911 0.296 3.382 1.047 0.243 5.926 1.447 1.562 
5.103 1.498 0.312 2.517 1.287 0.641 3.930 1.428 0.568 13.06 3.740 1.436 2.549 1.350 1.443 6.444 1.692 1.563 8.731 2.011 1.176 3.828 1.559 0.662 3.185 1.245 0.419 
3.508 1.400 0.548 2.124 1.183 1.090 2.611 1.270 0.282 4.835 1.735 0.453 2.858 1.408 1.572 4.341 1.628 2.134 3.277 1.510 0.666 6.322 1.781 1.578 2.532 1.177 0.466 
2.901 1.258 0.712 2.146 1.110 0.225 2.721 1.068 0.130 5.322 1.970 1.489 8.540 2.581 1.767 9.727 2.338 0.736 4.846 1.840 0.761 3.828 1.350 0.533 6.269 1.461 0.911 
2.412 1.224 0.940 2.663 1.109 0.192 3.662 1.300 0.560 5.408 1.980 1.542 2.599 1.252 0.983 7.146 2.403 0.762 4.111 1.757 0.645 2.354 1.180 0.809 3.944 1.597 1.104 
2.451 1.155 0.307 2.457 1.118 0.124 2.023 1.061 0.197 4.535 1.940 1.116 9.654 3.084 3.012 4.507 1.562 1.530 21.62 4.283 1.589 16.90 2.773 0.951 2.662 1.286 0.531 
3.276 1.214 0.455 2.387 1.158 0.261 3.119 1.185 0.094 15.30 2.177 0.347 3.172 1.505 2.204 6.169 2.744 2.142 2.328 1.260 0.644 8.668 2.492 2.106 16.20 4.954 0.706 
2.917 1.169 0.346 6.607 2.297 0.750 3.906 1.557 1.546 5.924 2.163 4.862 4.507 1.652 1.804 9.849 2.965 1.354 3.064 1.278 0.745 3.350 1.350 0.512 2.195 1.258 1.244 
3.284 1.176 0.196 5.886 2.391 1.518 0.496 1.733 1.845 5.055 1.979 6.114 2.975 1.617 1.519 5.693 1.925 1.258 2.766 1.215 1.152 2.662 1.329 0.548 2.411 1.295 0.933 
2.634 1.244 0.231 2.883 1.448 3.469 4.488 1.785 1.756 4.789 2.097 4.588 3.526 1.596 1.819 4.066 1.704 1.513 3.383 1.231 0.787 2.622 1.245 0.838 3.181 1.530 3.925 
4.265 1.389 2.501 3.135 1.425 2.144 4.070 1.606 4.478 7.158 2.305 3.571 3.851 1.522 2.101 8.159 2.256 2.029 27.26 9.013 1.605 2.113 1.152 0.706 4.138 1.453 5.550 
2.252 1.521 1.660 4.527 1.407 1.860 3.293 1.650 5.888 6.861 1.885 6.948 3.277 1.401 1.102 3.232 1.323 0.966 4.286 1.601 2.199 5.647 1.632 2.650 7.633 3.248 3.748 
6.607 1.871 0.401 3.237 1.297 2.133 3.419 1.730 4.849 4.822 1.476 1.916 8.798 3.134 0.617 6.412 1.930 1.067 11.24 2.954 0.744 2.850 1.172 0.584 5.776 1.955 2.647 
3.325 1.539 1.106 4.000 1.328 2.019 2.784 1.119 2.432 10.24 2.183 5.045 6.400 1.597 2.822 3.492 1.501 1.891 5.424 1.807 1.721 2.850 1.220 0.476 6.220 2.125 2.566 
3.532 1.617 3.403 5.180 1.764 3.223 2.073 1.143 2.220 2.760 1.234 6.369 4.587 1.851 2.017 7.667 2.866 1.762 10.83 3.098 1.172 2.264 1.217 0.837 12.43 3.467 1.006 
4.837 2.041 2.551 3.029 1.625 5.639 2.526 1.184 2.113 4.208 1.351 2.876 4.587 1.830 2.007 3.671 1.579 0.978 10.66 2.297 1.281 6.112 1.928 6.695 12.34 2.760 6.724 
4.981 2.595 2.284 4.487 1.637 3.310 3.930 1.571 4.196 7.747 3.157 0.561 10.06 4.717 0.777 3.949 1.674 1.327 3.711 1.717 2.479 13.06 4.069 4.598 6.431 2.968 1.622 
2.414 1.161 5.324 4.333 1.882 4.373 4.648 1.612 5.505 7.761 3.108 1.092 8.413 3.817 2.270 2.571 1.381 2.669 6.678 1.525 3.851 2.003 1.153 10.27 3.706 1.446 0.946 
2.901 1.365 4.478 5.111 2.240 5.246 3.019 1.466 5.368 
   
8.797 2.479 2.301 4.446 1.635 1.325 
   
3.110 1.176 13.44 2.710 1.274 0.776 
3.421 1.592 5.366 6.526 1.576 0.750 6.778 2.722 2.201 
   
6.085 1.811 2.131 8.039 2.118 2.746 
   
4.448 1.560 2.166 3.848 1.505 2.646 
4.412 1.683 2.261 6.249 1.145 0.107 3.094 1.506 5.543 
   
2.942 1.386 1.631 
      
8.265 2.596 0.512 8.812 2.431 1.280 
3.374 1.467 4.965 9.144 2.281 3.107 4.173 1.546 5.119 
   
9.279 2.640 2.355 
      
17.99 7.812 1.996 5.866 1.892 1.617 
8.675 2.727 0.947 6.882 2.196 3.774 4.601 1.635 3.181 
   
2.655 1.441 1.241 
      
19.03 6.060 1.270 15.37 5.124 1.940 
9.743 3.201 1.717 7.635 2.738 0.735 5.773 2.086 5.562 
   
3.422 1.633 0.867 
      
5.197 2.590 1.101 9.074 4.069 5.864 
6.189 1.837 0.909 8.814 1.743 0.823 13.30 2.268 5.109 
   
3.246 1.352 1.651 
      
9.722 2.713 7.320 
   6.599 2.222 2.195 3.521 1.163 0.273 4.709 1.914 9.926 
   
2.499 1.208 1.249 
      
11.98 3.065 1.759 
   6.914 1.784 4.302 4.463 1.276 0.271 4.665 1.515 1.316 
   
4.178 1.759 7.134 
      
6.585 2.182 0.705 
   
   
8.968 2.299 2.942 10.26 2.058 1.289 
   
3.248 1.579 4.920 
      
7.437 2.039 3.260 
   
   
4.776 1.981 6.065 8.762 1.941 2.119 
            
10.23 3.244 1.359 
   
   
6.178 1.888 3.593 4.295 1.293 1.987 
            
10.23 3.812 1.009 
   
   
6.465 2.265 5.325 6.595 2.324 4.820 
            
22.03 8.096 0.237 
   
   
5.593 1.736 4.062 14.31 2.964 2.046 
            
9.414 2.918 2.053 
   
      
11.16 2.070 4.091 
            
15.19 4.135 3.187 
   
      
5.996 2.290 4.723 
                  
      
6.523 2.210 4.425 
                  
      
4.497 2.024 2.942 
                  
SUPPLEMENTARY INFORMATION        XIII 
Supplementary Information 12 (SI 12) – Solut ion Size Dependent  
Aggregat ion 
 
Base Pair Avg B Max B 
120 1.32 56.17 
240 1.57 72.95 
495 1.69 72.58 
1000 1.21 75.95 
1985 1.06 88.22 
Linear - 5485 1.34 79.44 
Circular - 5485 1.17 86.51 
 
Supplementary Information 13 (SI 13) – Cytoplasmic  Size Dependent  
Aggregat ion 
 
 
DNA Size Avg B Max B Avg N 
8 Hr 
120 1.17 13.41 0.44 
240 1.18 17.71 0.52 
495 1.05 11.59 0.40 
1000 1.08 11.79 0.38 
1985 1.11 7.09 0.57 
5485 1.05 7.74 0.68 
5485 1.29 27.78 0.29 
     
 
DNA Size Avg B Max B Avg N 
24Hr 
120 1.19 7.31 0.71 
240 1.21 11.59 0.71 
495 1.08 7.36 0.36 
1000 1.06 6.77 0.38 
1985 1.19 5.59 1.59 
5485 1.02 5.55 0.81 
5485 1.03 6.68 0.73 
 
 
 
 
SUPPLEMENTARY INFORMATION       XIV 
 
Supplementary Information 14 (SI 14) – c cRICS Contro ls :  Bleed through 
check 
 
Description Green Channel Red Channel Cross  
 
G0 D1 G0 D1 G0 D1  
Green primer alone 
0.003196 40.48 0.000158 35.43    0.00344 35.18 0.000232 5.35 0.0002115 12.77  0.003803 59.68   0.0002944 81.42  0.003468 43.06      0.003704 57.37      
   0.024488 58.80    
Red primer alone 
  0.026006 59.24    
  0.025128 52.27    
  0.025285 69.00    
   0.024517 59.35    
Both primers together 
0.006421 57.61 0.032504 67.92    0.006659 81.64 0.034084 57.40    0.006693 58.94 0.030869 59.54   Ratio 
Cross/ch1,ch2 0.006688 59.98 0.033285 61.88   
Dual labelled DNA 
0.00601 36.07 0.031028 71.94    0.153118 13.06 0.237726 12.89 0.145792 10.05 0.75 
0.168629 18.29 0.254659 11.59 0.160024 9.94 0.76 
0.168202 16.76 0.25507 12.48 0.1752375 9.39 0.83 
0.161089 16.62 0.240512 11.46 0.17793 9.70 0.89 
0.161865 15.68 0.246243 11.92 0.1615108 8.04 0.79 
Digested DNA 
0.004898 30.54 0.008227 13.66   0.00 0.004972 30.77 0.018781 10.87   0.00 0.004669 28.21 0.007516 13.69 0.000491 22.11 0.08 
0.004394 19.92 0.007134 11.63 0.000538 8.66 0.09 
0.003997 29.93 0.006393 15.07 0.000423 9.32 0.08 
0.003869 22.27 0.006044 12.06   0.00 0.003537 20.19 0.005749 14.19 0.00011 10.39 0.02 
* Absence of a value represents zero 
When primers were imaged alone, or together no or very little cross-correlation was observed. Only 
significant cross-correlation was determined when the primers were used to produce the dual labelled 
DNA, as all cross-G0 values were >75% of the green and red channel G0 averages. When degraded 
this ratio was <9%, or no cross-correlation was observed at all. 
 
 
 
 
SUPPLEMENTARY INFORMATION       XV 
 
Supplementary Information 15 (SI 15) – PCR of  Cel l  Fract ions 
 
(A) Standards were run of various amount of DNA using the PCI-Neo plasmid as a template. 
Following delivery of the 495bp fragment cytoplasmic and nuclear extracts were obtained after 8h (B) 
and 24h (C). DNA was always present in the cytoplasm and at a greater amount compared to the 
nucleus, indicated by the earlier increase in fluorescence. (D) A high-resolution melt analysis was run in 
order to check for amplification specificity. All of the standards exhibited two peaks, at around 72 and 
85°C. The first peak was representative of the 495bp fragment amplified, whereas the later peak was 
due to the plasmid backbone present in the reaction. All positive samples demonstrated the first peak 
highlighted by a red allow, showing specific amplification. 
 
 
 
 
 
SUPPLEMENTARY INFORMATION       XVI 
 
Supplementary Information 16 (SI 16) – Spec tra l  Phasor 20% Serum 
 
 
No significant differences were observed between the control cells (maintained in 10% serum), and 
those maintained in 20% serum. Through the use of the spectral phasor approach, the spectrum of 
laurdan and nile red appear very similar between the two conditions throughout the cell. The images of 
the cells are coloured based on the linked cursors selected in the spectral phasor plots. 
